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Abstract 
In this thesis, a set of novel approaches has been developed by integration of Cased-
Based Reasoning (CBR) and Multi-Criteria Decision Making (MCDM) techniques. Its 
purpose is to design a support system to assist oncologists with decision making about 
the dose planning for radiotherapy treatment with a focus on radiotherapy for prostate 
cancer.  
CBR, an artificial intelligence approach, is a general paradigm to reasoning from past 
experiences. It retrieves previous cases similar to a new case and exploits the successful 
past solutions to provide a suggested solution for the new case. The case pool used in 
this research is a dataset consisting of features and details related to successfully treated 
patients in Nottingham University Hospital. In a typical run of prostate cancer 
radiotherapy simple CBR, a new case is selected and thereafter based on the features 
available at our data set the most similar case to the new case is obtained and its 
solution is prescribed to the new case. However, there are a number of deficiencies 
associated with this approach.  
Firstly, in a real-life scenario, the medical team considers multiple factors rather than 
just the similarity between two cases and not always the most similar case provides 
with the most appropriate solution. Thus, in this thesis, the cases with high similarity 
to a new case have been evaluated with the application of the Technique for Order of 
Preference by Similarity to Ideal Solution (TOPSIS). This approach takes into account 
multiple criteria besides similarity to prescribe a final solution. Moreover, the obtained 
dose plans were optimised through a Goal Programming mathematical model to 
improve the results. By incorporating oncologists’ experiences about violating the 
conventionally available dose limits a system was devised to manage the trade-off 
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between treatment risk for sensitive organs and necessary actions to effectively 
eradicate cancer cells.  
Additionally, the success rate of the treatment, the 2-years cancer free possibility, has 
a vital role in the efficiency of the prescribed solutions. To consider the success rate, 
as well as uncertainty involved in human judgment about the values of different 
features of radiotherapy Data Envelopment Analysis (DEA) based on grey numbers, 
was used to assess the efficiency of different treatment plans on an input and output 
based approach. In order to deal with limitations involved in DEA regarding the 
number of inputs and outputs, we presented an approach for Factor Analysis based on 
Principal Components to utilize the grey numbers. Finally, to improve the CBR base 
of the system, we applied Grey Relational Analysis and Gaussian distant based CBR 
along with features weight selection through Genetic Algorithm to better handle the 
non-linearity exists within the problem features and the high number of features.  
Finally, the efficiency of each system has been validated through leave-one-out 
strategy and the real dataset. The results demonstrated the efficiency of the proposed 
approaches and capability of the system to assist the medical planning team. 
Furthermore, the integrated approaches developed within this thesis can be also applied 
to solve other real-life problems in various domains other than healthcare such as 
supply chain management, manufacturing, business success prediction and 
performance evaluation.   
Keywords: CBR; MCDM; Radiotherapy dose planning; Organs at risks; TOPSIS; 
Goal Programming; DEA; FA; Grey numbers; GRA; Gaussian distance; Genetic 
Algorithm. 
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Chapter 1 
Introduction 
This thesis investigates the application of Multi-Criteria Decision Making (MCDM) 
techniques in hybridization with Cased-Based Reasoning (CBR) method to propose 
novel approaches to solve the radiotherapy dose planning problem for prostate cancer. 
The dataset available to this thesis, in order to test and measure the efficiency and 
applicability of the approaches, is provided by Nottingham University Hospital. The 
approaches developed in this thesis are all applied to the radiotherapy dose planning 
for the first time and are generic and transferable. These approaches can deal with the 
multicriteria nature of the problem at hand and furthermore, their applicability to other 
domains is possible through additional problem design. This chapter provides a brief 
background on the problem, the motivation for the research, research objectives and 
overall layout of the thesis.  
1.1 Background 
Cancer can be defined as a disease in which a group of cells in a part of the body 
proliferate uncontrollably despite the normal trends of cell division. Normal cells 
receive signals which indicate whether they should divide, transform or die, while 
cancer cells develop a degree of autonomy from mentioned signals which results in the 
overgrowth of them. This uncontrolled growth, if left untreated can be fatal to the 
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patient as the tumours created by abnormal proliferation can spread throughout the 
body (1). Cancer is usually named after the organ on which its growth was initiated. 
As an example, if the first cancer cells are being developed in lungs, the cancer is called 
lung cancer. Although it is not still of certainty and it remains impossible to indicate 
what makes a person develop cancer, there are factors contributing to increased risk of 
developing cancer. Apart from age which cannot be controlled, alcohol, being exposed 
to cancer-causing substances (chemical substances mostly), sunbeams, tobacco, 
chronic inflammation, hormones, diet, radiation, infectious agents, obesity and 
immunosuppression are the main contributors increasing the risk of developing cancer 
(2). 
Cancer represents a major healthcare concern, both in the UK and globally. Every two 
minutes someone in the UK is diagnosed with a form of cancer (3).  Mortality rates of 
cancer make it a substantial cause of death among people and a significant concern to 
researchers. In 2012, cancer caused 8.2 million loss of life: 4.7 million (57%) in males 
and 3.5 million (43%) among females (4). The highest cancer mortality rate in males 
(210 per 100,000) belongs to Armenia, while Zimbabwe possesses the highest rate 
among female population (146 per 100,000) (2012) (4). 
In the year 2012, UK ranked 56th out of 84 countries worldwide regarding the cancer 
mortality rate among males, while the similar rank for females was 36th. 163,444 deaths 
by cancer have occurred in the UK in 2014 of which more than 46% have been due to 
lung, bowel, prostate and breast cancer. Furthermore, 368,560 new cancer cases have 
been diagnosed in the UK in 2014. The fact that more than 29% of the total deaths in 
2011 in the UK has been caused by cancer can give us a better understanding of the 
significance of this class of diseases (3). Prostate cancer is the second most common 
cancer for adults in the UK and the most common cancer type for men in the UK. 
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Approximately 46,700 men are diagnosed with prostate cancer in the UK each year. 
That reflects 130 cases each day (3).  
1.2 Motivation 
The human body is a complex system and usually, tumours are located in close 
proximity to sensitive tissues or critical organs; thus, making the treatment planning an 
equally complex task. Radiotherapy is one of the major approaches to treat cancer 
patients.  All radiotherapy types involve risk because even a small error in treatment 
planning, delivery, or dosimetry can lead to negative consequences (5). Radiotherapy 
treatment planning involves different stages and dose planning, the process of 
determining the precise effective dose plan to be delivered to tumours and surrounding 
area, is among the most important of them. Applying doses higher than necessary may 
lead to surrounding organ damages and applying doses less than the effective amount 
may lead to an incomplete tumour and cancer cells removal (6).  
There has been much software developed to facilitate the task of treatment planning 
and are available in system planning markets. However, the radiotherapy process is 
performed differently in each hospital; thus, software is often specialized to find the 
treatment planning characteristics in different forms of outputs and based on different 
approaches. For example, in the Nottingham University Hospital oncologists consider 
a fixed number of beams (i.e. four beams) in prostate cancer treatment radiotherapy 
and therefore a software compatible with this approach is needed. Brainlab, Elekta, 
Philips, Prowess and Raysearch are among the most recognized software providers 
available in the market. Radiotherapy planning and the precise identification of values 
for different variables of the treatment is essentially an optimization process. However, 
the search space of this optimization problem is enormous and as a result, software 
applications commonly struggle with the problem of coming up with the global or near-
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global optimum solution. When it comes to dose planning the final goal of the 
optimization procedure is to find highly effective, but not excessive and harmful, 
uniform dose values over the organ under radiotherapy to maximize the success rate of 
the cancer treatment (6).  
Data imaging and information gathered from various simulation procedures form the 
basis of optimization algorithms in radiotherapy optimization software packages. 
However, due to numerous environmental factors in the radiotherapy process and 
complexities of human body organs, anticipating the outcome of a treatment plan is a 
highly difficult task, if not impossible. As a result, the success rate of a treatment plan 
can be significantly uncertain and it affects the confidence of oncologists in using the 
optimization packages (7). On the other hand, past oncologists’ experiences can be 
extremely insightful in assisting researchers to anticipate the success rate of the 
treatment to some approximation.  
The knowledge-based reasoning is a set of approaches that can utilize the previous 
knowledge gained by oncologists to new cases of patients (8). Thus, many researchers 
have focused on Cased-Based Reasoning, rule-based reasoning and hierarchical 
organization of knowledge to develop approaches which capture the experience gained 
by oncologists and generalize it to improve the treatment plan for a new cancer patient. 
However, still many issues and gaps have not been covered in the existing literature. 
The existing quantitative methods in the literature are commonly mathematical models 
or search algorithms which try to find an optimal solution in the search space area by 
just considering the amount of dose which is going to be radiated to the organ (a 
comprehensive list of research within this context can be found in table 2.3).  There is 
lack of methods which considers multi-attribute nature of the dose planning problem 
and this was the main motivation of this PhD thesis. It is important to consider that, 
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complexities involve in health care decisions, necessitate the trade off between 
multiple and often conflicting criteria (9). Moreover, the literature is missing case 
evaluations based not only on the similarity measure of knowledge-based approaches 
but also on other available criteria. Consideration of multiple criteria results in 
consideration of multiple similar cases, and this increases the chance of obtaining better 
results by increasing the number of potential solutions (10).   
1.3 Objectives 
In this thesis, a decision support procedure based on the integration of MCDM 
techniques with CBR method has been developed for radiotherapy dose planning in 
prostate cancer. After a complete investigation of the radiotherapy dose planning 
problem, the literature related to this problem and the existing approaches developed 
and proposed to improve the accuracy of the treatment plan the following objectives 
have been defined and will be followed within this thesis:  
1- To investigate the radiotherapy treatment planning and review the state-of-the-art 
literature with a focus on operational research approaches for radiotherapy dose 
planning of prostate cancer (chapter 2). 
2- To explore the decision-making principles based on which oncologists decide in 
real-life scenarios and multi-criteria nature of the problem and incorporate them in a 
Decision Support System (DSS) to assists oncologists with their decisions (chapter 3, 
5 and 6).     
3- To model a mathematical programming model which can direct the final doses 
towards optimal dose plans considered by oncologists and increase the efficiency of 
the dose plans while simultaneously looking after the risks of the treatment (chapter 
4).  
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4- To incorporate the existing uncertainties in oncologists’ judgments about the values 
of different criteria and factors in dose planning and thus making the evaluations and 
models closer to real-life scenarios (chapter 5).  
5- To develop a mechanism to assign optimal non-objective importance weight to each 
feature of the radiotherapy dose planning problem (chapter 6). 
1.4 Layout of the thesis 
This thesis is comprised of 7 chapters that are structured as follows (Figure 1.1): After 
this brief introductory chapter, the thesis continues with the second chapter focused on 
radiotherapy prostate cancer problem explanation and literature review on application 
of operation research in radiotherapy treatment planning. In chapter 3, a hybrid 
application of Cased-Based Reasoning and TOPSIS to prostate cancer radiotherapy 
dose planning is presented. Chapter 4 proposes a novel integrated Goal Programming 
optimization and case-base reasoning approach to optimize the doses in radiotherapy. 
In chapter 5 we develop an approach of Interval-valued Factor Analysis for variable 
reduction in grey Data Envelopment Analysis and its application in radiotherapy dose 
planning. Chapter 6 introduces two new similarity measures with better effectiveness 
for the data type used in this dissertation. A featuring weight mechanism through 
Genetic Algorithm has been embedded in each similarity calculation approach to find 
the optimal feature weights and increase the number of successful case retrieval. 
Finally, Chapter 7 includes the conclusion, limitations and suggested future works 
related to this research. This thesis can be divided into three main parts of introduction 
and literature review, the main body of empirical and methodological research and 
outputs and finally conclusion section. In figure 1.1 these three parts have been 
separated by a dashed line and where there is an original contribution of this research, 
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it is highlighted in grey and otherwise, where it exists in the literature it is shown in 
white. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1: Introduction 
A summary on background 
of the research 
Layout of the thesis and 
introduction of the chapters 
Motivation and research 
questions 
Chapter 2: Literature review and radiotherapy planning problem 
Radiotherapy planning problem 
and treatment approaches 
Methodologies applied in the 
literature for different sub-problems 
P
a
rt
 o
n
e 
Chapter 7: Conclusion, limitations and future researches 
Highlights of the contributions and 
limitations 
Suggestions for future research 
directions  
P
a
rt
 t
h
re
e 
Chapter 3: A Novel hybrid TOPSIS and CBR approach for radiotherapy in prostate cancer 
Introduction on 
prostate cancer 
radiotherapy, dose 
planning problem and 
Euclidian CBR 
TOPSIS evaluation for 
the most similar cases 
extracted 
A rule based system to 
modify the prescribed 
doses 
 Chapter 4: A Goal Programming-CBR model to optimize the dose planning for radiotherapy 
TOPSIS evaluation for the most 
similar cases extracted 
Goal Programming Model to 
move the prescribed doses 
toward optimal amount based 
on DVHs 
Chapter 5: Interval valued FA for unnecessary data reduction in DEA and its application in 
radiotherapy for prostate cancer 
Application of interval 
value grey data in 
expressing oncologists 
opinion 
Developing FA for 
grey data based on 
interval valued PCA 
and varimax rotations 
Applying interval 
DEA to evaluate the 
treatment plans and 
considering the 
success rate of the 
treatment 
P
a
rt
 t
w
o
 
Chapter 6: A combinatorial similarity measure of GRA and Gaussian distance for CBR with GA 
feature weight assigning 
Developing new similarity 
measures by GRA and Gaussian 
distance CBR 
Assigning optimal weights to each 
feature of the CBR by GA and 
minimizing a dose difference 
objective function 
Figure 1.1 Overview of the thesis and contributions 
9 
 
1.5 Summary of the chapters 
In this section, the summary of each chapter is given in order to lead the reader to a 
better understanding of the problem. 
Chapter 2 ‘Literature review and radiotherapy problem explanation’: In this chapter, 
an overview of the magnitude and importance of the cancer diseases and in particular 
prostate cancer has been given. The treatment options, various type of radiotherapies, 
the treatment planning process and significant tasks related to it have been explained. 
Moreover, the methodologies related to different stages of the treatment planning and 
in detailed works in the literature about the application of operational research and 
knowledge-based techniques have been reviewed. 
Chapter 3 ‘A novel hybrid TOPSIS and CBR approach for radiotherapy in prostate 
cancer’: Complexity of dose planning for radiotherapy has turned this process into a 
time and resource consuming task. Usually, oncologists use past experience and spend 
a large amount of time to determine the optimal combination of dose in phase I and II 
of treatment. In this chapter, a novel TOPSIS (Technique for Order Preference by 
Similarity to Ideal Solution) Cased-Based Reasoning (CBR) approach is proposed to 
capture the past experience and expertise of oncologists. Initially, cases that resemble 
new case are extracted from the database. Thereafter, inferred cases are evaluated using 
TOPSIS, a multi-criteria decision-making approach, to prescribe an optimal dose plan. 
Within this chapter hybridization of Multi-Criteria Decision Making and knowledge-
based techniques has been utilized to improve the success rate of the CBR. Robustness 
of the proposed method is validated on data sets collected from the City Hospital 
Campus, Nottingham University Hospitals, NHS, UK, using leave-one-out strategy 
(the description of leave-one-out strategy can be found in chapter 3, section 3.6.2). In 
the experiment, the proposed methodology outperformed CBR approach. The 
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methodology is generic in nature and can help oncologists both new and experienced 
in dose planning process. 
Chapter 4 ‘A Goal Programming-CBR model to optimize the dose planning for 
radiotherapy’: The main objective of dose planning process is to deliver high dose to 
the cancerous cells and simultaneously minimize the side effects of the treatment. In 
this chapter, a novel Cased-Based Reasoning and Goal-Programming approach have 
been proposed to optimize the dose plan for prostate cancer treatment. Firstly, a hybrid 
retrieval process TOPSIS-CBR is used to capture oncologists’ experience. Thereafter, 
the dose plans of retrieved cases are adjusted using Goal-Programming Mathematical 
model. This approach will not only help oncologists to make a better trade-off between 
different conflicting decision-making criteria but will also deliver a high dose to the 
cancerous cells with minimal unavoidable effect on surrounding organs at risk. The 
efficacy of the proposed method is tested on a real dataset collected from Nottingham 
City Hospital using leave-one-out strategy. In most of the cases, treatment plans 
generated by the proposed method are coherent with the dose plan prescribed by an 
experienced oncologist or even better. Developed decision support system can assist 
both new and experienced oncologists in the treatment planning process. 
Chapter 5 ‘Interval valued Factor Analysis for variable reduction in grey Data 
Envelopment Analysis and its application in radiotherapy dose planning’: While in 
previous chapters and within the evaluation process all criteria were treated as the 
same, within this chapter they were divided into two groups of input and output. Also, 
we added an extra criterion of the success rate of the treatment which is based on the 
probability of return of cancer after treatment. Data Envelopment Analysis (DEA) is a 
non-parametric technique to evaluate the efficiency of a set of peer entities (options) 
in presence of several inputs and outputs of different types (11). 
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Here, DEA has been used to identify the best suited and efficient case among 
previously treated cases. In order to adopt the decision-making process close enough 
to real-world scenarios, we converted the outputs and inputs, considered for each case, 
to grey linguistic variables which can better justify the oncologists’ judgments and 
include the uncertainty within their understanding of different factors. Thus, the use of 
interval DEA become necessary within our problem. By including a higher number of 
outputs and inputs in the DEA model it becomes possible to investigate the efficiency 
of treatment plans from more points of view. However, the problem of discrimination 
between efficient and inefficient DMUs in DEA occurs, when the number of variables 
is large relative to the number of units. To this end, Factor Analysis (FA) was 
developed and applied, a variable reduction technique, for interval variables in 
particular for grey numbers based on Principal Component Analysis (PCA) to deal with 
the aforementioned problem.  
Chapter 6 ‘A combinatorial similarity measure of GRA and Gaussian distance for CBR 
with GA features’ weight assigning’: The non-linear relation between the clinical 
factors and solution of each case, the high number of clinical factors in comparison to 
the number of the cases in the case pool and the inability of Euclidean CBR in dealing 
with data distributions require the introduction of other similarity measures to obtain 
more precise and reliable results. In this chapter, a combined similarity measure by 
Grey Relational Analysis and Gaussian distance CBR was applied. Moreover, the 
features weights which also play an important role in case retrieval have been 
optimized by a proposed Genetic Algorithm to increase the success rate of the retrieval 
process. The individual and combinatorial performances of each approach have been 
thoroughly tested and compared to each other.    
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Chapter 7’Conclusion and future work’: In this chapter, a discussion about the 
effectiveness of the proposed approaches is done and a conclusion is presented to 
highlight the contributions of the thesis. Furthermore, the shortcomings of the thesis 
are being reviewed and future suggestions for the development of the research is 
presented.  
In the following the outcomes of this thesis in terms of publications have been 
mentioned: 
[1] Malekpoor, H., Mishra, N., Sumalya, S. and Kumari, S., 2017. An efficient 
approach to radiotherapy dose planning problem: a TOPSIS Cased-Based Reasoning 
approach. International Journal of Systems Science: Operations & Logistics, 4(1), 
pp.4-12. 
In communication: Malekpoor, H., Mishra, N., Kumar, S. A novel TOPSIS-CBR Goal 
programming approach to sustainable healthcare treatment. (2017) Annals of 
Operational Research (revised and resubmitted, minor revisions)  
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Chapter 2 
Literature review of radiotherapy planning problem for cancer 
2.1 Introduction 
Cancer is a crucial public health issue and a significant cause of morbidity and 
mortality, with around 14 million new cases diagnosed in 2012 and 8 million cancer-
related deaths in the same year which reached to 8.8 million in 2015, affecting 
populations in all countries and all regions (3). Cancer has been recognised as the 
second cause of death globally and is responsible for 1 out of every 6 deaths (12) and 
the number of new cases is expected to be raised by 70% in the next two decades. 
Cancer is a disease where cells in a particular segment of the body proliferate 
abnormally. Globally, the most common types of cancer are Lung, Breast, Colorectum 
and Prostate (Figure 2.1). 
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Figure 2.1 the most common cancer types diagnosed globally (13) 
 
 
The mortality rate of the cancer is not the same in different countries. Asia, Africa, 
Central America and South America are associated with 70% of the cancer occurrence 
and 60% of the cancer-related deaths (2).  The UK has 36th highest rate of mortality 
for females globally and among the European countries possesses a high mortality rate 
for both genders. Figure 2.2 illustrates the mortality age-standardized rate per 100 
thousand in a sample of European countries and as can be seen, the UK has the second 
rank after Denmark. 
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Figure 2.2 Mortality age-standardized rate of cancer in European countries (14) 
Usually, cancer begins in one part of the body and spread to the other parts affecting 
the functionality of the host and surrounding healthy organs. This process is known as 
metastasis. In metastasis, cancer cells separate from the primary location where they 
initially formed and move through the blood or lymph system and create new tumours 
(metastatic tumours) in other parts of the body. A metastatic tumour has similar 
characteristics to the primary tumour type (2). 
The initial phase of a cancer diagnosis is done through a lab test. High or low levels of 
certain substances in your body can indicate the presence of cancer. Thus, doctors seek 
assistance from lab tests of body fluids i.e. blood and urine in their diagnosis. However, 
as important as lab tests are, they are not the only source that doctors rely on. Imaging 
procedures are a set of useful diagnostic tools which create pictures of areas inside your 
body that help the doctors to see whether a tumour is present. Computerized 
0
20
40
60
80
100
120
140
160
1
9
7
5
1
9
7
8
1
9
8
0
1
9
8
1
1
9
8
3
1
9
8
5
1
9
8
8
1
9
9
0
1
9
9
3
1
9
9
5
1
9
9
8
2
0
0
0
2
0
0
3
2
0
0
5
2
0
0
8
2
0
1
0
Year
Denmark UK Finland France Spain
17 
 
Tomography scan (CT scan), Nuclear scan, Positron Emission Tomography scan (PET 
scan), Magnetic Resonance Imaging (MRI) and ultrasound are among the most 
common imaging procedure tools. CT scan uses X-rays to make detailed pictures of 
parts of the body and the structures inside the body (15). In CT scan, several beams are 
sent simultaneously from different angles. This allows highly detailed images from 
within the body to be interpreted by doctors. However, it cannot distinguish between 
normal and pathological cells.  
Therefore, MRI or in some cases a combination of MRI and Nuclear scans becomes 
necessary. MRI is a strong magnet linked to a computer that is used to make detailed 
pictures of areas in the human body. Also in Nuclear scans, a small amount of 
radioactive material is injected into the body. It flows through the bloodstream and 
accumulates in certain bones or organs. A scanning device detects and measures the 
radioactivity. The scanner creates pictures of bones or organs on a computer screen or 
on film. All the aforementioned tests are part of the diagnosis procedure and in order 
to reach a conclusive evidence about malignant cancer performing a Biopsy is essential 
(16). In Biopsy a small part of a tissue is removed as a sample to be further examined. 
A Pathologist then looks at the tissue under a microscope to confirm the existence of 
malignant cancer (17).  
Treatment options depend on the type, size and stage of cancer and moreover, whether 
it has spread throughout the body, the level of spread and the patient’s general health 
condition. Based on the abovementioned factors there exist a range of treatment 
methods that include surgery, chemotherapy or cancer drugs, hormone therapy and 
radiotherapy (2). Surgery is a primary treatment and is suggested by oncologists when 
the cancer is not spread and is in very first stages. In this treatment, the cancerous cells 
are physically removed. Chemotherapy literally means drug treatment (16). In cancer 
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treatment, it means using anti-cancer drugs to destroy cancer cells. One or a 
combination of several drugs is used to slow the growth or reducing the size of the 
tumours and in some more advanced cancer stages, it is done as a complementary 
treatment along with other treatment methods.  
Hormone therapy blocks or lowers the amount of hormones in the body to stop or slow 
down the growth of cancer and it is usually applied to treat hormone-dependent cancers 
such as breast and prostate cancer (18). Hormone therapy stops the natural hormone 
production or prevents hormones from making cancer cells grow and reproduce. In 
radiotherapy, Gamma or X-rays are used to kill cancerous cells. Radiotherapy 
annihilates the cancer cells in the treated area by impairing the structure of DNA within 
these cells. About 4 out of 10 people struggling with cancer (40%) are prescribed to 
perform radiotherapy as a part of their treatment (3). 
The purpose of radiotherapy is to eradicate cancer cells while causing as little damage 
as possible to healthy cells as radiations not only destroy the cancer cells but also affect 
the healthy surrounding cells which are exposed to it. The cells do not die at once and 
the process of dying usually takes up to a few weeks. During this period some of the 
damaged cells recover through reproduction. However, the recovery pace for healthy 
cells is much faster than the cancerous ones. Thus, the radiation is delivered to the 
patient in doses of approximately 2Gy each day over a course of several weeks to let 
the recovery of healthy cells be done appropriately. Gy (pronounced as Gray) is the 
unit to indicate the absorbed dose. One Gy is equal to one Joule (J) of energy deposited 
in one kilogram (kg) of matter (19). 
There are various methods of radiotherapy being performed in hospitals based on 
existing circumstances and in different conditions. Depending on where oncologists 
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locate the radiation during treatment, we can classify radiotherapy into three main 
categories of external beam radiotherapy, internal radiation therapy or Brachytherapy 
and systemic radiation therapy.  
In internal radiation therapy, the source of radiation is implanted inside the body in or 
near a tumour and depending on the cancer type and stage it could be temporary or 
permanent. In systemic radiation therapy, a radioactive drug (radiopharmaceuticals) 
through oral digestion or vein injection (IV) is delivered to the body (20). These kinds 
of drugs are sometimes bound to a special antibody (called a monoclonal antibody) 
that attaches to the cancer cells and it is more commonly in use for certain cancers, 
such as thyroid, bone, and prostate cancer. External radiation (or external beam 
radiation) is the most common type of radiation therapy used for cancer treatment (21). 
In this type of treatment, a machine called linear accelerator (Linac) aims high-energy 
rays (or beams) from outside the body into a tumour. Nowadays advancements in 
medical technologies allow oncologists to focus the beams with high precision on the 
tumours and thus reduce the side effects of treatment significantly (22). External beam 
radiotherapy is divided into several categories which are shown in table 2.1.  
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Table 2.1 Different types of external beam radiotherapy 
Method Description 
Three-dimensional 
conformal radiation 
therapy (3D-CRT) 
Radiation beams which are designed to match the tumour shape are delivered 
from different angles. The aim of this method is to deliver radiation to the 
gross tumour volume with a margin for microscopic tumour extension called 
the clinical target volume and a further margin uncertainty due to organ 
motion and setup variations called the planning target volume(23).  
Intensity modulated 
radiation therapy 
(IMRT) 
IMRT enables oncologists to create irregularities in the beam shapes and thus 
control the doses that conform to a tumour whilst simultaneously prevent 
damages to critical organs. Higher doses in necessary parts of the organ and 
lesser doses in some parts can significantly improve the results of the 
radiotherapy. Multi-leaf collimators are used to modulate the beam, by 
creating barriers in the beam path where necessary. This has improved the 
therapeutic ratio of the treatment for several tumour sites, such as head and 
neck cancers (24), prostate cancers(25) and gynaecological cancers (26).  
 
Image-guided 
radiotherapy 
(IGRT) 
IGRT is sort of a 3D-CRT in which imaging scans (e.g. a CT scan) are done 
prior to each treatment session. This allows the radiation oncologist to adjust 
the position of the patient to the most updated relevant position or alter the 
focus of beams to hit the essential targeted area of a tumour and restrain the 
extent of damages. This approach is becoming common in nearly all the 
IMRT treatments to increase the precision of the treatment (27). 
 
Proton beam 
radiation therapy 
In this method, proton beams are applied instead of electrons or x-rays. When 
proton beams are radiated to the body, they cause a minimal damage to the 
tissues they passed through, however they effectively eradicate the cells at the 
end of their path. This behaviour makes proton beams able to enhance the 
radiation delivery to the tumour target zone while reducing side effects on 
normal tissues. Special machines called cyclotron or synchrotron are used to 
put out the protons. Proton therapy is beneficial in particular to the patients 
with tumours near vital organs, such as base of the skull, and patients who are 
struggling with cancer at younger age and therefore minimization of the long-
term effects of treatment is an advantage (such as hormonal imbalances, 
intellectual development delay and secondary cancers) (13). 
 
Stereotactic body 
radiation therapy 
(SBRT) 
Technological advances enable oncologists in cooperation with surgeons to 
precisely deliver high individual doses of radiation over only a few treatment 
fractions to ablate small, well-defined primary and oligometastatic tumours. 
Due to high doses used in this method any cell, healthy or cancerous adjusted 
by the radiation is going to be damaged, however, because of low rate 
existence of healthy cells in regions of high doses in this method, the damages 
to healthy cells are negligible (13).   
 
Designing radiotherapy treatments is a complicated task and modern advancements in 
treatment technologies have made it even more complex, however more flexible for 
physicians to improve patients care. Consequently, treatment design is increasingly 
automated by means of optimization techniques, and many of the advances in the 
design process are accomplished by a collaboration between medical physicists, 
radiation oncologists, and optimization experts (28). While previously the treatment 
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design was done by physicians through trial and error with the help of operational 
researchers, the designing plan process has been becoming more optimized, automated 
and significantly improved. Each of the experts in a planning team has their specialized 
responsibility. While the oncologists diagnose the source of cancer, outline the tumour 
volume and prioritize the organs at risks, the medical physicists are in charge of the 
equipment needed to deliver the doses and perform the actual radiation delivery. The 
role of the operational researchers is to optimize all treatment stages through 
mathematical modelling, artificial intelligence methods and simulations in such a way 
that other experts can achieve their goals with the best possible results (29).  
2.2 Radiotherapy planning process 
The treatment plan for radiotherapy consists of three main steps of imaging and pre-
planning, simulation and confirmation and execution. The main goal of radiation 
therapy is to damage the DNA of cancer cells and deprive them of their multiplication 
potential and eventually kill them. While doing so, the inevitable damage to healthy 
cells surrounding the tumour or standing in the way of radiation to reach a tumour must 
be minimized (30). 
Observing symptoms related to cancer is the first step for diagnosis. Thereafter the 
patient is referred to imaging scanning or in some cases to biopsy to investigate the 
suspected lesion. The imaging process may be performed by CT scans, magnetic 
resonance imaging (MRI) or positron emission tomography (PET). Through 
consultation with oncologists for required details, each of the abovementioned options 
can provide unique information about the patient’s condition. CT scans can provide 
bone anatomy and tissue density information. Information regarding the soft tissues 
can be obtained through MRI and PET and is useful in gaining functional information 
on the tumour metabolic activity. Information provided by imaging can be decisive in 
22 
 
selecting a treatment modality, the tissues that should be focused in radiotherapy and 
the ones that should be spared.  
Gross Tumour Volume (GTV) is a primary tumour or other tumour mass which is 
identified either through imaging or examination under anaesthetic (EUA) (20). 
Clinical Target Volume (CTV) contains the GTV as well as other microscopic cancer 
cells which have to be eradicated in order to effectively treat cancer. Throughout the 
treatment due to patient’s movements or changes in the size of different organs, the 
position of the CTV may also vary compared to its original position. It is necessary to 
deliver homogenous and sufficient radiation to the CTV thus a margin called Planning 
Target Volume (PTV) is defined and contains the CTV as well as a safe margin to 
ensure the delivery of the actual dose plan to CTV (Figure 2.3). 
 
 
Figure 2.3 Different target volumes in radiotherapy (31) 
 
After outlining different tumour volumes, oncologists begin to specify the Organs At 
Risks (OARs) and prioritize them based on the location of a tumour in the body, seen 
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in the images. There are critical normal tissues the vulnerability of which may force 
significant restriction so special care should be assigned to them. The next step is 
preparing and designing a treatment plan which is a collaboration between oncologists 
and medical physicists. This treatment plan should determine the amount of radiation 
dose to be received by different target volumes, the beams specifications including the 
shape, size number and their concentration target, number of wedges and the 
configuration and beam intensity profile for each beam. There are two different 
approaches for determining the treatment plan, namely forward and inverse planning. 
In forward planning physicists and oncologists manually select all the specification of 
the treatment and after that calculate how the radiation is absorbed and deposited in 
different organs. If the result is unsatisfactory then another treatment plan is created 
and this trial and error process continues until a near to satisfactory result is obtained. 
However, in reverse planning, the amount of optimum doses to be accumulated in the 
organs is prescribed and then the treatment specifications are calculated through 
algorithms and models. In this approach, the role of the operation researchers and 
mathematical models are more highlighted. Next is the simulation phase to examine 
the effects of the treatment on different organs within different volumes of them.  
Dose Volume Histogram (DVH) has an important role in reviewing and simulating the 
treatment plan. DVH is a graphical representation of the dose that is received by normal 
tissues and target volumes within a 3-D radiation therapy plan. They provide 
information on the volume of a structure receiving a given dose over a range of doses 
(32). Based on the DVHs values and other circumstances a final treatment plan, which 
is both effective and minimizes the damages to surrounding healthy cells is suggested 
by the treatment plan team. Once the suggested treatment has been confirmed and 
finalized the radiation is delivered to the patient by using a linear accelerator or Linac. 
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In order to ensure the appropriate position of the patient during the treatment, some 
immobilization devices may be used. These immobilization devices can be a simple 
cotton band to fix the patients feet or in some more extreme sensitive cases like brain 
radiotherapy, it could be some pins placed into the skull to affix the patient’s head in 
the right position.  
Then Linac is equipped with a device called multi-leaf collimator. A multi-leaf 
collimator consists of individual leaves made up of a high atomic numbered material, 
i.e. tungsten. These leaves are responsible to block a portion of a particle beam by 
creating barriers in the beam path. Furthermore, most modern Linacs take digital 
images, which are called an EPI (Electronic portal image) or PI (portal image). These 
images are compared against those generated during the radiotherapy planning, by the 
radiographers and physicists, before they deliver any treatment as verification. A multi-
leaf collimator is shown in figure 2.4.  
 
 
Figure 2.4 Multi-leaf collimator 
 
Operational research is a very helpful instrumentation in assisting to find a solution to 
different problems in radiotherapy treatment planning and optimized a large number 
of parameters involved. The issues covered by the literature in radiotherapy planning 
problem and their summarized description is presented in table 2.2.  
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Table 2.2 Issues of the radiotherapy planning problem covered by literature  
Problem 
investigated 
Problem description references 
Geometry 
problem or beam 
configuration 
optimization 
problem 
Selection of the optimal number of beams, 
determining the optimal angle between beams and 
the beams’ weights 
 
(33-70) 
Wedges 
configuration 
problem 
Find the optimal configuration of the wedges 
including their position, number and angle 
 
(71-76) 
Segmentation 
problem 
Selection of optimal delivery sequence (77-83) 
Outline of the 
treatment volume 
and movement of 
organs 
Determination of different treatment volumes, organs 
at risks and calculation of organ movements during a 
treatment 
(84-109) 
Dose Planning 
Problem 
Obtaining the optimal dose plan to be delivered in 
different phases of the treatment to different 
treatment volumes 
(45,110-130) 
 
 
2.2.1 Beam configuration (Geometry problem): 
Determination of an ideal beam configuration is an important step in radiotherapy 
planning and has significant influence in treatment quality both to enhance the 
eradication of the tumour cells and surrounding organ sparing. The main two objectives 
in beam configuration optimization are determining the optimal number of the beams 
and the perfect angle between them. Since the last decade, due to its advantages, 
application of IMRT in treating the patients has been increased. IMRT is being used 
most widely to treat certain types of cancer including prostate, head and neck, and 
central nervous system. If necessary and some limitations are satisfied, IMRT can also 
be used to treat breast, thyroid, lung, as well as in gastrointestinal, gynecologic 
malignancies and certain types of sarcomas. Pediatric malignancies can be also treated 
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effectively by IMRT in some limited situations. The main difference between 
traditional external radiotherapy methods with IMRT is in the number of the beams. In 
the traditional method, a few beams are used while IMRT delivers hundreds of small 
radiation beams with different intensities, entering the body from a number of different 
angles. In traditional treatment, the planning team usually sets their configuration 
through trial and error and based on previous experiences, however, in order to deliver 
the IMRT to the patient such a task is almost impossible manually and relying on past 
experiences.  
Pugachev and Xing (37), developed a Simulated Annealing (SA) algorithm to search 
for the optimal set of beam configuration to speed up the beam configuration 
optimization. At first, they investigated the quality of each possible beam orientation 
by a method called beams-eye-view dosimetrics (BEVD) which was developed in 
Pugachev et al. (131). Then, after the optimal set of beam orientations was calculated 
by taking into account the BEVD scores of different incident beam directions. 
However, in this approach, the beams interactions with each other were not considered 
which can change the results significantly. Yang et al. (132) applied a mixed integer 
linear programming with binary variables to represent a candidate for beam orientation 
and a positive float variable to represent a beam weight. They solved their model by 
use of branch and bound method and the main goal of their research was to avoid the 
possibility of obtaining a local optimal solution instead of global optimal solution 
which can be a result of stochastic and heuristic search algorithms used by Hou et al. 
(133), Li et al. (134) and (33) in previous research. Although branch and bound method 
in comparison with random search algorithms can increase the solving time in presence 
of big solution space. Li and Lei (36) proposed a DNA genetic algorithm (DNA-GA) 
in order to improve the computation time of solving the beam angle problem (BAO). 
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A feasible mapping was constructed between the universal DNA-GA algorithm and 
the specified engineering problem of BAO. Experiments on clinical as well as 
simulated cases showed the efficiency of the proposed method can be higher than GA 
in some cases. Cabrera et al. (70) proposed a two-phase optimization process to solve 
the BAO problem by treating it as a multi-objective problem that takes into account 
the trade-off between different goals in radiotherapy. In the first phase by using a 
deterministic local search algorithm, they created a set of locally optimal beam angle 
configurations and in the second phase by performing a dominance analysis they 
presented the set of promising optimal solutions.  
2.2.2 Wedges configuration 
In radiotherapy treatment by high energy beams, the isodose distribution needs to be 
modified through compensating dose inhomogeneity. Wedges filters are a common 
instrument for this dose modification (135). Principally, wedges represent metallic 
absorbent blocks (lead or steel) and they are placed into the path of the X-ray beam at 
the output of a Linac. Nowadays, static wedges have been replaced by dynamic wedges 
which have improved the dose distribution and is capable of achieving any wedge angle 
by the movement of one pair of independent jaws of the wedge. To be more specific 
there are two main wedges uses: 
- Wedges are used to compensate for a sloping surface, as for example in some 
cases for the missing tissues.  
- Placing a wedge pair of beams which is most often used in the treatment of low 
lying lesions so that two beams can be set to form an angle of less than 180º 
(hinge angle). 
Determining the number of wedges, their positions and their optimal angle is a complex 
and time-consuming task. The main goal of the operational research working in this 
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area is to set all the factors involved in this process in their optimal situation as well as 
reducing the time needed for calculation and decision making. Albertini et al. (136), 
studied various starting conditions in intensity modulated proton therapy (IMPT) based 
on different wedges features. Through the quasi-Newton method, they optimized the 
plans with different starting conditions and after finding local optimal solutions, they 
compared the results of the plans by considering the OARs vulnerabilities and 
determined the best starting conditions for IMPT. 
2.2.3 Outline of the treatment volume and movement of organs 
During a fractionated course of radiotherapy shifts in patient’s position and also 
sometimes in alignments of the beams and thus unpredictable organ motions will 
happen. So, after initial imaging and determining different organ volumes, margins set 
up for CTV and PTV should account for the intra and inter-fractionally movements of 
organs and tumours during the treatment. These margins can compensate for the errors 
that happen systemically and randomly. While systematic errors are the results of 
incorrect data transfer between planning department and delivery team or inaccurate 
equipment set up are avoidable and have to be corrected, the random errors are due to 
changes in daily patient anatomy and are impossible to correct. So researchers, based 
on image-guided techniques and systems as well as circumstances of the tumours and 
organs involved, try to optimize to most efficient way to consider the necessary 
margins. Khan et al. (102) proposed a study to model inter-fraction CTV variation in 
patients with intact cervical cancer and design a PTV that minimizes normal tissue 
dose while maximizing CTV coverage. To do so they performed computed-
tomography techniques to obtain a probability function that can predict the optimal 
volume targets. Lens et al. (109) introduced a probabilistic treatment planning 
approach that prospectively incorporates respiratory-induced motion in the treatment 
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plan optimization. They performed a comparison between two methods of probabilistic 
respiratory motion-included (RMI) approach and Internal Target Volume (ITV) 
approach by taking into account the information related to 18 pancreatic cancer 
patients. The comparison results revealed that by applying probabilistic treatment 
planning approach dose gradients are yielded significantly steeper and thus the dose 
damaging surrounding healthy tissues is lower comparing to ITV approach.  
2.2.4 Dose planning problem 
A critical step in radiotherapy treatment for cancer is determining the optimal dose plan 
in different phases of the treatment. After defining all the aforementioned parameters, 
including beam configurations, wedges configurations, outlining different treatment 
volumes, prioritizing organs at risks and obtaining DVHs of different organs, dose 
prescription is the next task to be done. Through CT scans the 3-D tumour information 
is provided to oncologists and they are in charge of prescribing a dose plan which can 
kill cancerous cells as much as possible while limiting damage to healthy organs, in 
particular, the ones lying next to the main tumour area. The oncologists are seeking to 
find a dose plan that does not impair the healthy cells, however, sometimes sacrifices 
are inevitable to deliver the effective dose of radiation to cancer cells so that the patient 
can be in a cancer-free condition in the future. Romeijn et al. (137) proposed a linear 
programming approach to radiotherapy dose planning problem. The main constraints 
of the developed model were hard bounds regarding the dose limits for normal and 
cancerous cells. In this approach, various dose-planning parameters were fixed before 
the optimization, which is a complex task.  Their exact values may vary from patient 
to patient. Moreover, the proposed model is able to generate only one treatment plan 
for each run. In case of a need for multiple plans or necessary compromises, the planner 
is obligated to launch a series of experiment and the calculation time is going to be 
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increased. Zhang and Merritt (129) formulated a new least-squares model that can 
resolve the non-convexity and not be differentiable problems associated with objective 
functions of the previous models, caused by incorporating the dose-volume constraints 
(DVCs) into the problem in IMRT. They concluded that compared to a widely used 
existing model at the time, the new approach was capable of generating clinically 
relevant plans at a significantly faster speed. Modiri et al. (130) used particle swarm 
optimization (PSO) algorithm to solve a 4D radiation therapy (RT) inverse planning 
problem. By using respiratory motion as an additional degree of freedom in lung cancer 
radiotherapy, they tried to find an optimal dose plan and beam configuration for the 
treatment. To do so they proposed a new PSO algorithm and called it virtual search 
algorithm. This algorithm despite the previous algorithms (unconstrained and hard 
constrained) select one objective (based on different weighting approaches) as a critical 
objective and use it to navigate the search agents. The approach can reduce the 
calculation time for large-scale non-convex problems.  
2.3 Operational research approaches applied in radiotherapy treatment 
planning process 
Besides biological and laboratory research that were done to improve the treatment 
plans quality, the operational research techniques applied within this area can be 
classified into two major groups of optimization and knowledge-based approaches. 
Typically the optimization methods consist of obtaining the optimal value (minimum 
or maximum) of a real function by systematically choosing input values from within 
an allowed set, which is called the constraints and computing the value of the function. 
However, this function can be of a linear, non-linear, fractional, continuous or discrete 
type. Furthermore, multiple objective functions can be considered in a problem to reach 
a compromising solution between various available goals and factors. In order to solve 
31 
 
an optimization problem, depending on the nature of the problem, linear programming, 
non-linear programming, integer programming, heuristics and evolutionary 
algorithms, stochastic or robust optimization techniques may be applied. Knowledge-
based approaches usually rely on the existing knowledge and utilize the past solutions 
found for a problem in order to suggest a new one for the problem at hand. Cased-
Based Reasoning (CBR) and rule-based reasoning are two major methodologies 
applied within the knowledge-based approaches.  
Craft (138) proposed a gradient-based optimization model which used linear 
programming duality theory to optimize the beam angle in IMRT planning. It was able 
to produce a set of local optima for the treatment plan; however, it was not able to deal 
with the non-linearity which is the result of a 3-D imaging and target volumes. Still, 
the gradient-based optimization follows the basics of local search methods. Zhang et 
al. (139) argued that the use of heuristics and local search approaches, such as SA, GA 
and gradient-based optimization, despite the high speed in handling the large-spaced 
and timely expensive IMRT planning, has some particular disadvantages. They could 
be stuck in the local optima and not obtaining a global optimal answer. Thus, in IMRT 
planning where a feasible and bound problem can be formulated the use of exact 
approaches can be more attractive. They modified the traditional two-stage IMRT 
optimization process by augmenting the second stage via an accurate Monte Carlo-
based kernel superposition dose calculation corresponding to beam apertures. After 
that, they combined the calculations with a sequential optimization approach based on 
exact linear mathematical programming. Finally, they calculated the dose plan for 
IMRT more efficiently than previous existing approaches and was able to obtain a 
global optimal solution.  
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Taskin et al. (140) developed a mixed integer programming model for IMRT intensity 
matrix calculation and provided an upper and lower bound for a set of acceptable 
solutions in the optimal Pareto. However, comparing the derived solutions and 
choosing the optimal for a specific patient in IMRT task is still missing in this research. 
Fiege et al. (141) proposed a multi-objective GA in order to improve the results 
obtained by a single-objective fluence optimizer commercial pack and simultaneously 
calculate the beam angles and fluence patterns in IMRT treatment planning. In their 
approach, a set of the non-dominated solution, as the Pareto frontier was obtained by 
applying the algorithm to a real patient dataset and the results were showing good 
correlation with the actual treatment prescribed. 
The Pareto frontier or non-dominated Pareto set of solutions in multi-objective 
optimization is highly dependent on the weights selected for different objectives and 
this task is usually done by the planning team, manually adjusting the objective weights 
using a trial-and-error procedure. Yang et al. (142) developed a new particle swarm 
optimization (PSO) method which can adjust the weighting factors automatically to 
contribute to the development of a fully automated planning process. A perturbation 
strategy – the crossover and mutation operator hybrid approach – is employed to 
enhance the population diversity in each iteration. The treatment plans designed by this 
approach were promising.  
A summary of different optimization techniques applications in radiotherapy for cancer 
treatment is shown in table 2.3.  
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Table 2.3 Optimization techniques in radiotherapy planning problem 
Methodology Main problem focus reference 
Linear Programming and 
Mixed Integer Programming 
Beam configuration  (143-151) 
Dose planning  (152,153) 
Non-linear programming 
Beam configuration  (154,155) 
Dose planning  (156,158) 
Wedges configuration (159) 
Quadratic programming Dose planning  (160-162) 
Genetic Algorithm (GA) 
Beam configuration  (163-167) 
Dose planning  (168-170) 
Particle Swarm 
Optimization (PSO) 
Beam Configuration (171) 
Simulated Annealing (SA) 
Beam configuration  (172,177) 
Dose planning  (178-180) 
 
Advancements in Artificial Intelligence (AI) has led to a set of approaches called 
knowledge-based methods. These approaches do not use optimization techniques and 
instead, they are based on the assumption that the solution to a new problem can be 
found based on the searches done in the similar problems already solved. The rule-
based reasoning is an approach in which the decision makers come up with a hierarchy 
of rules which can be applied to a new problem based on their previous experiences 
and practical observations. While the Cased-Based Reasoning is based on the similarity 
between a new case and past successful cases. Generally, the solution of the most 
similar past successful case is prescribed or suggested for the new case (8).  
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Rossille et al. (181) applied both the rule-based and Cased-Based Reasoning to model 
a decision support system in order to find the treatment plans for new cancer cases. In 
this research firstly, a rule-based system depending on the type of cancer selects the 
most critical attributes for the case. Thereafter a Cased-Based Reasoning approach 
based on the selected attribute extracts the most similar case to the new case. 
Teodorovic et al. (124) used Cased-Based Reasoning approach for dose planning in 
thyroid cancer. Bee Colony Optimization (BCO) was used to assign weights to various 
attributes of the cases to measure the similarity between a new case and cases in the 
case pool.  
Ping et al. (182) proposed a multiple measurements Cased-Based Reasoning 
(MMCBR) method for liver cancer recurrence predictive models. This approach used 
pairing method through time series and dynamically determined matching pairs among 
cases and paired all cases in the database with the new case. In above method, various 
similarity measures were considered but results were not outstanding. Learning from 
past experiences can be a lucrative approach in particular for the sensitive tasks. In 
radiotherapy for cancer determining the volume targets, OARs and DVH values are 
examples of such sensitive tasks which can be penalized if being done with errors. 
Deshpande et al. (183) designed a decision support system by coupling a database of 
retrospective DICOM RT for neck and head cancer radiotherapy to a Cased-Based 
Reasoning model. This decision support system indicated cases within the database 
that are anatomically similar to a new case of cancer. The dose profiles of these 
database cases can assist physicians to modify their estimations more accurately for 
dose distributions in the surrounding organs based on similar cases and empirical data 
available for their treatment. Also, the large size of data enabled the system to compare 
the new cases with a high variety of previous cases in order to find the most similar 
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case. A summary of the application of knowledge-based approaches is illustrated in 
table 2.4.  
Table 2.4 Knowledge-based approaches in radiotherapy planning problem 
Methodology Main problem focus reference 
Knowledge-based reasoning Dose Planning  (184-186) 
Cased-based reasoning 
(CBR) 
Beam Configuration  (187-190) 
Dose planning  (6,7,191-194) 
 
 2.4 Conclusion 
Within this chapter, we have explained the nature of the cancer disease and provided 
an introduction to its different types and the various treatment measures which can be 
applied to confront it. Moreover, different types of radiotherapy and the treatment 
planning process have been reviewed. The body of literature consists of two main parts. 
Firstly, the different characteristics and actions needed for the radiotherapy planning 
and secondly, the methodologies which have been used to overcome the problems, 
barriers and gaps existing in decision making and optimization process to design an 
optimal treatment plan.  
Beam configuration, wedges configuration, segmentation problem, determining 
outline of the treatment volumes and movement of organs as well as finding the optimal 
dose plan are the main issues covered by the operational research techniques in the 
literature and two categories of optimization techniques including linear, non-linear 
and quadratic programming, heuristic algorithms and knowledge-based approaches 
including case-based and rule-based reasoning are the most commonly applied 
approaches. However, in the models developed in the literature many criteria have not 
been considered in the process of planning the treatment and in final evaluations, the 
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multi-criteria nature of the problem, as well as some significant limitations and 
compromising actions that usually are done by real world oncologists, have been 
neglected. Furthermore, in knowledge-based approaches, the uncertainties involved in 
human judgment have not been considered in the process of reusing human past 
experiences.  
In this research with the help of multi-attribute and multi-objective decision-making 
techniques the gaps mentioned will be addressed for dose planning in prostate cancer 
radiotherapy. The multi-criteria nature of the problem is considered, introducing 
compromises and uncertainty in human judgment that reflect those required by 
oncologists and medical treatment teams to improve the efficiency of a Cased-Based 
Reasoning system for radiotherapy prostate cancer.  
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Chapter 3 
A novel hybrid TOPSIS and CBR approach for radiotherapy in prostate cancer 
3.1 Introduction 
Prostate cancer is the most common cancer among male population in the UK (13) and 
the second most common cancer in all male population around the world with a share 
of 15% of all patients diagnosed with cancer (3). In 2011, about 42,000 of cases of 
prostate cancer were reported in the UK and it has caused approximately 11,000 deaths 
in 2012. In 2014, there were an estimated 3,085,209 men living with prostate cancer in 
the United States. Treatment of choice for prostate cancer is radiotherapy with X-rays 
or Gamma rays. However, complementary treatments such as surgery in combination 
with radiotherapy are common depending on the size of a tumour and stage of cancer. 
Oncologists and medical physicists dedicate a lot of time to produce an optimal 
treatment plan for each patient. They also get aid from planning software in 
determining the initial, near optimal values for different parameters of radiotherapy 
like the number of the beams, beam angles, position and angle of the wedges. 
Thereafter they create DVHs related to various organs and volume targets involved in 
the treatment. Based on their past experiences and a trade-off between the possibility 
of killing cancer cells and the risk of threatening sensitive organs, they prescribe a dose 
plan.  
39 
 
It is almost impossible for a medical team to predict the outcome of a treatment and 
mathematically it is a highly complex task to set a model to anticipate the expected 
success rate of a treatment. However, similar previous cases and the experiences gained 
through them can be an elucidative guide for the medical team as they have already 
been done and the results due to the treatment plan prescribed to them are available. 
Moreover, oncologists may need to consider several factors in order to make a decision 
and efficiently use their past experiences while human brain has limited capacity to 
consider a high number of factors simultaneously and evaluate multiple options 
effectively.  
In this chapter, a hybrid approach of Cased-Based Reasoning (CBR) and multi-criteria 
decision-making technique is proposed. That is the Technique for Order of Preference 
by Similarity to Ideal Solution (TOPSIS), in order to suggest the most appropriate dose 
plan for prostate cancer radiotherapy based on the previous experiences and patients 
treated. Through applying CBR the most similar cases to a new case can be extracted 
and thus the experience gained through their treatment can be applied to the new cases. 
However, not all the time the most similar case is the most appropriate scenario to be 
suggested and so based on various criteria the most similar cases with a minimum 
limitation on similarity rate have competed with each other in TOPSIS evaluations. 
Furthermore, oncologists in real life scenarios do not rely only on one successful past 
scenario and usually, they combine the solutions of some equally successful cases 
together. To do so we have provided a rule-based system that performs the same kind 
of case combinations is provided and makes this system as close as possible to the real 
life medical decision-making process. The rest of this chapter is structured as follows: 
in section 2 the Cased-Based Reasoning (CBR) approach and its different steps are 
being explained and a summary of the literature related to CBR application in cancer 
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treatment is given. In section 3, TOPSIS methodology is presented and thereafter in 
section 4 radiotherapy process for prostate cancer and its features is explained in detail. 
Our proposed methodology for developing a more realistic and successful treatment 
planning based on TOPSIS and CBR is explained in section 5, followed by a numerical 
example provided in section 6 to better illustrate the efficiency of the proposed 
methodology and the results are being discussed. Finally, section 7 is the conclusion 
of this chapter.   
3.2 Cased-Based Reasoning 
In order to deal with a new problem, past solutions that were developed to solve similar 
problems are good indicators of which solutions have been successful and which of 
them have led to failure. Furthermore, these past experiences could teach us about the 
factors essential to success and also those that cause failure. Cased-Based Reasoning 
is a general paradigm for reasoning from experience. It uses a memory model for 
representing, indexing, and organizing past cases and a process model for retrieving 
and modifying old cases and assimilating new ones (195,196). Case‐based reasoning, 
a knowledge-based system is a problem‐solving approach that relies on past similar 
cases to find out solutions to new problems (8,197,198). 
In Cased-Based Reasoning, cases are similar events or problems consisting of two main 
parts; several features which define a case and a solution part. Case pool is a place 
where these cases are stored to be used by the system. Figure 3.1 shows the main 
procedure of a Cased-Based Reasoning system. There are four main stages in Cased-
Based Reasoning: retrieval, reusing, adaptation or revising and retaining.  
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Figure 3.1 Case Based Reasoning process (adopted from Aamodt & Plaza (199)) 
3.2.1 Retrieval: 
Case retrieval is often seen as the most important step of a CBR problem and due to its 
pivotal role in CBR, it has gained the attention of many researchers in the field. The 
first thing that must be done in a CBR system, as soon as a case enters the system, is 
to search for an appropriate match for the new case. An appropriate match often refers 
to a case highly similar to the new case. Thus, the adopted similarity measure of the 
system has a significant influence on its performance and success of a CBR is directly 
depended on the strategy adopted for the similarity measure.   
K nearest neighbour or simply K-NN is the most popular retrieval approach in the 
literature. The similarity between two cases in this approach is usually a number 
belonging to [0, 1] and is calculated based on the distance between the feature vector 
of the two cases. The most common distance applied is based on the location of the 
vector features in Euclidean space. The Euclidean distance is able to deal with negative 
and proportionate numbers and is sensitive to small differences between two vectors 
(200). The geometrical distance between any to point in the space is obtainable with 
Euclidean distance. The Euclidean distance is easily transferable to various forms of 
similarity measure (201) and the low complexities in assigning weights to different 
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features of the vector and calculation process make it an attractive option to be used in 
problems with a high number of variables (202).  
We can calculate the Euclidean distance of two cases by equation 1 and 2: 
𝑑(𝐶1, 𝐶2) = √∑(𝑤𝑘 × 𝑑𝑘(𝐶1, 𝐶2))2
𝐾
𝑘=1
                                                                             (1) 
𝑑𝑘(𝐶1, 𝐶2) = |𝑥1𝑘 − 𝑥2𝑘|                                                                                                    (2) 
 
Where 𝑑(𝐶1, 𝐶2) is the Euclidian distance between two cases of 𝐶1 and 𝐶2. k is the 
number of features for each case and 𝑤𝑘 is the relative importance of feature k 
compared to other features. 𝑥1𝑘 and 𝑥2𝑘 are the values of k
th feature in cases 1 and 2 
respectively. After the distance between two cases has been calculated, we can obtain 
the similarity between the pair of cases based on equations 3 or 4.  
𝑆𝐼𝑀(𝐶1, 𝐶2) =
1
1 + 𝑑(𝐶1, 𝐶2)
                                                                                               (3) 
𝑆𝐼𝑀(𝐶1, 𝐶2) = 1 − 𝑑(𝐶1, 𝐶2)                                                                                                (4) 
 
3.2.2 Reusing and Revision: 
Reuse is the step of CBR process when a solution of a retrieved case is being used for 
a new case. In some situations, reusing would be easily done by just assigning the old 
solution as the new solution. An example of such a situation is classification problems 
where the cases in one class are usually so similar in nature that just the most similar 
case can contain the solution for a new case. However, in some situations when the 
new case and retrieved case differ significantly from each other, another process (3rd 
step) revising or adaptation for the retrieved solution is needed. Medical decision 
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making is one domain in which adaptation is commonly required. Adaptation becomes 
particularly relevant when CBR is used for constructive problem-solving tasks such as 
design, configuration, and planning (203). In revisions, the goal is to investigate the 
applicability of the solution proposed for the new case and if required altering parts of 
the solutions in order to make it compatible with the new case. 
3.2.3 Retaining: 
When a solution has been assigned to a new case (by using the solution of the most 
similar case, the reusing step) through a revising process (if the assigned solution 
requires changes to better adapt the problem), a completely new case has been 
generated and this new case needs to be stored in order to update the case pool. The 
case retention or maintenance should be managed intelligently and systematically. 
Maintenance issues appear when the effectiveness of the system is being discussed 
regarding the nature of the problem in focus. In some cases, the new (learned) case 
may not be retained as its solution is provided by Artificial Intelligence (AI) and some 
researchers believe that knowledge should only be gained by real-life experiences in 
CBR. However, some researchers believe that learned knowledge through AI could be 
helpful to increase the frequency of the cases in the case pool and subsequently to 
increase the alternatives available for a new case.  
We can summarize the CBR steps as, firstly, each case is divided into 2 parts of the 
case features and case solutions. Then the similarity between a new case and the cases 
in the case pool is being calculated so we can retrieve the most similar case. After that, 
the solution of the most similar case is being reused for the new case. Depending on 
the circumstances of the problem, the solution can be revised in the revision step to 
better fit the new case. Finally, in the last step, the retaining step, the new case features 
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and solution are being merged to form a new case and is being added to the case pool 
to be utilized in the future.  
The efficiency of CBR approaches in the healthcare domain and medical decision 
making, and in particular in different stages of the cancer treatment has been proved 
by its widely used applications. An initial stage for many treatment planning problems 
is classification.  Achieving a well-suited classification can reduce the prediction errors 
in treatment planning. Thus, many researchers have applied CBR individually or in 
combination with other techniques to solve the classification problem. De Paz et al. 
(204) proposed a hybrid CBR and decision tree approach that classified the leukaemia 
patients from data obtained from microarray profiles. Huang et al. (205) applying 
logistic regression model, compared three different methods of Particle Swarm 
Optimization (PSO) based on neural networks (ANNs), the adaptive neuro-fuzzy 
inference system (ANFIS) and CBR classifier for breast cancer diagnosis problem. 
However, they showed that application of individual CBR could lead to lower accuracy 
in comparison to other methodologies.  
In addition to classification of the patients by CBR, pairing patients and prescribing 
the treatment solution of a treated patient to a new one, which is the main application 
of CBR, has been abundant in the literature. Petrovic et al. (7) combined Cased-Based 
Reasoning and Dempster–Shafer theory to combine the solution of the most similar 
cases retrieved by CBR to apply in radiotherapy dose planning for prostate cancer, 
however, they consider the similarity measure as the only factor for retrieving a 
solution. Mishra et al. (125) applied non-linear programming to radiotherapy dose 
planning for prostate cancer and used two different success rates as other criteria for 
retrieving a solution. Although they did not apply an MCDM approach despite the 
existence of several criteria and simply used criteria as filters with different priorities. 
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Gu et al. (194) applied CBR with a new distance measure named weighted 
heterogeneous value distance metric and GA to set the weights for the feature attributes 
in breast cancer diagnosis and reported increased efficiency compared to previous CBR 
with other distance types.  
 
3.3 TOPSIS 
TOPSIS (Technique for Order Preference by Similarity to an Ideal Solution) is an 
MCDM method developed by Hwang and Yoon (206). The main purpose of this 
technique is to rank different alternatives based on their distances from ideal positive 
and negative solutions.  TOPSIS can be performed using the following steps:   
At the beginning of the process, a decision Matrix DM is constructed. The row of each 
matrix represents alternative solutions, while columns represent different criteria.  
 
𝐷𝑀 = [𝑦𝑖𝑗] =  [
𝑦11 ⋯ 𝑦1𝑟
⋮ ⋱ ⋮
𝑦𝑛1 ⋯ 𝑦𝑛𝑟
]                                                                                           (5) 
Where 𝑦𝑖𝑗 (𝑖 = 1,⋯ , 𝑛 ; 𝑗 = 1,⋯ , 𝑟) are the elements of the decision matrix DM.  
After that, the following steps are performed to select the best alternative: 
Step 1- Decision Matrix is normalized using equation 6: 
𝑅𝑖𝑗 =
𝑦𝑖𝑗
√∑ 𝑦𝑖𝑗
𝑗
𝑗=1
                                                                                                                     (6)  
 𝑅𝑖𝑗 is the normalized value of the element 𝑦𝑖𝑗 in decision matrix. 
 
Step 2- Weighted normalized decision matrix is calculated using equation 7.  
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𝑣𝑖𝑗 = 𝑤𝑖𝑅𝑖𝑗                                                                                                                                 (7) 
 
Step 3-Positive and negative ideal solutions are specified using equations 8 and 9 
respectively: 
 
𝑃𝐼𝑆 = {𝑣1
∗, ⋯ , 𝑣𝑟
∗} = {
𝑚𝑎𝑥
𝑗
𝑣𝑖𝑗| 𝑖 ∈ 𝑏𝑒𝑛𝑒𝑓𝑖𝑡
min
𝑗
𝑣𝑖𝑗| 𝑖 ∈      𝑐𝑜𝑠𝑡
                                                                   (8)  
𝑁𝐼𝑆 = {𝑣1
−, ⋯ , 𝑣𝑟
−} = {
𝑚𝑖𝑛
𝑗
𝑣𝑖𝑗| 𝑖 ∈ 𝑏𝑒𝑛𝑒𝑓𝑖𝑡
max
𝑗
𝑣𝑖𝑗| 𝑖 ∈      𝑐𝑜𝑠𝑡
                                                                  (9) 
Step 4- Distance of each alternative from Positive Ideal Solutions (PIS) and Negative 
Ideal Solutions (NIS) are calculated using equations 10 and 11 respectively.  
𝐷𝑗
+ = √∑(𝑣𝑖𝑗 − 𝑣𝑖
∗)
2
𝑛
𝑖=1
                                                                                                        (10) 
𝐷𝑗
− = √∑(𝑣𝑖𝑗 − 𝑣𝑖
−)
2
𝑛
𝑖=1
                                                                                                      (11) 
Step 5- Finally, relative closeness coefficient is calculated using equation 12 and the 
alternative with the highest coefficient is ranked as the best alternative.  
𝐶𝑗
∗ =
𝐷𝑗
−
𝐷𝑗
− + 𝐷𝑗
+                                                                                                                       (12) 
TOPSIS is one of the most widely used MCDM techniques in health-care decision 
making and medical decision support systems. Ferrari et al. (207) applied TOPSIS to 
evaluate Triptan treatment options in a migraine. In the proposed method trade-offs 
between conflicting criteria are made and seven available Triptan used in the treatment 
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process are ranked using the TOPSIS methodology. Rahimi et al. (208) applied 
TOPSIS and fuzzy logic to develop a diagnosis system. They considered a set of 
diseases as alternatives and the most similar case (highest ranked in being similar to 
the new patients’ symptoms) in symptoms is being diagnosed as the condition that the 
patient is dealing with. Using TOPSIS method, La Scalia et al. (209) developed a 
decision support system for pancreatic islet transplantation. The proposed system can 
help doctors calculate the probability of transplant success in relation to four classes of 
identified variables (donor, organ, isolation and recipient).  
3.4 Prostate cancer radiotherapy formulation 
Radiotherapy planning for prostate cancer problem is a complex and time-consuming 
process. The treatment is usually performed in two stages, phase I and phase II. In 
phase, I, prostate and surrounding organs where cancer has spread are treated. While 
in the second phase only prostate will be the focus of radiation. Figure 3.2 shows a 
prostate tumour and surrounding area in a schematic picture.  
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Figure 3.2 Phase I and II of the radiotherapy for prostate cancer and organs involved 
 
The main objective of treatment is to kill the cancerous cells without affecting the 
functionality of surrounding organs. In Nottingham City Hospital usually, doses are 
prescribed in the range of 46-64Gy and 16-24Gy in Phase I and II of the treatment 
respectively. The prescribed total dose of 70 to 76 Gy is usually delivered in fractions, 
and each fraction approximately accounts for 2 Gy. The overall process of radiotherapy 
treatment is explained in figure 3.3.   
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Radiotherapy planning process is generally performed in several steps. The Oncologist 
examines the new patient and tests the level of PSA (Prostate Specific Antigen). 
Prostate cancer can increase the production of PSA, and so a PSA test looks for raised 
levels in the blood that may be a sign of the condition in its early stages. Through PSA 
test, Digital Rectal Examination (DRE) and biopsy the oncologists can detect prostate 
cancer and prescribe different clinical tests such as Computed Tomography (CT) scan 
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Figure 3.3 Radiotherapy dose planning process 
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and Magnetic Resonance Imaging (MRI) to determine the stage of cancer. After that, 
medical physicists in the planning department, sketch the tumour volume and 
determine the organs at risks, considering the scans. Throughout this process areas 
involved crucially within cancerous cells and areas containing only microscopic 
tumour cells can be segregated.  
Based on the sketched volume and characteristics of the patient, different planning 
parameters and Dose Volume Histogram (DVH) for both phases of treatment are set 
by the oncologists and medical physicist. DVH is a graphical representation of the dose 
that is received by normal tissues and target volumes within a 3-D radiation therapy 
plan. It allows oncologists to calculate the amount of radiation that would be received 
by different volume percentage of the rectum. For example, if DVH value of 66 % of 
the rectum in phase II of treatment is 0.7 and prescribed dose in phase II of treatment 
is 20 GY than the dose received by 66 % of the rectum will be 14 GY (0.7×20 
GY=14GY).  
Based on calculated DVH value and Clinical stage, Gleason Score and Prostate 
Specific Antigen (PSA) value oncologists perform several successive experiments to 
determine doses in Phase I and II of the treatment so that cancerous cells can be killed 
effectively without impairing the normal organs near to the cancerous cells, 
particularly bladder and rectum. Compared to the bladder, the rectum is a very sensitive 
organ. In a feasible dose plan dose received by different volume percentage of rectum 
must be within the constraints. The recommended dose limits of different volume 
percentages of the rectum are given in table 3.1. In some cases, these dose limits can 
be overlooked to some extent so that sufficient dose can be delivered to the cancerous 
cells.  
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Table 3.1 Dose limits for different volume percentage of the rectum 
Rectal volume % Total dose limits 
66 45 
50 55 
25 65 
10 70 
 
In order design, a condign treatment plan, oncologists and medical physicists usually 
consider five features of Clinical Stage, Gleason Score, Prostate Specific Antigen 
(PSA) value, and DVH values in phases I and II of treatment. Table 3.2 describes these 
features in detail.  
Table 3.2 Features of interest in prostate cancer radiotherapy 
Features Description 
Clinical stage A labelling system that indicates the local extent of a prostate tumour and its spread 
to surrounding organs. It includes T1a, T1b, T1c, T2a, T2b, T3a and T3b categories. 
 
DVH A graphical representation of the dose that is received by normal tissues and target 
volumes within a 3-D radiation therapy plan. They provide information on the 
volume of a structure receiving a given dose over a range of doses. In Prostate cancer 
radiotherapy, rectum’s volumes of interest are 66, 50, 25 and 10 percent.  
 
Gleason 
Score 
A classification of prostate cancer grade on the basis of histology with predictive 
value for progression. The values are in the range of 1 to 10. Cancers with a higher 
Gleason score are more aggressive and have a worse prognosis. 
 
PSA Prostate Specific Antigen. The PSA test measures the level of PSA in a man’s blood. 
Elevated amounts of PSA could be the result of inflammation of the prostate, 
infection or prostate cancer. The values are within the range of 1 to 40.   
 
3.5 Proposed method for dose plan suggestion 
In real life, to prescribe a dose plan, oncologists not only take into consideration the 
clinical attributes of a patient but also recall previous cases they have treated to utilize 
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their past experiences. Based on above-mentioned facts, Cased-Based Reasoning 
(CBR), a knowledge-based technique is an appropriate approach to deal with this 
healthcare problem. A case usually consists of two major parts: problem features which 
describe the conditions under which similar case(s) should be retrieved and the solution 
to the problem (195). Based on the extracted most similar case a solution for the new 
case is suggested. The advantage of this method is its capacity to consider more cases 
than a doctor can recall and that it shares the experiences of other oncologists and 
provides a more comprehensive base to make decisions. The solution, second aspect 
of a retrieved case, is usually suggested to a new case. However, extracting the most 
similar case and prescribing solution based on that may not provide a thorough answer. 
As previously mentioned, a solution is prescribed by means of extracting several most 
similar cases and evaluating them by TOPSIS in comparison to an ideal solution and 
prescribe the final solution based on the obtained results.  
3.5.1 Representation of the case 
In the radiotherapy treatment of prostate cancer usually, the clinical stage of cancer and 
the geometry of prostate are taken into consideration. Attributes related to both the 
factors are listed in table 3.3.  
Table 3.3 Range of values and their type for features of prostate cancer radiotherapy 
Feature Values Type of values 
Stage of the cancer T1a, T1b, T1c, T2a, T2b, T3a, T3b Ordinal 
Gleason Score [1, 10] Integer number 
PSA [1, 40] Real number 
DVH [0, 1] Real number 
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The data type, measurement unit and scale of the aforementioned parameters vary. To 
develop a comprehensive similarity measure, clinical stage, Gleason score and PSA 
are represented by fuzzy sets. Normalized fuzzy sets low, medium, and high, whose 
membership functions take values from [0, 1] interval are defined for each feature. 
Parameters of these membership functions are set in collaboration with an expert 
oncologist in Nottingham City Hospital. Each, features l (clinical stage (l =1), Gleason 
Score (l =2), PSA (l =3)) of case 𝐶𝑝is represented by a triplet (𝜈𝑝𝑙1, 𝜈𝑝𝑙2, 𝑣𝑝𝑙3), where 
𝜈𝑝𝑙𝑚 , m = 1, 2, 3 are membership degrees of feature l to fuzzy sets low (m = 1), 
medium (m = 2) and high (m = 3). The membership functions of sets applied for 
Gleason Score and PSA are shown in Figures 3.4 and 3.5. 
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Figure 3.4 Membership function for Gleason score 
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3.5.2 Retrieval process of similar cases  
Clinical stage is an important decision-making criterion; cases having the same clinical 
stage are relevant to the prescribed dose plan for a new patient. According to the stage 
of cancer, the clinical stage can be sorted in the following order: {T1a, T1b, T1c, T2a, 
T2b, T3a, T3b}. At first, cases presenting the same clinical stage or adjacent to the new 
case in the ordered list are filtered. Thereafter, from the filtered list cases similar to the 
new case are retrieved. 
The distance between new case 𝐶𝑝 and case in the database 𝐶𝑞 is calculated using 
equation 13. It takes into consideration fuzzy membership values of Gleason Score (l 
= 1) and PSA (l = 2).  
𝑑1(𝐶𝑝, 𝐶𝑞) = (∑∑(𝜈𝑝𝑙𝑚 − 𝜈𝑞𝑙𝑚)
2
3
𝑚=1
2
𝑙=1
)
1
2
                                                                      (13) 
 
Taking into account numerical values of different DVH volume percentage of rectum 
66%, 50%, 25% and 10% represented by 𝑚 = 1, 2, 3, 4 respectively distance between 
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Figure 3.5 Membership function for Gleason score 
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two cases of 𝐶𝑝 and 𝐶𝑞 is calculated using equation 14. In this equation (i =1, 2) 
represents the phase of treatment.  
𝑑2(𝐶𝑝, 𝐶𝑞) = (∑∑(𝑢𝑝𝑖𝑚 − 𝑢𝑞𝑖𝑚)
2
4
𝑚=1
2
𝑖=1
)
1
2
                                                                     (14) 
 
The overall similarity measure between cases 𝐶𝑝 and 𝐶𝑞 is measured by equation 15.   
𝑆(𝐶𝑝, 𝐶𝑞) =
1
1 + 𝑑1(𝐶𝑝, 𝐶𝑞) + 𝑑2(𝐶𝑝, 𝐶𝑞)
                                                                      (15) 
 
3.5.3 Solution methodology which improves CBR 
In a simple CBR usually, decisions are based on the extracted most similar case. 
However, in radiotherapy dose planning the most similar case may not be the most 
appropriate one to base decisions on. In addition to the similarity measure, there are 
other criteria, which have an influence on the preference of a case over others. It was 
found experimentally that in some instances, the case having the highest similarity 
measure was not convincing to base a decision on. Sometimes they have low success 
rate or DVH level has exceeded the recommended restrictions. For this study, the 
MCDM method is used to overcome the problem above. Firstly, cases most similar to 
the new case are retrieved from the database. Thereafter, an MCDM technique called 
TOPSIS is used to compare them based on the similarity measure, quality of dose plan, 
success rate and side efferent of treatment. Figure 3.6 shows the architecture of the 
proposed method. 
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3.5.4 Radiotherapy dose planning criteria 
In this study, the following criteria have been selected to evaluate the extracted most 
similar cases using TOPSIS method: dose plan in phases I and II of the treatment; 
similarity measure; and the distance of each DVH values to the standard dose limitation 
in respected volume percentage. These parameters are set in collaboration with 
oncologists working at Nottingham City Hospital. It supports the proposed method to 
prescribe a dose plan that provides higher accuracy and fewer treatment side effects to 
patients.  
In the decision matrix, the dose plan having a higher dose in the first phase of the 
treatment is considered as an added advantage. It will annihilate the cancer cells to the 
maximum because in the first phase of the treatment cancer cells and the surrounding 
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organs where cancer has spread are treated. Although in the second phase of 
radiotherapy treatment the beams only target the prostate gland and the purpose is to 
concentrate on the prostate rather than affecting the surrounding area which has already 
gone through removal process in phase I. In the decision matrix the plan with higher 
share of the total dose is considered to be a better dose plan. In case the total dose plans 
for two related treatment plans are equal, the priority is with the dose plan with a higher 
dose in the first phase of the treatment (7). In order to minimize the side effects of the 
treatment, the dose received by the rectum should be as low as possible. Cases, where 
the dose received by different volume percentage of the rectum in phase I and phase II 
of treatment are far from maximum specified value, is considered as a better dose plan. 
In the evaluation process firstly, the distance between actual dose received by different 
volume percentage of the rectum and specified maximum value for all extracted cases 
is calculated. The higher the distance is, the better possibility of keeping other organs 
out of risk. As an example, the dose received with different volumes of a patient in the 
treatment and their distance from the maximum standard values in Table 3.1 is given 
in Table 3.4.  
Table 3.4 An example of correspondence distance value based on the dose received by each 
percentage of the rectum volume 
Rectum 
Volume 
66% 50% 25% 10% 
Dose received 36.18 46.98 52.92 53.46 
Distance value 8.82 8.02 12.08 16.54 
 
 
3.6 An example of the case base reasoning combined with TOPSIS 
To demonstrate the step-by-step execution process of the proposed method in a lucid 
way an illustrative example is constructed. In this example, a case is extracted from the 
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case base and treated as a new case.  Dose planning parameters of the new case are 
given in Table 3.5.  Firstly, cases presenting the same or adjacent clinical stage to the 
new case are extracted from the case base. Thereafter, from the filtered list the five 
cases most similar to the new case are retrieved. The detailed description of the 
extracted cases similar to our new case depicted in Table 3.5 and the related criteria 
values for running the evaluation process are shown in Table 3.6. As can be seen dose 
plan in phase I and II of the treatment, distance to the different volume level, 
recommended by standards and similarity measures are the considered criteria.  
Table 3.5: Values for numerical example cases 
 PSA GS 
DVH1 
66% 
DVH1 
50% 
DVH1 
25% 
DVH1 
10% 
DVH2 
66% 
DVH2 
50% 
DVH2 
25% 
DVH2 
10% 
Cnew 7 11.90 0.50 0.60 0.94 0.99 0.47 0.49 0.69 0.98 
C1 7 6.80 0.50 0.60 0.94 0.99 0.48 0.49 0.61 0.95 
C2 7 6.40 0.50 0.58 0.92 0.97 0.50 0.53 0.86 0.90 
C3 7 12 0.51 0.69 0.97 0.99 0.47 0.50 0.87 0.98 
C4 7 7.10 0.55 0.64 0.95 0.98 0.53 0.57 0.92 0.99 
C5 7 13 0.52 0.55 0.91 0.98 0.52 0.53 0.87 0.98 
 
 
Table 3.6 Decision Matrix applied for TOPSIS evaluation of the numerical example 
 Criteria 
Alternative 
Dose 
plan in 
phase I 
Dose 
plan in 
phase II 
Dis to 
R66% 
Dis to 
R50% 
Dis to 
R25% 
Dis to 
R10% 
Similarity 
Measure 
C1 54 18 9.36 13.78 3.26 0.56 92.08 
C2 46 24 10.00 15.60 2.04 3.78 83.51 
C3 46 24 10.26 11.26 0.5 0.94 83.06 
C4 46 24 6.98 11.88 0.78 1.16 79.40 
C5 46 24 8.60 16.98 2.26 1.40 79.15 
 
 
Thereafter, extracted cases are evaluated based on the similarity measure, success rate 
and side effect of treatment. With the use of TOPSIS technique, the relative closeness 
59 
 
coefficient is calculated for each case (Table 3.7). Among all the extracted cases, case 
number 5 is found to be the best possible option due to its greater relative coefficient 
despite relatively lower similarity measures. The doses prescribed by the treatment 
alternative 4 are 46 and 24 Gy in the first and second phase of treatment respectively.  
Table 3.7 Final ranking of alternatives through TOPSIS 
Alternative 
treatment 
Relative 
closeness   
Rank 
5 0.7923 1 
4 0.7132 2 
2 0.5893 3 
3 0.4142 4 
1 0.4131 5 
 
In the final step it is necessary to check the feasibility of the suggested doses by the 
best alternative solution through the following restriction: 
1- The suggested dose in Phase I should be more than that suggested for Phase II. 
2- All the doses received by different volumes of the rectum must be lower than 
the recommended standards in Table 3.1.  
 
3.6.1 Modification and repair mechanism of treatments 
In some instances, the prescribed dose by the retrieved case does not fit in the 
limitations of recommended dose as mentioned in Table 3.1. To overcome this 
situation a modification process has been proposed. In this process, the prescribed dose 
plan is modified by the next best alternative. The modification will be done based on 
the alternative distances with positive ideal solutions. The modification process will be 
performed based on these rules: 
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Step 1: First the second-best alternative will be checked. If the dose plan corresponding 
to second-best alternative satisfies the restrictions, then it will be selected. 
Step 2: Next if the second option is not feasible, a combination of first and second-best 
alternatives will be elicited with the help of equations 16 - 18. 
Step 3: If the outcome of Step 2 is not a feasible plan, a combination of the first, second 
and third option will be considered. 
 Assume the doses prescribed by the first alternative (P) are P1 and P2 and the doses of 
the second-best alternative with a lower amount of doses (E) are E1 and E2 respectively 
in the first and second phase of treatment. The distance of each alternative from the 
ideal solution is: 
   
 𝐷𝑖𝑠(𝐴𝑝) = √∑(𝑣𝑖𝑗 − 𝑣𝑖
∗)
2
𝑛
𝑖=1
                                                                                           (16)  
 𝑣𝑖𝑗 are the normalized vector elements for each alternative and 𝑣𝑖
∗ is the best 
performance in criterion j which consist the ideal solution. If the distance of 
alternatives P and E from the ideal solution is Disp and Dise the outcome dose plan of 
this modification iteration is as follows: 
 
𝐷𝑜𝑠𝑒 𝑝𝑙𝑎𝑛 𝑖𝑛 𝑝ℎ𝑎𝑠𝑒 𝐼  =     
𝐷𝑖𝑠𝑝. 𝑃1 + 𝐷𝑖𝑠𝑒 . 𝐸1
𝐷𝑖𝑠𝑝 + 𝐷𝑖𝑠𝑒
                                                          (17) 
 𝐷𝑜𝑠𝑒 𝑝𝑙𝑎𝑛 𝑖𝑛 𝑝ℎ𝑎𝑠𝑒 𝐼𝐼 =  
𝐷𝑖𝑠𝑝. 𝑃2 + 𝐷𝑖𝑠𝑒 . 𝐸2
𝐷𝑖𝑠𝑝 + 𝐷𝑖𝑠𝑒
                                                           (18) 
In the above equation, 𝑃1,2 and 𝐸1,2 are dose plans in phase I and II of alternative P and 
E respectively.  
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3.6.2 Results accuracy and methodology effectiveness 
To test the effectiveness and robustness of the proposed method, the leave-one-out 
strategy has been employed. In leave-one-out strategy, each case stored in case base is 
taken out one by one as is treated as a new case. The dose plan for each extracted case 
is estimated using proposed methodology. Thereafter, the estimated dose plan is 
compared with the dose plan prescribed by the expert oncologist. The dataset used in 
this research is based on anonymized data collected from Nottingham City Hospital 
which are stored in a database. This data collection provided 69 different cases. 
If there is any inconsistency between the dose plan estimated by the used method and 
that prescribed by the oncologist, then firstly the received dose is calculated by 
different volume percentage of the rectum and if it is within the constraint then the 
quality of the plan is judged on the basis of the total dose prescribed. When a dose plan 
has a higher amount of the total dose it is considered better because it will help to kill 
more cancerous cells without affecting surrounding organs. However, if two dose plans 
have the same amount of total dose then the quality of the plan is judged based on the 
amount of dose prescribed in Phase I of the treatment. Since in Phase I of the treatment 
both cancer and its surrounding organs where cancer has spread is treated, the dose 
plan having higher amount of dose in phase I of treatment is considered as better dose 
plan compared to other dose plans which have less amount of dose in phase I. In Leave-
one-out strategy the dose plan suggested by our method is considered to be successful 
if it is same or better (based on the abovementioned criteria) then the plan prescribed 
by the expert oncologist. 
During the experiment, the success rate of the proposed method is 86.88%. More 
precisely in 53 out of 61 cases, the dose suggested by the method has been the same or 
higher than that prescribed by oncologists. In 33 cases dose plan suggested by the 
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method was the same as that of oncologists while in 20 cases was higher than the 
prescribed dose. To demonstrate the suitability of case-base reasoning with TOPSIS 
we have compared it with the success rate of normal case base reasoning as shown in 
Table 3.8. The success rate of normal case base reasoning is 73.43% while the success 
rate of case-base reasoning with TOPSIS is 83.6%. The use of TOPSIS also helped 
case-base reasoning to generate a better plan in a higher number of cases. It is increased 
from 15 to 18. Further to investigate the relevance of modification rule experiment has 
been conducted where it was found that success rate has increased to 86.88% from 
83.6%. The proposed modification rule also helped case base reasoning with TOPSIS 
method to generate more number of better dose plan. It has increased from 18 to 20. 
Table 3.8 Comparative success rate for different approaches applied in this chapter 
 Success rate 
Number of cases with better dose plan 
than the original one 
 Simple CBR 73.43% 15 
 
CBR+TOPSIS 
 
83.6% 18 
CBR+TOPSIS 
+ 
Modification rule 
86.88% 20 
 
3.7 Conclusion 
In this chapter, a novel approach to radiotherapy dose planning for prostate cancer has 
been developed by combining TOPSIS, an MCDM technique with Cased-Based 
Reasoning, a knowledge-based approach. Previously, as was reviewed in the literature, 
the extent of similarity between two cases has been the singular feature that the 
researchers have focused on. Only one study has applied other factors in addition to 
similarity; however, still, the first filter was the similarity measure and thus played the 
most important role. In this chapter, the problem has been structured as a multi-criteria 
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problem and a wide range of attributes have been included to ensure close similarity to 
real-life scenarios, where oncologists rely on several factors to decide on dose planning 
for a patient.  
Firstly, with the help of CBR approach, the case similarity measures between a new 
case and cases in the case pool were calculated. Thereafter, the cases, satisfying a 
certain minimum amount of similarity measure, were selected as potential final 
solutions to the new case. Retrieved cases are evaluated using multi-criteria evaluation 
method. Due to the nature of medical problems, the proposed solution should be the 
nearest to the most ideal solution and the furthest from the worst scenario. It will 
enhance the advantages and avoid potential damages as far as possible by minimising 
the treatment side effects. In order to achieve this target, we have used TOPSIS as our 
chosen method for multi-criteria decision making. The highest ranked retrieved case is 
then prescribed for the new case. Although if the prescribed doses are not within the 
DVH’s maximum limitations, then the modification rules try to modify the doses and 
finalize the dose plan. This approach has been applied to a real data set obtained from 
Nottingham University Hospital and shows significant improvements compared to 
simple CBR which only considers similarity measure. However, there is still place for 
improving the dose plans toward more optimized values and a multi-objective 
optimization method to optimize the dose plans is being explained in the next chapter.  
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Chapter 4 
A Goal Programming-CBR model to optimize the dose planning for radiotherapy  
4.1 Introduction 
Treatment planning can be referred to as the heart of radiotherapy planning and its 
precision results in better outcomes for patients. An important step in designing a 
treatment plan is radiotherapy dose planning. The primary goal of oncologists and 
medical physicists is to deliver an effective amount of radiation dose to the patient, 
which should be concomitant with two principal features. Firstly, the dose should be 
high enough to eradicate the main tumour and cancer cells within the main organ 
involved as well as spreading microscopic tumours in surrounding organs. Secondly, 
the dose plan should be prescribed and shaped in such a value to allow the organs 
imposed by radiation to maintain their functionality. While an endeavour by treatment 
plan team is made to a trade-off between the two features, sometimes sacrifices are 
inevitable and require that healthy organs are exposed to some extent of radiation, in 
order to kill the cancer cells effectively(210).  
In chapter 3, an approach to determine the dose plan for radiotherapy in prostate cancer 
was introduced. As radiotherapy in prostate cancer is done in two phases, the developed 
system suggested the dose plan for each of the phases. In this approach, a hybrid 
TOPSIS-CBR method is developed to consider multiple criteria for prescribing a dose 
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plan rather than just the similarity measure which is the only feature used by simple 
CBR to find a solution to the problem. In the experiment, it was found that the case 
which has a high similarity measure is not always the most appropriate to base a 
decision on, because sometimes they have low success rate or dose received by 
different volume percentages of rectum surpass the restrictions as shown in table 4.1. 
In the developed method, initially, the similarities between a new case and the existing 
cases in the case pool are calculated through Euclidean CBR. Thereafter, the most 
similar cases to the new case, which satisfy a minimum similarity measure, are being 
evaluated by TOPSIS in respect of criteria related to dose planning. If the highest 
ranked case does not satisfy the dose limits regarding the rectum volumes, in the next 
step with a rule based-system, the solution will be modified by the second highest 
ranked case and the modified dose plan solution will be finally suggested to be 
prescribed for the new patient.  
The aforementioned approach achieved success rate improvements were demonstrated 
in the experiments and in comparisons of the doses with original dose plans with 
consideration of the DVH values of different percentages of the rectum. However, we 
find that the dose plans prescribed by TOPSIS-CBR are not optimal and there is scope 
for improvement. In some cases, the dose plan can increase without deviating the 
standard limitations and thus kill the cancer cells more effectively. Such an example is 
provided in table 4.1.  
Table 4.1 An example of a non-optimal solution 
Case 
number 
Dose in 
phase 1 
Dose in 
phase 2 
Distance to 
66% 
limitation 
Distance to 
50% 
limitation 
Distance to 
25% 
limitation 
Distance to 
10% 
limitation 
Case 37 54 10 5.68 2.4 2.48 6.74 
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In Table 4.1, the dose plan in phase I and II of the treatment provided by TOPSIS-CBR 
is 54 and 10 Gy respectively. However, this dose plan results in positive dose distances 
(detailed explanation about how to calculate these is provided in section 3) from 
limitations regarding different volumes of the rectum. These positive distances indicate 
that the dose plan is increasable without causing any considerable damages to OARs if 
necessary.    
In some other cases simply, the dose prescribed by the system is violating the 
limitations and thus is considered as a failure due to its hazardous effects on OARs. 
Such an example is provided in Table 4.2.  
Table 4.2 An example of non-feasible solution 
Case 
number 
Dose in 
phase 1 
Dose in 
phase 2 
Distance to 
66% 
limitation 
Distance to 
50% 
limitation 
Distance to 
25% 
limitation 
Distance to 
10% 
limitation 
Case 38 64 8 -2.6 -6.48 -5.32 -1.2 
 
In Table 4.2, the dose plan prescribed by TOPSIS-CBR is 64 and 8 Gy in phases I and 
II of the treatment respectively. Despite the fact that it provides with a more effective 
dose plan, compared to the original dose plan, all the standard limitations have been 
violated due to negative values of the distances.  
The aforementioned problems provided the motivation to develop an approach that 
prevents them happening as much as possible. To achieve more optimal dose plans, in 
this chapter Goal Programming is used to calculate the optimal dose plans for the 
treatment by endeavouring to achieve nearest dose plans to oncologists’ ideal dose 
plans while considering the side effects of the treatment and avoiding risks endangering 
patients. 
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4.2 Goal Programming 
Goal programming (GP) is basically a multi-objective linear optimization tool, which 
assists a solution to move towards an ideal goal. In some situations, conflict of interests 
or incompleteness of information makes it challenging to formulate a reliable 
mathematical model that captures the preferences of decision makers (211). Moreover, 
there are problems that the decision makers are already aware of regarding their desired 
final goals or targets for variables of the model and they demand an answer as close as 
possible to their goals. In such an environment GP is the perfect tool to deal with the 
multi-objective optimization problem.  
Goal programming consists of the following attributes: an objective function, a set of 
limitations related to goals and systematic constraints related to the geometry of the 
problem. The aim of the objective function is to minimize deviations from the given 
goals. The deviation in the objective function is usually weighted to define the priority 
of some objectives over others. Mathematical formulation of the Goal Programming is 
as follows: 
𝑚𝑖𝑛 𝑍 =∑(𝑤𝑘𝑑𝑘
+ + 𝑤𝑘𝑑𝑘
−)
𝑛
𝑗=1
                                                                                               (1) 
s.t.  
𝑓(𝑥1, ⋯ , 𝑥𝑖)𝑘 − 𝑑𝑘
+ + 𝑑𝑘
− = 𝑔𝑘            𝑘 = 1,2,⋯ , 𝑛;  𝑎𝑛𝑑 𝑖 = 1,2,⋯ ,𝑀;                (2) 
𝐴𝑋 ≤ 𝑜𝑟 ≥ 𝐵                                                                                                                            (3) 
Where, X is a set of variables, that is, 𝑋 = {𝑥1, 𝑥2, ⋯ , 𝑥𝑀}, A is a matrix consisting of 
coefficients for variables in our systematic constraints, B is a matrix for right side 
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values of systematic constraints and 𝑔𝑘 represents the goal corresponding to constraint 
k.  
𝑑𝑘
+and 𝑑𝑘
− are the auxiliary variables that demonstrate the upper and lower deviations 
from the goal 𝑔𝑘. In GP we try to minimize the undesirable deviations (211). When the 
objective is reaching a certain goal (exactly equal to the number which is considered 
as our goal), we try to minimize both upper and lower deviations from the goal as they 
are both undesirable for us. While the goal is to achieving equal or less than a certain 
value, then only the upper deviation (𝑑𝑘
+) is minimized as higher values than our goal 
is considered to be undesirable. On the other hand, when the goal is to achieving equal 
or more than a value, then only the lower deviation (𝑑𝑘
−) is minimized. In the objective 
function, we try to minimize the deviations based on our goals to satisfy the goals and 
𝑤𝑘 is the importance of the k
th goal compared to other goals.  
The application of these equations which converts the multi-objective optimization 
problem into single objective linear programming and can be solved by Simplex 
methods is available in numerous mathematical modelling packages such as LINGO 
and MATLAB.  
Application of GP is wide-ranging in different health-care domains of scheduling and 
outpatient prioritizing (212-216), healthcare planning (217,218) and waste 
management (219, 220). However, application of GP in healthcare interventions and 
medical decision making is scarce. The reason for this could be uncertainty and 
problems in determining the values of goals required. In this chapter, the real dataset 
case pool (used previously) is used again to provide an effective scenario to determine 
the ideal dynamic goals for the radiotherapy doses objectives which are explained in 
detail in section 3.1. Dynamic goals refer to the feature that goals for the objective 
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function can change and improve themselves based on the cases created in the pool 
(finding new solutions for cases) or by adding other real-life data.  
4.3 Solution methodology for improving CBR and optimizing the final dose plan 
During the study, it was found that sometimes the dose plan suggested by TOPSIS-
CBR is not optimal dose plan and there is a scope for improvement. Moreover, 
sometimes the calculated dose plan is not suitable for a new case as it may violate the 
recommended dose limits associated with different volume percentages of the rectum. 
To solve the above problem optimization of dose planning is performed using integer 
goal programming mathematical model, where the deviation from DVH recommended 
values is calculated with the help of best similar case suggested by CBR-TOPSIS. 
Thereafter, deviations corresponding to different volume percentages of the rectum are 
calculated using equation 4: 
𝑆𝑣
𝑝 = 𝑑𝑞1𝐷𝑉𝐻1𝑝
𝑣 + 𝑑𝑞2𝐷𝑉𝐻2𝑝
𝑣 − 𝑅𝑒𝑐𝑜𝑚𝑚𝑒𝑛𝑑𝑒𝑑 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑                                      (4) 
𝑆𝑣
𝑝
 represents devthe iation of a new case p corresponding to the different volume 
percentage of rectum v (v = 66%, 50%, 25%, 10%) that we consider for this new case-
based on the extracted case assigned to it from TOPSIS. Where 𝑑𝑞1 and 𝑑𝑞2 represent 
the dose of the extracted case in phases I and II of treatment respectively. This value 
shows how much the case, as determined by CBR-TOPSIS as the most appropriate for 
a new case, has either violated the recommended standard dose limits or kept its 
distance from them, based on the dose received by different volume percentage of the 
rectum.   
To treat cancerous cells, in real life sometimes oncologists overlook the recommended 
dose limit. The amount of deviation from the recommended limit is usually based on 
oncologist’s past experience. To employ the oncologist’s knowledge and expertise, 
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deviations are calculated based on the extracted past treated patients’ information 
stored in the database. The overall decision-making process applied in this chapter is 
shown in figure 4.1.  
 
 
 
                        
  
 
 
 
 
 
 
 
 
 
  
                                                               
 
 
 
 
 
 
 
 
Figure 4.1 Overview of the decision-making system in CBR-TOPSIS-GP 
C3 
 
C3 
Finding similarity 
measure 
 
Finding similarity 
measure 
S
am
e 
cl
in
ic
al
 s
ta
g
e 
fi
lt
er
 
 S
am
e 
cl
in
ic
al
 s
ta
g
e 
fi
lt
er
 
C1 
 
C1 
C4 
 
C4 
C3 
 
C3 
C5 
 
C5 
C2 
 
C2 
Similar cases 
 
Similar cases 
Similar cases 
evaluation through 
TOPSIS 
 
Similar cases 
evaluation through 
TOPSIS 
Case added to the 
case base 
 
Case added to the 
case base 
Dose plan optimization through Goal-
Programming  
 
Dose plan optimization through Goal-
Programming  
Necessary 
Modification if 
needed  
 
Necessary 
Modification if 
needed  
C1 
 
C1 
CBR 
improvement  
 
CBR 
improvement  C6 
 
C6 
Retrieval 
Process  
 
Retrieval 
Process  
C5 
 
C5 
Results feedback to 
oncologist for dose 
plan suggestion  
 
Results feedback to 
oncologist for dose 
plan suggestion  
C2 
 
C2 
C4 
 
C4 
Cn 
 
Cn 
Defining related 
Criteria for Case 
evaluation 
 
Defining related 
Criteria for Case 
evaluation 
New Case 
Entrance  
 
New Case 
Entrance  
72 
 
4.3.1 Determining the goals for Goal Programming  
During discussions with oncologists, it was found that the main objective of dose 
planning process is to maximize overall total dose while respecting the dose 
corresponding to the different volume percentage of the rectum. If two-dose plans have 
the same value of total dose and the dose received by different volume percentage of 
the rectum is within the constraint then the dose plan having the higher amount of dose 
in phase I is considered as a preferable dose plan. In this chapter, goals are set based 
on the abovementioned criteria. Goal objectives are as follows: 
Objective 1: Goal objective of the total dose plan is to assign the maximum amount of 
recommended dose in our case pool. 
Objective 2: Goal objective of the dose in Phase I is to deliver the maximum amount 
of dose prescribed in Phase I in the case pool. 
Objective 3: Goal objective of the dose plan in Phase II is to assign the maximum 
amount of dose prescribed in Phase II in the case pool. 
Figure 4.2 shows the process of modelling the GP problem.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 The process of modelling GP problem by using CBR and TOPSIS results 
Selection of the best-
ranked case from TOPSIS 
evaluation 
 
Selection of the best 
ranked case from TOPSIS 
evaluation 
Use the dose plan 
prescribed for the 
selected case 
 
Use the dose plan 
prescribed for the 
selected case 
Calculating the 
allowed deviation for 
50% of the rectum 
 
Calculating the 
allowed deviation for 
50% of the rectum 
Calculating the 
allowed deviation for 
66% of the rectum 
 
Calculating the 
allowed deviation for 
66% of the rectum 
Calculating the 
allowed deviation for 
25% of the rectum 
 
Calculating the 
allowed deviation for 
25% of the rectum 
Calculating the 
allowed deviation for 
10% of the rectum 
 
Calculating the 
allowed deviation for 
10% of the rectum 
Use the dose plan 
prescribed for the selected 
case 
 
Use the dose plan 
prescribed for the selected 
case 
Considering the ‘Goals’ 
for the objective function 
and ‘allowed deviations’ 
as constraints + adding 
technical constraints 
 
Considering the ‘Goals’ 
for th  objective function 
and ‘allow d deviations’ 
as constraints + adding 
technical constraints 
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The mathematical formulation for integer goal programming related to prostate cancer 
dose planning process is as follows: 
  
𝑀𝑖𝑛 𝑍 =∑(𝑤𝑘𝑑𝑘
+ + 𝑤𝑘𝑑𝑘
−)                                                                                               (5)
3
𝑗=1
 
𝑥1 + 𝑥2 − 𝑑1
+ + 𝑑1
− = 𝑔1                                                                                                       (6) 
𝑥1 − 𝑑2
+ + 𝑑2
− = 𝑔2                                                                                                             (7) 
𝑥2 − 𝑑3
+ + 𝑑3
− = 𝑔3                                                                                                             (8) 
𝐷𝑉𝐻66%
1𝑝 𝑥1 + 𝐷𝑉𝐻66%
2𝑝 𝑥2 + 𝑆66%
𝑝 ≤ 45;                                                                              (9) 
𝐷𝑉𝐻50%
1𝑝 𝑥1 + 𝐷𝑉𝐻50%
2𝑝 𝑥2 + 𝑆50%
𝑝 ≤ 55;                                                                              (10) 
𝐷𝑉𝐻25%
1𝑝 𝑥1 + 𝐷𝑉𝐻25%
2𝑝 𝑥2 + 𝑆25%
𝑝 ≤ 65;                                                                              (11) 
𝐷𝑉𝐻10%
1𝑝 𝑥1 + 𝐷𝑉𝐻10%
2𝑝 𝑥2 + 𝑆10%
𝑝 ≤ 70;                                                                              (12) 
𝑥1, 𝑥2 ≥ 0 and integer;                                                                                                     (13) 
𝑑1
+,−, 𝑑2
+,−, 𝑑3
+,− ≥ 0;                                                                                                            (14) 
Where, 
𝑘 = 1,2,3                The goals 
𝑥1                            Dose plan in Phase 1 of the treatment 
𝑥2                            Dose plan in Phase II of the treatment 
𝑤𝑗                            Weight of k
th goal 
𝑔1, 𝑔2 and 𝑔3           Goal objectives 
𝐷𝑉𝐻66,50,25,10%
1𝑝
         DVH values of case p, in the first phase of treatment corresponding 
to 66, 50, 25 and 10 percent of the rectum volume 
𝐷𝑉𝐻66,50,25,10%
2𝑝
         DVH values of case p, in the first phase of treatment corresponding 
to 66, 50, 25 and 10 percent of the rectum volume 
𝑆66,50,25,10%
𝑝
           The amount of deviation oncologists committed corresponding to               
different volume percentage of rethe ctum for the new case p.   
Equation 5 is the objective function for minimizing the deviations from our goals. 
Equations 9 to 14 are our goal related constraints, which determine deviations from 
total dose plan, dose plan in Phase I and II of the treatment respectively. Equations 6 
74 
 
to 8 are the systematic goals which restrict the optimization process to find solutions 
without violating the recommended doses based on oncologist’s suggestions and pre-
prescribed standards. Equation 13 achieves positive integer values for the dose plan.  
In above GP model, we try to optimize the total amount of dose plan, the dose in Phases 
I and II of the treatment so that they are as close as possible to the ideal dose amounts 
which are obtained from the dataset and in collaboration with oncologists’ suggestions. 
To do that we consider the deviations, gained from the best case selected for a new 
case by CBR-TOPSIS, from recommended standards (equation 4) as our constraints 
and the optimized dose is calculated to be as much as possible close to our goals. 
4.3.2. Maximization of dose plan within the safe risk zone 
If the dose received by different volume percentages of the rectum is within the 
constraint the dose plan is acceptable. The higher total dose increases the probability 
to kill the cancerous cells. So, in cases where there are positive 𝑆𝑣
𝑛, this means that a 
higher dose can be received and tolerated by the rectum without causing any significant 
damage. In the final step, modification is performed to minimize the deviation from 
recommended standards as described in equation 15.    
 
𝑆𝑣
𝑝 = {
𝑆𝑣
𝑝   𝑖𝑓  ≥ 0
0    𝑖𝑓    ≤ 0
                                                                                                              (15)     
 
In real life sometimes, oncologists overlook the recommended dose limit associated 
with a different volume percentage of the rectum. Similarly, in our proposed model the 
system will retrieve the past similar cases and it will decide the dose limit associated 
with a different volume percentage of the rectum. The proposed model will overlook 
the recommended dose limit if oncologists have taken similar decisions in the past. 
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Once the dose limit is set, goal programming method will search for the optimal dose 
plan.   
4.3.3. Modification rule for integer programming 
Usually, the dose is delivered in 2Gy packs. Hence, the dose in phase I and II of the 
treatment must be an even number. In order to solve the problem of odd numbers the 
following conditions are incorporated in programming: 
1- If calculated dose in Phases I or II is an odd number, then: 
a. Increase the dose by 1Gy. If dose received by different volume percentages of 
rectum violate the constraint, then decrease the dose by 1Gy. 
2- If dose plan in both Phases is an odd number, then: 
a. Increase the dose plan in both Phases of the treatment by 1Gy and check the 
limitation suggested by oncologists; if violated go to step b. 
b. Increase the dose plan in Phase I by 1Gy and decrease dose plan in Phase II by 
1Gy. Check the limitation suggested by oncologists; if violated go to step c. 
c. Decrease the dose plan in Phase I by 1Gy and increase dose plan in Phase II by 
1Gy. Check the limitation suggested by oncologists; if violated go to step d. 
d. Decrease the dose in Phase I and II by 1 GY.  
4.4 Numerical example 
In this section, a numerical example is considered to illustrate the execution process of 
the proposed method. In this example, a case is extracted from the database and 
assumed as a new case. Firstly, cases having the same clinical stage or adjacent to the 
new case are extracted from the database. After that, from the extracted cases the five 
most similar cases are retrieved and evaluated using TOPSIS method. The features 
values of five selected cases are depicted in Table 4.3. Corresponding to every five 
cases the numerical values of different evaluation criteria used in TOPSIS, are shown 
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in Table 4.4 Subsequently, the distance from PIS and NIS are calculated to find 
closeness coefficients as shown in Table 4.5. In the given example, case 4 has higher 
closeness coefficient compared to other cases and thus is selected as our guide (as an 
oncologist opinion) to calculate deviations from the recommended standard. 
Thereafter, with equation (4) the deviations from recommended dose limit are 
calculated (Table 4.6). 
 
Table 4.3: Features values of five retrieved cases  
 
 PSA GS 
DVH 
Phase 
I 
66% 
DVH 
Phase 
I 50% 
DVH 
Phase I 
25% 
DVH 
Phase 
I 
10% 
DVH 
Phas
e II 
66% 
DVH 
Phase 
II 
50% 
DVH 
Phase 
II 
25% 
DVH 
Phase II 
10% 
Cnew 7 
11.
9 
0.50 0.60 0.94 0.99 0.47 0.49 0.69 0.98 
Case
1 7 
6.8 0.50 0.60 0.94 0.99 0.48 0.49 0.61 0.95 
Case
2 7 
6.4 0.50 0.58 0.92 0.97 0.50 0.53 0.86 0.90 
Case
3 7 
12 0.51 0.69 0.97 0.99 0.47 0.50 0.87 0.98 
Case
4 7 
7.1 0.55 0.64 0.95 0.98 0.53 0.57 0.92 0.99 
Case
5 7 
13 0.52 0.55 0.91 0.98 0.52 0.53 0.87 0.98 
 
 
 
 
 
 
 
 
 
 
77 
 
Table 4.4 Numerical value of evaluation criteria used in TOPSIS 
Criteria 
 
Alternatives 
Dose 
plan in 
Phase I 
Dose 
plan in 
Phase 
II 
Deviation 
𝑆66% 
Deviation 
𝑆50% 
Deviation 
𝑆25% 
Deviation 
𝑆10% 
Similarity 
Measure (%) 
Case1 54 18 9.36 13.78 3.26 0.56 92.08 
Case2 46 24 10 15.6 2.04 3.78 83.51 
Case3 46 24 10.26 11.26 0.5 0.94 83.06 
Case4 46 24 6.98 11.88 0.78 1.16 79.4 
Case5 46 24 8.6 16.98 2.26 1.4 79.15 
 
 
Table 4.5 Distance from positive and negative ideal solution    
 NIS PIS CC Rank 
Case1   0.01200 0.00780 0.60311 3 
Case2 0.00151 0.01486 0.09260 5 
Case3 0.01693 0.00112 0.93760 2 
Case4 0.01456 0.00096 0.93791 1 
Case5 0.00727 0.00510 0.58735 4 
 
 
Table 4.6 Deviations from recommended dose limit 
Rectum volume 66% of rectum 50% of rectum 25% of rectum 10% of rectum 
Allowed 
deviations 
-10.7200 -15.6400 -5.2000 -0.9400 
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The initial number of similar cases is limited (i.e. five in this paper) based on an average 
similarity measure between a new case and cases in the case database. All the cases 
have been chosen as a new case and average similarity measure between 𝑡 =
3, 4, 5, 6 𝑎𝑛𝑑 7 most similar cases to them was calculated (Table 4.7). As can be seen 
by moving forward from 5 to 6 similar cases the average similarity measure of t cases 
with the new case significantly reduces from 81.1 to 70.5 percent and some outliers 
with less than 50% similarity to a new case were found. So, we chose 5 most similar 
cases as our initial number for the dose planning process.  
 
Table 4.7 Average similarity measure between first t similar case and a new case 
Number of similar cases t = 3 t = 4 t = 5 t = 6 t = 7 
Average similarity 
measures 
85.2% 83.6% 81.1% 70.5% 63.2% 
 
To optimize the dose plan goal programming is formulated. The importance of each of 
the goals needed to be assigned prior to execution of the model. In this research, the 
weight associated with total dose, the dose in Phases I and II are set as 0.70, 0.25 and 
0.05 respectively. Following weights have been assigned based on consultations and 
discussions with an oncologist in Nottingham City Hospital which reflect his expertise 
and experience gained regarding the importance of each phase of the treatment. It 
should be considered that there is a difference between each oncologist’s opinion 
regarding the importance of each stage of the treatment and there could not find a 
global optimal set of weights and as an advantage of a DSS, each oncologist can enter 
his desirable opinion as weight inputs.   
Here, higher weight is assigned to the total dose of treatment to maximize the overall 
recommended dose. When the maximum total dose is achieved the next goal is to 
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maximize the dose in Phase I. In Nottingham City Hospital maximum total dose, 
highest dose in Phases I and II are prescribed as 74Gy, 64Gy and 14Gy respectively. 
Hence, in this model, the constraint related to maximum total dose, the dose in Phases 
I and II is set as 74Gy, 64Gy and 14Gy respectively. 
The overall goal programming for the selected case is as follows: 
  
𝑀𝑖𝑛 𝑍 = 0.7𝑑1−
+ + 0.7𝑑1
− + 0.25𝑑2
− + 0.05𝑑3
− 
𝑥1 + 𝑥2 − 𝑑1
+ + 𝑑1
− = 74 
𝑥1 − 𝑑2
+ + 𝑑2
− = 64 
𝑥2 − 𝑑3
+ + 𝑑3
− = 14 
𝐷𝑉𝐻66%
1 𝑥1 + 𝐷𝑉𝐻66%
2 𝑥2 + 10.72 ≤ 45; 
𝐷𝑉𝐻50%
1 𝑥1 + 𝐷𝑉𝐻50%
2 𝑥2 + 15.64 ≤ 55; 
𝐷𝑉𝐻25%
1 𝑥1 + 𝐷𝑉𝐻25%
2 𝑥2 + 5.2 ≤ 65; 
𝐷𝑉𝐻10%
1 𝑥1 + 𝐷𝑉𝐻10%
2 𝑥2 + 0.94 ≤ 70; 
𝑥1, 𝑥2 ≥ 0 and integer; 
𝑑1
+,−, 𝑑2
+,−, 𝑑3
+,− ≥ 0; 
 
Due to positive values of DVH violation (𝑆𝑝 ≥ 0), there is a scope for improvement.  
To determine the dose limit of different volume percentage of the rectum we eliminated 
all the 𝑆𝑘 based on what we described in section 3.2. After solving the linear integer 
goal programming, the value of dose in Phases I and II is 56 GY and 14 GY 
respectively, which is within the safe recommended limit.  
4.5 Experimental Results 
In order to examine the effectiveness of the proposed methodology, the leave one out 
strategy was employed. Anonymous records of previously treated patients were 
collected from Nottingham City Hospital and stored in the database forming a 
collection of 69 cases. In leave-one-out approach, cases stored in our case base are 
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extracted one-by-one and considered as a new case. The dose plan related to each of 
the taken out cases is calculated through the proposed methodology and the result is 
compared with the dose plan prescribed by the oncologist. If there is any discrepancy 
between the dose plan computed by the proposed methodology and that prescribed by 
the oncologists’ then firstly the dose received by different volume percentage of the 
rectum is calculated. If dose received by the different volume percentages of the rectum 
is less than or equal to the recommended limit then the quality of dose plan is judged 
based on the following conditions.  
 
The dose plan having a higher amount of total dose is considered preferable because 
while radiation received by rectum is in the safe zone (lower than recommended 
standards) the probability of killing cancerous cells without damaging surrounding 
organs, especially rectum, is higher (125). However, if two plans have the same amount 
of total dose then the quality of the plan is judged based on the amount of dose 
prescribed in Phase I. In Phase I both cancer cells and the surrounding organs where 
cancer has spread are treated and the dose plan having the higher amount of dose in 
Phase I is preferable. If the dose plan generated by the proposed system is equal or 
better (based on abovementioned criteria) compared with the oncologist prescription 
then it is considered as a successful case.  
 
The success rate of the proposed method is 87.6%. In 57 cases (out of 65 cases) the 
dose plan suggested by the proposed method is the same as prescribed by the 
oncologists or better. More precisely, in 29 cases it generates a better dose plan. 
Further, in order to demonstrate the suitability of TOPSIS and goal programming 
method, it is compared with CBR and CBR-TOPSIS (Table 4.8 and Figure 4.3). The 
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performance of CBR-TOPSIS Goal programming is better than that of other 
approaches. 
Table 4.8 Comparison of the proposed methodology with other approaches 
 Simple CBR CBR+TOPSIS 
CBR+TOPSIS 
+ 
Modification rule 
CBR+TOPSIS 
+ 
GP 
Success rate (%) 73.43 83.6 86.88 87.6 
Number of cases 
with better dose 
plan 
15 18 20 29 
 
 
 
Figure 4.3 Graphical representation of success rate 
Also in order to further consider the number of retrieved most similar cases for 
consideration in TOPSIS evaluation, the whole experiment has been done for 𝑡 =
3, 4, 5, 6, 𝑎𝑛𝑑 7 most similar case to a new case (Table 4.9). Increasing the number of 
most similar cases from 4 to 5, the success rate of the process increased by 7.6%. 
Increasing the number of cases from 5 to 6 and 7 cases did not have an effect on the 
outcome of the process simply because the extra similar cases due to their low 
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similarity to the new case were not evaluated positively by TOPSIS to be considered 
as the reference case for GP optimization.     
Table 4.9 Success rate of the approach by considering different number of similar cases 
Number of cases 
Success rate 
t = 3 t = 4 t = 5 t = 6 t = 7 
Success rate (%) with 
CBR+TOPSIS+GP approach 
75.3 80 87.6 87.6 87.6 
Number of cases with better 
dose plan 
17 21 29 29 29 
 
4.6 Conclusion 
In this chapter a novel hybrid approach of TOPSIS, CBR and goal programming is 
proposed to help oncologists with decision making in radiotherapy dose planning for 
prostate cancer. Previously, in order to improve the simple CBR, an MCDM approach 
of TOPSIS has been merged with CBR to solve the radiotherapy dose planning 
problem and to include more factors in the process. However, through investigating all 
the cases solved through the TOPSIS-CBR approach and their prescribed solutions two 
main problems with cases counted as failures were found; ability to increase the dose 
plans without violating the recommended standards (non-optimality of some solutions) 
and trespassing of the standard limitation and putting surrounding organs at risk 
(solutions out of the feasible area of interest). 
 To optimize the solutions (obviating the first issue) within the feasible area considered 
by oncologists’ experiences (obviating the second issue) and propel the solutions 
towards desirable dose plans goal programming was used. Firstly, the similar process 
of choosing the most similar cases through CBR and evaluation of the extracted cases 
through TOPSIS was performed. Then based on deviations from the highest ranked 
case by TOPSIS the constraints of the goal programming model were determined. 
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Thereafter, the goal regarding the doses was formulated with respect to the values in 
the case pool and finally by solving the goal programming model the optimized doses 
for the new case were prescribed. The robustness of the proposed method was tested 
on real datasets collected from Nottingham City Hospital using leave-one-out strategy. 
In experiments, it was found that the proposed system helped oncologists to make a 
trade-off between different decision-making criteria and to decide on the optimal dose 
plan for the treatment.  
The success rate of the treatment can be considered as an output of the radiotherapy 
dose planning and it is measured by years of cancer-free probability determined by 
PSA values 2 years and 5 years after the treatment. Developing a model that is able to 
differentiate success rate with other factors involved in radiotherapy dose planning in 
evaluations can significantly improve the oncologist's ability to determine the extent 
of each solution’s efficiency. Furthermore, the uncertainty involved in oncologists’ 
judgments and scales in real life scenarios is an unavoidable aspect of the decision-
making process. The two mentioned problems will be the focus of further development 
of a model for radiotherapy dose planning in the next chapter.   
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Chapter 5 
Interval-valued Factor Analysis for unnecessary data reduction in DEA and its 
application in radiotherapy for prostate cancer 
5.1 Introduction 
Finding the appropriate amount of radiation dose is an important step in radiotherapy 
for prostate cancer. Use of intelligence systems, which is also known as, Artificial 
Intelligence (AI) is popular within the healthcare domain, and in particular, Cased-
Based Reasoning has been used extensively in order to help oncologists with decisions 
in radiotherapy planning. The application of CBR has been successful in dealing with 
simple diseases. However, when it comes to complex healthcare problems with 
multiple domains and several factors to be considered, CBR suffers lack of accuracy 
and may not provide a comprehensive solution (221).  
Dose planning is a complex problem and requires the consideration of many aspects of 
the process of planning. Thus, CBR may suffer from the same issue mentioned before 
subsequently. In order to improve the CBR results, in previous chapters, we applied 
MCDM methods to consider the multiple criteria nature of the problem. Furthermore, 
to direct the solutions toward optimized dose plans we used multi-objective 
optimization. By applying TOPSIS and defining various criteria, we considered not  
only the similarity between two cases but also took into account the values for other 
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dose planning characteristics and safe distance to the standard limitations. The obtained 
answers benefit from multi-aspect evaluations and have been filtered through various 
criteria. Their suitability to real-world decision-making scenarios dealt with by 
oncologists has been proven by their higher success rate compared to simple CBR.  
Moreover, these solutions made of a larger number of experiences, provided by CBR 
and TOPSIS, than a human brain can utilize. To obtain even more efficient answers, 
we applied a Goal Programming model using goals from the case pool of data and 
setting hard constraints regarding the DVH values to prevent the optimized solutions 
from violating the harmful dose amounts for OARs. The solutions provided not only 
exceed the success rate of previous approaches but also improved the number of dose 
plans with better solutions. 
For prostate cancer, the success rate of the treatment is determined by the Prostate 
Specific Antigen (PSA) value, measured two years after the treatment. The lower the 
level of the PSA, the higher is the possibility of cancer cells being eradicated 
effectively and the lower the probability of a cancer tumour reappearing. 
Accommodating this criterion in evaluations of cases can benefit patients significantly, 
as it gives higher importance weight to cases with better treatment results.  
While TOPSIS evaluates alternatives, and ranks them based on a distance approach, in 
the presence of criteria, which are dividable into sets of inputs and outputs as a result 
of the inputs, Data Envelopment Analysis (DEA) is a more reasonable method to 
calculate the efficiency of each of the alternatives.  DEA is an efficient and relatively 
common approach to compare the performance of a set of competing Units called 
Decision Making Units (DMUs). DEA has been applied on various forms of DMUs 
i.e. to evaluate the performance of countries from different perspectives [(222), (223)], 
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regions (224), hospitals (225), business firms (226), etc. However, due to very few 
assumptions required, DEA has also opened opportunities to evaluate the performance 
of cases which are difficult to investigate because of the complex relations between 
inputs and outputs of each DMU (227). 
Applying DEA to obtain the efficiency of the cases retrieved from CBR can equip us 
with a valuable tool to separate the criteria in our evaluations based on their essence 
and perform a better assessment. DEA does not come without limitations, the most 
important of which is a limitation on the number of inputs and outputs. Through 
increasing the number of inputs and outputs we can investigate the performance of a 
DMU from multiple points of view and increase the precision of the assessment. 
However, DEA in the presence of a high aggregative number of inputs and outputs in 
comparison to the number of DMUs can be unreliable and results in incorrect 
efficiency predictions.  
Furthermore, in recent years with massive data generation in various fields decision 
makers and managers are not dealing with small-scale problems and the massive 
number of alternatives and criteria can affect the calculation’s precision and 
computational time. In our problem, we are also dealing with a considerable number 
of criteria, as we used 7 criteria for TOPSIS evaluations. These criteria are dose plan 
in phase I and II of the treatment, similarity measure (indicates the similarity between 
a new case and the most similar cases) and the distance between the standard dose 
limitations and dose received by different volumes of the rectum (10%, 25%, 50% and 
66% of the rectum volume) which indicates the risk of the treatment (the higher the 
distance, the lower the risk of prescribed treatment is).  
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Adding up the success rate of the treatment is going to increase the number of criteria 
to 8. Thus, applying a methodology to decrease the dimensions of the problem, and 
reduce the unnecessary information and variables would be helpful. Adler and Golany 
(228,229), suggested using Principal Component Analysis (PCA), a methodology that 
produces uncorrelated linear combinations of original inputs and outputs, to improve 
discrimination in DEA with minimal loss of information. In this approach, it is assumed 
that removal of the Principal Components (PCs) with less exploratory ability has a 
venial effect on discrimination of our DMUs efficiency scores. Thus, a higher number 
of criteria are waved in the calculations and only principal components, which account 
for most of the variance of the observed variables, are considered.  
Although PCA is a reliable variable reduction method it is different in several aspects 
with Factor Analysis (230). Principal Components in PCA retained account for a 
maximum amount of variance of observed variables. The main goal in PCA is to create 
a few index variables out of a large set of measured variables in an optimal way. The 
number of the components, existing variables in each component and the weight of the 
variables in the components are calculated in an optimal way. FA is a method to 
measure a latent variable which cannot be measured with a single variable and must be 
seen through the relationship it creates between a set of other variables (231).   
In FA, factors account for common variance in the data. In PCA, Component scores 
are a linear combination of the observed variables weighted by eigenvectors while in 
FA observed variables are linear combinations of the underlying and unique factors. 
Identification and interpretation of inputs and outputs, which decrease or improve the 
efficiency is important to us in DEA. Therefore, applying FA and exploratory factors 
as the source of DEA inputs and outputs entry can be helpful in post-analysis 
discussions.  
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In real life scenarios, oncologists, in order to make a decision about a dose plan, do not 
treat all the parameters involved with exact precision based on crisp numbers and there 
is some level of uncertainty in their judgment. To reflect this uncertainty in our dose 
plan calculation and approach the way oncologists take decisions we found applying 
grey numbers associated with opinions of oncologists in real life scenarios, an 
advantageous method. Grey theory and consequently grey numbers application are 
suitable to handle the incomplete and uncertain interval-valued data within the 
preferences of decision makers. Thus, the main aim of this research is to develop a 
solution to apply Data Envelopment Analysis (DEA) in the presence of numerous 
interval data inputs and outputs and obtain as much as possible precise efficiency 
scores for the Decision-Making Units (DMUs) to calculate the appropriate dose plan 
for radiotherapy dose planning. In order to do so, we apply FA based on PCA to reduce 
the dimension of our data.  
In this chapter, the interval-valued PCA for grey numbers is synchronised and the 
exploratory factors (EFs) for a set of inputs and outputs are obtained. The purpose is 
to illustrate the proposed MCDM approach of Data Envelopment Analysis combined 
with Factor Analysis for interval grey numbers and demonstrate its efficiency in 
solving the issues faced in radiotherapy dose planning. The EFs and PCs will be used 
as variables separately to be fed into DEA and results of efficiency scores based on 
interval-valued DEA will be carried out for them. In order to closely reflect a real-life 
scenario, where the oncologists expressed their preferences about one criterion by 
approximated linguistic terms, the data acquired from real cases will be transformed to 
grey intervals of 𝐺 = [𝐺, 𝐺] where it is appropriate and matches reality. The benefits 
of applying variable reduction techniques by performing FA-PCA-DEA on grey type 
data are demonstrated and the analysis is extended by interpreting the factors and 
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highlighting the important inputs and outputs for the evaluation of this certain problem. 
The main contributions of this chapter can lie on: 
• Firstly, the introduction of a platform to perform more inclusive and accurate 
evaluation. This is achieved by considering more input and output attributes in 
presence of uncertainty preference of DM about an alternative, applying PCA 
and FA on grey data and preparing the obtained variables to be used in MCDM 
methods, specifically in this approach, the DEA method.  
• Secondly, to provide a better solution for radiotherapy dose planning problem 
for prostate cancer by considering uncertainty involved in human judgments 
and a detailed step by step approach (Figure 5.1).  
 
 
 
 
 
 
Figure 5.1 Overview of PCA-FA-DEA based on CBR solution to radiotherapy dose planning problem  
 Application of PCA as an approach, which produces data with lower complexity in 
order to be used by other methods, has drawn the attention of many researchers. Lam 
et al. (232) applied ANP to principal components obtained from a fuzzy decision 
matrix of judgments by decision-makers in the construction industry to evaluate their 
material suppliers. However, before applying PCA, they defuzzified their fuzzy data 
and thus did not develop any method to perform PCA on fuzzy data. Doukas et al. 
(233) applied PCA to produce sustainable energy performance indicators for different 
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communities in the EU. The authors never tried to present an approach that can actually 
evaluate these communities and sufficed to just prepare the background for future 
research. As previous research in the direction of utilizing PCA for data reduction to 
be used in DEA is concerned, Adler and Golany (228), for the first time evaluated the 
efficiency of deregulated airline networks in European Union by the means of DEA 
and in order to overcome the excessive amount of inputs and outputs, applied PCA.  
Jenkins and Anderson (234) argued that omitting even highly correlated variables can 
extensively impact the efficiency score results and Dyson (235) pointed out that only 
analysing simple variances is in some levels insufficient to distinguishing unimportant 
variables. Poldaru and Roots (236) used the same combination of PCA and DEA to 
compare the quality of life in Estonian counties and through comparison of PCA-DEA 
with simple DEA demonstrated the valuable distinction improvement that PCA can 
add to DEA. All the aforementioned examples applied crisp values and datasets, while 
the uncertainty in real life scenarios necessitates the application of interval data in 
evaluations.  
Cazes et al. (237) introduced two methods of Centralized PCA (CPCA) and vertex 
PCA (VCPA) to deal with applying PCA of interval-data and Wang et al. (238) extend 
their method to Complete Information PCA (CIPCA) by introducing a new squared 
norm of an interval-valued variable. Liu et al. (239) developed the PCA method for 
intuitionistic fuzzy numbers and introduced new operators to deal with them in order 
to apply them in group decision-making problems over a large set of data. After that, 
they obtained each alternative's overall evaluation value by utilizing conventional 
information aggregation operators. An extensive literature review has not revealed any 
research in which PCA for grey data has been considered and furthermore the 
application of FA in DEA has been investigated.    
92 
 
 5.2 Methodology 
In this section, different methodologies applied within this chapter are presented. 
Following an initial review of the interval grey numbers the method enabling PCA in 
the presence of grey numbers is introduced. After that, the Factor Analysis is described 
by using components of PCA and explanatory comments about why and how to rotate 
the final factors for simpler structure. Finally, Interval DEA is illustrated and discussed.  
5.2.1. Interval Grey Numbers 
Deng (240), through combining System theory, Space theory and Control theory 
introduced a new type of expressing data called grey theory and grey sets. A grey 
system is defined as a system capable of covering uncertain information presented by 
a grey number and a grey variable. For defining a grey number let X be the universal 
set and 𝑥 ∈ 𝑋. Then a grey set G of X is defined by its two mappings in equation 1 and 
2: 
?̅?𝐺(𝑥): 𝑥 → [0,1]                                                                                                                     (1) 
𝜇𝐺(𝑥): 𝑥 → [0,1]                                                                                                                     (2) 
In above equations, ?̅?𝐺(𝑥) and 𝜇𝐺(𝑥) are upper and lower membership functions 
respectively. Generally, Grey numbers are expressed as: 
⨂𝐺 = 𝐺| ?̅?
𝜇
                                                                                                                               (3) 
While the lower and upper memberships can be estimated and an interval-valued grey 
number with lower and upper bound can be defined as: 
⨂𝐺 = [𝐺, 𝐺]                                                                                                                           (4) 
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If we assume⨂𝐺1 = [𝐺1, 𝐺1] and ⨂𝐺2 = [𝐺2, 𝐺2] two Grey interval numbers then, the 
main operations on grey numbers is done through following: 
⊗G1 + ⊗G2 = [𝐺1 + 𝐺2 , 𝐺1 + 𝐺2]                                                                                    (5) 
⊗G1 − ⊗G2 = [𝐺1 − 𝐺2, 𝐺1 − 𝐺2]                                                                                     (6) 
⊗G1×⊗G2=[min( 𝐺1 𝐺2, 𝐺1 𝐺2, 𝐺1 𝐺2, 𝐺2 𝐺1), 
max(𝐺1 𝐺2, 𝐺1 𝐺2, 𝐺1 𝐺2, 𝐺2 𝐺1)]                                                                            (7) 
⊗G1 ÷ ⊗G2 = [𝐺1 , 𝐺1] × [
1
𝐺2
 ,
1
𝐺2
]                                                                                       (8) 
Also, the lengths of a grey number can be calculated as follow: 
𝐿(⨂𝐺) = |𝐺 − 𝐺|                                                                                                                   (9) 
Application of grey system theory has been common in medical treatment literature as 
it can perfectly deal with the ambiguity of medical data. Xuerui and Yuguang (241) 
applied Grey Relational Analysis (GRA) on several experimental and trial medical data 
set to analyse and evaluate them. Icer at al. (242) applied grey data and GRA to assess 
the values for fatty liver and developed an approach based on GRA and 
ultrasonography, which eliminated the visual evaluation of radiologists and improved 
the diagnosis results. Li et al. (243) applied GRA in combination with Dempster–
Shafer theory of evidence to find an appropriate level of soft sets for fuzzy soft sets 
and demonstrated its effectiveness in medical diagnosis where the final diagnosis of 
medical experts comes along with levels of uncertainty and improved the precision of 
diagnosis.   
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5.2.2. PCA 
There are two main viewpoints of algebraic and geometrical approaches to drive 
Principal Components (PCs). The main goal of PCA is to describe variations in a set 
of relatively correlated variables 𝑋′ = (𝑥1, 𝑥2, ⋯ , 𝑥𝑚), due to a new set of uncorrelated 
variables of 𝑍′ = (𝑧1, 𝑧2, ⋯ , 𝑧𝑘). Each of the PCs is a linear combination of variables 
of 𝑋 array. The PCs are driven out in such a way that the first PC accounts for the most 
variations among others and there is a decreasing order of importance (fewer 
variations) between first and last PC. Given m random variables  𝑥1, 𝑥2, ⋯ , 𝑥𝑚, we can 
express the PCs as 𝑍𝑘 = ∑ 𝐿𝑗𝑘𝑋𝑗
𝑚
𝑗=1 . Initially, the variances of 𝑍𝑘 should be 
maximized subject to 𝐿𝑘
′ 𝐿𝑞 = 0 for all the 𝑙 ≠ 𝑞 and 𝐿𝑘
′ 𝐿𝑘 = 1. If we define H as the 
known covariance matrix of the x variables, then we can demonstrate through Lagrange 
multiplier technique that vector of coefficients related to the kth Component of Z is 
eigenvectors of the H matrix respected to the kth largest eigenvalue. So as if we denote 
the p biggest eigenvalues of the H by 𝜆𝑖 𝑎𝑛𝑑 𝑖 = (1, 2,⋯ , 𝑝) then the variance of the 
ith PC is described by 𝜆𝑖.  
5.2.2.1 PCA for Grey data: 
Each grey number is an interval-valued number, in the form of a uniform distributed 
variable in the 𝐺 and 𝐺 intervals as lower and upper boundaries respectively. 
Furthermore, grey numbers are regarded with infinitely density over their boundaries. 
So, some of the basic operators have been commonly used for interval uniformly 
distributed and infinite dense numbers, variance-covariance matrix for interval valued 
data (237) and the process of extracting principal components for interval valued data 
[(238), (239)] has been reviewed and made compatible with Grey numbers as follow.  
Definition 1. The mean of a grey number is calculated based on the following equation: 
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𝐸(⨂𝐺) =
∫ 𝐴.𝑑𝐴
𝐺
𝐺   
𝐺−𝐺
=
1
2
(𝐺 − 𝐺)                                                                                          (10)           
So if we have a variable 𝐺𝑗
′ = ([𝐺1𝑗, 𝐺1𝑗] , [𝐺2𝑗, 𝐺2𝑗] ,⋯ , [𝐺𝑚𝑗, 𝐺𝑚𝑗]) then the mean 
of such a variable is given by 
𝐸(𝐺𝑗
′) = 1/𝑚∑𝐸(𝐺𝑖𝑗)                                                                                                   (11)
𝑛
𝑖=1
 
Thus, a centralized matrix of 𝑥𝑖𝑗 is based on following formula: 
𝐺𝑖𝑗 − 𝐸(𝐺𝑗
′) = [𝐺𝑖𝑗 − 𝐸(𝑋𝑗
′), 𝐺𝑖𝑗 − 𝐸(𝑋𝑗
′)]                                                                    (12) 
Definition 2. Where (𝑙 ≠ 𝑚), for any two grey interval variables of 𝑋𝑙
′ and 𝑋𝑚
′  the 
inner product of these two numbers, denoted by (𝑋𝑙
′, 𝑋𝑚
′ )  is calculated based on 
summation the of inner product of 𝐺𝑖𝑙 and 𝐺𝑖𝑚.  
(𝑋𝑙
′, 𝑋𝑚
′ ) =∑(𝐺𝑖𝑙, 𝐺𝑖𝑚)
𝑛
𝑖=1
                                                                                                    (13) 
The term (𝐺𝑖𝑙, 𝐺𝑖𝑚) is calculated based on following: 
(𝐺𝑖𝑙, 𝐺𝑖𝑚) =
∫ ∫ 𝐴𝑇. 𝑑𝐴𝑑𝑇
𝐺𝑖𝑚
𝐺𝑖𝑚
𝐺𝑖𝑙
𝐺𝑖𝑙
  
(𝐺𝑖𝑙 − 𝐺𝑖𝑙)(𝐺𝑖𝑚 − 𝐺𝑖𝑚)
=
1
4
(𝐺𝑖𝑙 + 𝐺𝑖𝑙)(𝐺𝑖𝑚 + 𝐺𝑖𝑚)                         (14) 
While the inner product operator defined in definition 2 is only applicable for two 
different variables, we cannot drive the squared norm of a variable 𝑋𝑗 as ‖𝑋𝑗‖
2
 and 
equal it by (𝑋𝑗, 𝑋𝑗). Instead, we add a new definition based on Wang et al. [238] and 
calculate the mentioned value through it. 
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Definition 3. The squared norm of an interval variable of 𝑋𝑗 is obtained by 
‖𝑋𝑗‖
2
=∑‖𝐺𝑖𝑗‖
2
                                                                                                              (15)
𝑛
𝑖=1
 
Where the term ‖𝐺𝑖𝑗‖
2
 is given by following integral 
‖𝐺𝑖𝑗‖
2
= ∫ 𝐴2.
1
𝐺𝑖𝑗 − 𝐺𝑖𝑗
𝐺𝑖𝑗
𝐺𝑖𝑗
𝑑𝐴 =
1
3
(𝐺𝑖𝑗
2 + 𝐺𝑖𝑗𝐺𝑖𝑗 + 𝐺𝑖𝑗
2
)                                            (16) 
The most important operator for conducting PCA is how to calculate the covariance 
matrix. So, the terms 𝐶𝑜𝑣(𝑋𝑙
′, 𝑋𝑚
′ ) and 𝑉𝑎𝑟(𝑋𝑗
′) is given by 
𝐶𝑜𝑣(𝑋𝑙
′, 𝑋𝑚
′ ) =
1
𝑛
(𝑋𝑙
′, 𝑋𝑚
′ )                                                                                                  (17) 
𝑉𝑎𝑟(𝑋𝑗
′) =
1
𝑛
‖𝑋𝑙‖
2                                                                                                              (18) 
In order to demonstrate the covariance matrix of  𝑋𝑛×𝑝 all the variables 𝐺𝑖𝑗 have to be 
centralized based on equation 12 and after that, the covariance matrix is computed 
based on the following: 
(
 
 
𝑉𝑎𝑟 𝑋1     𝐶𝑜𝑣(𝑋1, 𝑋2)   ⋯     𝐶𝑜𝑣(𝑋1, 𝑋𝑝)
𝐶𝑜𝑣(𝑋2, 𝑋1)       𝑉𝑎𝑟𝑋2   ⋯    𝐶𝑜𝑣(𝑋2, 𝑋𝑝)
⋮                        ⋮              ⋱                 ⋮     
𝐶𝑜𝑣(𝑋𝑝, 𝑋1)    𝐶𝑜𝑣(𝑋𝑝, 𝑋2)  ⋯    𝑉𝑎𝑟𝑋𝑝    )
 
 
=
(
 
 
 
 
1
𝑛
 (𝑋1, 𝑋1)      
1
𝑛
 (𝑋1, 𝑋2)  ⋯   
1
𝑛
(𝑋1, 𝑋𝑝)
1
𝑛
(𝑋2, 𝑋1)       
1
𝑛
(𝑋2, 𝑋2)   ⋯   
1
𝑛
(𝑋2, 𝑋𝑝)
⋮                  ⋮         ⋱          ⋮
1
𝑛
(𝑋𝑝, 𝑋1)       
1
𝑛
(𝑋𝑝, 𝑋2)   ⋯   
1
𝑛
(𝑋𝑝, 𝑋𝑝))
 
 
 
 
 
=
(
 
 
 
 
 
1
3
(𝐺𝑖1
2 + 𝐺𝑖1𝐺𝑖1 + 𝐺𝑖1
2
)   
1
4
(𝐺𝑖1 + 𝐺𝑖1)(𝐺𝑖2 + 𝐺𝑖2)  ⋯   
1
4
(𝐺𝑖1 + 𝐺𝑖1)(𝐺𝑖𝑝 + 𝐺𝑖𝑝)
1
4
(𝐺𝑖2 + 𝐺𝑖2)(𝐺𝑖1 + 𝐺𝑖1)  
1
3
(𝐺𝑖2
2 + 𝐺𝑖2𝐺𝑖2 + 𝐺𝑖2
2
)    ⋯  
1
4
(𝐺𝑖2 + 𝐺𝑖2)(𝐺𝑖𝑝 + 𝐺𝑖𝑝) 
    ⋮                                               ⋮                      ⋱                             ⋮
1
4
(𝐺𝑖𝑝 + 𝐺𝑖𝑝)(𝐺𝑖1 + 𝐺𝑖1)  
1
4
(𝐺𝑖𝑝 + 𝐺𝑖𝑝)(𝐺𝑖2 + 𝐺𝑖2)   ⋯    
1
3
(𝐺𝑖𝑝
2 + 𝐺𝑖𝑝𝐺𝑖𝑝 + 𝐺𝑖𝑝
2
))
 
 
 
 
 (19) 
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5.2.3 Linear Combination of Interval Value Data 
Based on Moore’s work (244) each interval-valued data unit of 𝐺𝑖 = [𝐺𝑖, 𝐺𝑖] and 𝑖 =
1,2,⋯ , 𝑛 the data can also be indicated as a continuous numeric set with lower and 
upper boundaries i.e. 𝐺𝑖 = {𝑠|𝑠𝜖[𝐺𝑖, 𝐺𝑖]}. Thus, if we have a function of various G we 
can say: 
𝑓(𝐺1, 𝐺2, ⋯ , 𝐺𝑛) = {𝑓(𝑠1, 𝑠2, ⋯ , 𝑠𝑛)|𝑠𝑖𝜖𝐺𝑖}                                                                  (20) 
The fact that f is a continuous function of Moore’s linear combination algorithm for 
interval value data is based on: 
𝑌 =∑𝑢𝑗𝑋𝑗 = ([𝑦1, 𝑦1] , [𝑦2, 𝑦2] ,⋯ , [𝑦𝑛, 𝑦𝑛])                                                           (21)
𝑛
𝑗=1
 
Assuming 𝑋𝑗 as an interval valued variable with n interval value data, for 𝑢𝑗𝜖𝑅, 𝑗 =
1,2,⋯ ,𝑚 we are able to define a new variable Y like above which is a linear 
combination of our primary 𝑋𝑗 variables in which lower and upper boundaries of 𝑦𝑖 are 
given by: 
𝑦𝑖 = ∑ 𝑢𝑗(𝜇𝐺𝑖𝑗 + (1 − 𝜇)𝐺𝑖𝑗)              𝑓𝑜𝑟 1 ≤ 𝑖 ≤ 𝑛                                               (22)
𝑝
𝑗=𝑚
 
𝑦
𝑖
= ∑ 𝑢𝑗 ((1 − 𝜇)𝐺𝑖𝑗 + 𝜇𝐺𝑖𝑗)           
𝑝
𝑗=𝑚
𝑓𝑜𝑟 1 ≤ 𝑖 ≤ 𝑛                                               (23)  
And respect to the fact that 𝜇 = {
0    𝑖𝑓      𝑢𝑗 ≤ 0
   
1    𝑖𝑓      𝑢𝑗 > 0
                                                        (24)  
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5.2.4 Eigen Vector and Eigen values computation in Grey Principal Components 
Analysis 
Similar to previous sections, all the interval value grey numbers have been centralized 
through equation (12). Given 𝑝 grey variables of 𝑋1, 𝑋2, ⋯ , 𝑋𝑝, the 𝑘th PC 𝑌𝑘 (𝑘 =
1,2,⋯ , 𝑝) is a linear combination of grey variables, i.e. 𝑌𝑘 = 𝑋𝑒𝑘 = ∑ 𝑒𝑗𝑘𝑋𝑗
𝑝
𝑗=1  where 
we can define 𝑒𝑗𝑘 = (𝑒1𝑘, 𝑒2𝑘, ⋯ , 𝑒𝑚𝑘)
𝑇 which is subject to 𝑒𝑘
𝑇𝑒𝑘 = 1 and 𝑒𝑘
𝑇𝑒𝑙 = 0, 
∀ 𝑙 ≠ 𝑘. The variance of 𝑌𝑘 can be defined as  
𝑉𝑎𝑟(𝑌𝑘) = 𝐶𝑜𝑣(𝑌𝑘, 𝑌𝑘) =
1
𝑛
(𝑌𝑘, 𝑌𝑘)                                                                                (25) 
Where  
1
𝑛
(𝑌𝑘, 𝑌𝑘) = 𝑒𝑘
𝑇𝐶𝑒𝑘                                                                                                                (26) 
In equation (26), C represents for the covariance matrix of grey variables of  
𝑋1, 𝑋2, ⋯ , 𝑋𝑝.  
The following derivation is the same one for a classical PCA in which we are looking 
after the 𝑚 orthonormalized vectors of 𝑒1, 𝑒2, ⋯ , 𝑒𝑚 that maximize the total variance 
term of ∑ 𝑉𝑎𝑟(𝑌𝑘)
𝑚
𝑘=1  subject to 𝑉𝑎𝑟(𝑌1), 𝑉𝑎𝑟(𝑌2),⋯ , 𝑉𝑎𝑟(𝑌𝑚) by solving the 
following optimization problem: 
𝑀𝑎𝑥 ∑𝑒𝑘
𝑇𝐶𝑒𝑘,
𝑚
𝑘=1
                                                                                                                    (27) 
𝑠. 𝑡.
{
 
 
𝑒𝑘
𝑇𝑒𝑘 = 1,                                      
𝑒𝑘
𝑇𝑒𝑘 = 0,                                       
𝑒1
𝑇𝐶𝑒1 ≥ 𝑒2
𝑇𝐶𝑒2 ≥ ⋯ ≥ 𝑒𝑚
𝑇 𝐶𝑒𝑚
𝑙 = 1,2,⋯ ,𝑚 𝑎𝑛𝑑 𝑙 ≠ 𝑘.          
                                                                               (28) 
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The optimal solution of above problem, 𝑒1, 𝑒2, ⋯ , 𝑒𝑚 are the eigenvectors of C 
corresponding to eigenvalues of 𝜆1, 𝜆2, ⋯ , 𝜆𝑚. By means of such an 
eigendecomposition of covariance matrix C, the derivation of PC coefficients is 
converted to a simple eigendecomposition problem. Through obtaining  𝑒1, 𝑒2, ⋯ , 𝑒𝑚 
we can finally have the 𝑘th PCs of 𝑌1, 𝑌2, ⋯ , 𝑌𝑚. 
5.2.5 Inclusion of data by PCs 
As eigenvectors of each PC (𝜆𝑖) are equal to the variance of that component, this could 
be interpreted as the amount of the total variance of the data which is being included 
in the component. If we chose the first 𝑘th PCs then the amount of total variance 
included by them can be calculated through the following: 
𝑉𝑎𝑟𝑖𝑎𝑛𝑐𝑒 𝑖𝑛𝑐𝑙𝑢𝑠𝑖𝑜𝑛 𝑎𝑚𝑜𝑢𝑛𝑡 =
∑ 𝜆𝑖
𝑘
𝑖=1
∑ 𝜆𝑖
𝑚
𝑖=1
                                                                        (29) 
 
 5.2.6 Factor Analysis 
Factor Analysis (FA) pursues the same goals as PCA. The most important of them are 
describing 𝑝 variables in a a lower number of factors to decrease the complexity of 
further calculations and understanding the relying relation between the variables. One 
way to calculate the Factors in FA is first obtaining the PCs of the data and apply them 
as the primary un-rotated Factors. Given the 𝑝 variables of  𝑋1, 𝑋2, ⋯ , 𝑋𝑝, we have 𝑝 
Principal Components we calculated in previous sections as follow: 
𝑌1 = 𝑒11𝑋1 + 𝑒12𝑋2 +⋯+ 𝑒1𝑝𝑋𝑝 
𝑌2 = 𝑒21𝑋1 + 𝑒22𝑋2 +⋯+ 𝑒2𝑝𝑋𝑝 
.                                                                                                                                     Step(1) 
. 
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𝑌𝑝 = 𝑒𝑝1𝑋1 + 𝑒𝑝2𝑋2 +⋯+ 𝑒𝑝𝑝𝑋𝑝 
 
This transformation of 𝑋 is orthogonal to 𝑌 so that the following equations are simply 
acquired 
𝑋1 = 𝑒11𝑌1 + 𝑒12𝑌2 +⋯+ 𝑒1𝑝𝑌𝑝 
𝑋2 = 𝑒21𝑌1 + 𝑒22𝑌2 +⋯+ 𝑒2𝑝𝑌𝑝 
.                                                                                                                                     Step(2) 
. 
𝑋𝑝 = 𝑒𝑝1𝑌1 + 𝑒𝑝2𝑌2 +⋯+ 𝑒𝑝𝑝𝑌𝑝 
Regarding section 2.3 about the inclusion of PCs only the first 𝑚 PCs are being selected 
which include the majority of information and so the model 2 is being transformed to 
following to model 3: 
𝑋1 = 𝑒11𝑌1 + 𝑒12𝑌2 +⋯+ 𝑒1𝑚𝑌𝑚 + 𝐸1 
𝑋2 = 𝑒21𝑌1 + 𝑒22𝑌2 +⋯+ 𝑒2𝑚𝑌𝑚 + 𝐸2 
.                                                                                                                              Step(3)  
. 
𝑋𝑝 = 𝑒𝑝1𝑌1 + 𝑒𝑝2𝑌2 +⋯+ 𝑒𝑝𝑚𝑌𝑚 + 𝐸𝑝 
Elimination of some PCs will cause errors. 𝐸𝑝s are residuals with zero means and 
correlations of zero with the factors.  Now by standardization of the PCs should be 
done so that they have unit variance and can be transformed into appropriate Factors. 
To do so each PC of 𝑌𝑚 is being divided by its standard deviation √𝜆𝑚 which is the 
root of the related eigenvalue in covariance matrix for  𝑌𝑚 and thus the equations above 
become as follow: 
𝑋1 = 𝑎11𝐹1 + 𝑎12𝐹2 +⋯+ 𝑎1𝑚𝐹𝑚 + 𝐸1 
𝑋2 = 𝑎21𝐹1 + 𝑎22𝐹2 +⋯+ 𝑎2𝑚𝐹𝑚 + 𝐸2 
.                                                                                                                                    Step(4) 
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. 
𝑋𝑝 = 𝑎𝑝1𝐹1 + 𝑎𝑝2𝐹2 +⋯+ 𝑎𝑝𝑚𝐹𝑚 + 𝐸𝑝 
 
In model 4 𝐹𝑚 and 𝑎𝑚 are based on follow 
 
𝐹𝑚 =
𝑌𝑚
√𝜆𝑚
                                                                                                                              (30) 
𝑎𝑝𝑚 = √𝜆𝑚 × 𝑒𝑝𝑚                                                                                                               (31) 
So, the 𝑝 variables of  𝑋1, 𝑋2, ⋯ , 𝑋𝑝 are being described through 𝑚 Factors of 
𝐹1, 𝐹2, ⋯ , 𝐹𝑚.  
In order to obtain the factors, we rely on matrix algebra relations by Harman (245). 
The final equations calculated above can be described in Matrix form based on 
equation 32. 
𝑋𝑚×𝑝 = 𝐴𝑝×𝑚
𝑇 𝐹𝑝×𝑚                                                                                                              (32) 
F can be obtained by the following calculations: 
𝐹 = 𝐴−1𝑇𝑋 = (𝐴. 𝐴𝑇)−1𝐴. 𝑋                                                                                              (33) 
5.2.7 Varimax Rotation 
Factors rotation is performing an arithmetic operation to obtain a new set of factor 
loadings which explain the structure of the original factors simpler and more 
interpretable. This operation is done through rotating axis or dimensions of the factor 
loadings (246-248). For correlated factors oblique rotation and for uncorrelated factors, 
orthogonal rotation are the best options. While after the rotation the partition of 
variances explained by axes is changed, but the part of variance explained by the total 
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subspace after rotation is the same as it was before rotation. Assuming we have only 
two dimensions of X and Y in an exemplary problem, figure 5.2 shows what happens 
during a rotation.  
 
Figure 5.2 visualization of factor rotation 
In figure 5.2 the original X and Y axes, are X1 and Y1 in black and factor loadings are 
the dots. Following axes rotation, the factor loadings are better explained by new X or 
Y axes (X2 and Y2). While the factor loadings are same before just the axes have been 
rotated to better explain the situation. In this research, because our exploratory factors 
have been obtained from Uncorrelated PCS, we have selected the Varimax rotation by 
Kaiser criterion which is the most common orthogonal rotation. The process will be 
done through MATLAB software and statistical toolbox.  
5.2.8 Interval DEA 
Data Envelopment Analysis (DEA) is a data-oriented approach to evaluate the 
performance of a set of peer entities called Decision Making Units (DMUs). As a linear 
programming technique, DEA measure the efficiency of the aforementioned DMUs on 
the basis of multiple weighted inputs and multiple weighted outputs (227). The weights 
are estimated in such a way to maximize the efficiency of the unit under evaluation. In 
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recent years a variety of DEA applications in different fields involving various types 
of DMU have been developed. Furthermore, because of few assumption requirements 
in DEA, it has become the preferable method for a range of fields to handle the complex 
relation between inputs and outputs of a problem. A common use of DEA is in finding 
the efficiency of hospitals and healthcare deliveries. Nayar and Ozcan (249), evaluated 
the efficiency of Virginia hospitals and classified the efficient and inefficient hospitals 
regarding both technical and quality efficiencies and remedied suggestions for 
inefficient hospitals to improve their performance. Kawaguchi et al. (250) applied a 
dynamic network DEA to calculate the efficiency of the municipal hospitals in Japan. 
They used network DEA to calculate the efficiency of two types of departments within 
the hospital, medical and administrative, simultaneously with the overall efficiency of 
the hospital. They applied the dynamic model to calculate the results for a series of 
years. Thanassoulis et al. (251) applied DEA on Chronic obstructive pulmonary disease 
patients and obtained the most efficient length of stay for each of them in terms of 
savings for the hospital. Some of the literature above highlight the fact that in some 
occasions different types of DEA model need to be applied to the problem in order to 
deal with the problem and data type appropriately.  
While including uncertain opinions and judgments of a medical team requires us to use 
grey numbers, we have to use a model of DEA that is able to deal with interval data. 
As the classical DEA methodologies have been fully addressed in Molinero and 
Woracker (252) and Cooper et al. (253), here we discuss the preliminaries and 
methodology for performing DEA on interval values to include grey data in our 
evaluations. Assume there are n DMUs, denoted by 𝑗(𝑗 = 1,2,⋯ , 𝑛), and each of them 
are producing k outputs from m inputs. 𝑦𝑟𝑗 and 𝑥𝑖𝑗 stand for the level of rth output (𝑟 =
1,2,⋯ 𝑘) and ith input (𝑖 = 1,2,⋯ ,𝑚) in jth DMU respectively. Despite the classical 
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DEA in which the 𝑦𝑟𝑗 and 𝑥𝑖𝑗 are crisp values, in our approach, within this chapter they 
are grey numbers and based on following: 
𝑦𝑟𝑗 = [𝐺𝑟𝑗, 𝐺𝑟𝑗]   and    𝑥𝑖𝑗 = [𝐺𝑖𝑗 , 𝐺𝑖𝑗]    
As far as each of our output and input levels are grey numbers which make it probable 
each of our variables related to a unit lies within their lower and upper bounds, the 
classical points in the frontier diagram are transformed into quadrangles. So, units are 
allowed to assign any values within the quadrangle to maximize its efficiency. Figure 
5.3 elucidate the differences between classical and Grey DEA frontier shapes.  
 
Figure 5.3 Classical and grey Frontiers of efficient units in DEA 
The left diagram in figure 5.3 shows the efficiency frontier for eight DMUs of A to H 
in respect of one input and one output in a classical crisp value problem. The units on 
the efficiency frontier are considered as efficient units by using the lowest possible 
level of resources, they are producing the highest possible amount of output. The units 
E, F, G and H are inefficient units as they can produce more outcome by using current 
amount of resources or by using current amount of resources they can increase their 
output levels. In the right diagram through the output and input are defined by interval 
grey values. If a DMU selects the upper left corner of its quadrangle due to the 
production of maximum output by consuming a minimum amount of input it could 
have the maximum efficiency, while on the contrary, the lower right corner will cause 
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a DMU to perform in its lowest possible efficiency. There are two probable frontier 
lines for the interval grey diagram in figure 3. While units R1 and R2 are efficient and 
unit R4 is inefficient in the probable selection of both frontiers, according to the 
selection of line 1 the R3 unit will be inefficient while designation of line 2 will result 
in efficiency of the unit R3.  
Application of grey data instead of traditional crisp data will transform a linear CCR 
input-oriented DEA model to a non-linear model as in addition to 𝑢1, 𝑢2, ⋯ , 𝑢𝑠 and 
𝑣1, 𝑣2, ⋯ , 𝑣𝑚 which are outputs and inputs weights respectively, the level of variables 
𝑥𝑖𝑗and 𝑦𝑟𝑗 should be also estimated in order to evaluate the efficiency level of unit j.  
max𝐷𝑗0 =∑𝑢𝑖𝑦𝑟𝑗0
𝑠
𝑟=1
 
𝑠. 𝑡.  ∑𝑣𝑟𝑥𝑖𝑗0
𝑚
𝑖=1
= 1                                                                                                    𝑀𝑜𝑑𝑒𝑙(1)  
∑𝑣𝑖𝑥𝑖𝑗
𝑚
𝑖=1
−∑𝑢𝑟𝑦𝑟𝑗
𝑠
𝑟=1
≥ 0  , 𝑗 = 1,2,⋯ , 𝑛 
𝑢𝑟 𝑎𝑛𝑑 𝑣𝑖 ≥ 𝜀   ∀r, i 
In this research based on following, we apply the Despotis and Smilris (254) 
transformation to convert the non-linear DEA to the linear formulation. 
𝑥𝑖𝑗 = 𝑥𝑖𝑗
𝐿 + 𝑠𝑖𝑗(𝑥𝑖𝑗
𝑈 − 𝑥𝑖𝑗
𝐿 ),   𝑖 = 1,2,⋯ ,𝑚;  𝑗 = 1,2,⋯ , 𝑛  𝑤𝑖𝑡ℎ 0 ≤ 𝑠𝑖𝑗 ≤ 1         (34) 
𝑦𝑟𝑗 = 𝑦𝑟𝑗
𝐿 + 𝑡𝑟𝑗(𝑦𝑟𝑗
𝑈 − 𝑦𝑟𝑗
𝐿 ),   𝑟 = 1,2,⋯ , 𝑠;  𝑗 = 1,2,⋯ , 𝑛  𝑤𝑖𝑡ℎ 0 ≤ 𝑡𝑟𝑗 ≤ 1       (35) 
Variables 𝑠𝑖𝑗 and 𝑡𝑟𝑗 are introduced in above transformation, which locate the levels 
of inputs and outputs within the bounded intervals of [𝑥𝑖𝑗
𝐿 , 𝑥𝑟𝑗
𝑈 ] and [𝑦𝑟𝑗
𝐿 , 𝑦𝑟𝑗
𝑈 ] 
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respectively, to be superseded with variables 𝑥𝑖𝑗 and 𝑦𝑟𝑗 in model 1. Although due to 
products of 𝑣𝑖𝑠𝑖𝑗 for inputs and 𝑢𝑟𝑡𝑟𝑗 for outputs, model one still remains non-linear. 
Writing the 𝑣𝑖𝑥𝑖𝑗 and 𝑢𝑟𝑦𝑟𝑗 based on 𝑠𝑖𝑗 and 𝑡𝑟𝑗 results in the following equations.  
 𝑣𝑖𝑥𝑖𝑗 = 𝑣𝑖𝑥𝑖𝑗
𝐿 + 𝑣𝑖𝑠𝑖𝑗(𝑥𝑖𝑗
𝑈 − 𝑥𝑖𝑗
𝐿 )                                                                                    (36) 
𝑢𝑟𝑦𝑟𝑗 = 𝑢𝑟𝑦𝑟𝑗
𝐿 + 𝑢𝑟𝑡𝑟𝑗(𝑦𝑟𝑗
𝑈 − 𝑦𝑟𝑗
𝐿 )                                                                                (37)    
Then in the process of linearization, we replace 𝑣𝑖𝑠𝑖𝑗 by 𝑞𝑖𝑗 and 𝑢𝑟𝑦𝑟𝑗 by 𝑝𝑟𝑗. So, the 
weighted sum composite for inputs will transform into equation 38.  
∑𝑣𝑖𝑥𝑖𝑗 =∑𝑣𝑖𝑥𝑖𝑗
𝐿 + 𝑞𝑖𝑗(𝑥𝑖𝑗
𝑈 − 𝑥𝑖𝑗
𝐿 )
𝑚
𝑖=1
𝑚
𝑖=1
                                                                           (38) 
Where 0 ≤ 𝑞𝑖𝑗 ≤ 𝑣𝑖; 𝑠𝑖𝑗 =
𝑞𝑖𝑗
𝑣𝑖
, 𝑣𝑖 ≥ 0 and  0 ≤ 𝑠𝑖𝑗 ≤ 1  ∀𝑖, 𝑗                                  (39)  
Similarly, the weighted sum composite for outputs will transform to equation 40.  
  
∑𝑢𝑟𝑦𝑟𝑗 =∑𝑢𝑟𝑦𝑟𝑗
𝐿 + 𝑝𝑟𝑗(𝑦𝑖𝑗
𝑈 − 𝑦𝑖𝑗
𝐿 )                                                                         (40)
𝑠
𝑟=1
𝑠
𝑟=1
 
Where 0 ≤ 𝑝𝑟𝑗 ≤ 𝑢𝑟; 𝑡𝑟𝑗 =
𝑝𝑖𝑗
𝑢𝑟
, 𝑢𝑟 ≥ 0 and  0 ≤ 𝑡𝑟𝑗 ≤ 1  ∀𝑟, 𝑗                
By applying the abovementioned equation and substituting the transformations, model 
1 can be elucidated as following linear programming: 
 max𝐷𝑗0 =  ∑ 𝑢𝑟𝑦𝑟𝑗
𝐿 + 𝑝𝑟𝑗0(𝑦𝑖𝑗0
𝑈 − 𝑦𝑖𝑗0
𝐿 )𝑠𝑟=1  
𝑠. 𝑡.  ∑𝑣𝑖𝑥𝑖𝑗0
𝐿 + 𝑞𝑖𝑗0(𝑥𝑖𝑗0
𝑈 − 𝑥𝑖𝑗0
𝐿 )
𝑚
𝑖=1
= 1                                                              𝑀𝑜𝑑𝑒𝑙 (2) 
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∑𝑢𝑟𝑦𝑟𝑗
𝐿 +∑𝑝𝑟𝑗(𝑦𝑖𝑗
𝑈 − 𝑦𝑖𝑗
𝐿 ) −
𝑠
𝑟=1
∑𝑣𝑖𝑥𝑖𝑗
𝐿 +∑𝑞𝑖𝑗(𝑥𝑖𝑗
𝑈 − 𝑥𝑖𝑗
𝐿 )
𝑚
𝑖=1
𝑚
𝑖=1
𝑠
𝑟=1
≤ 0  , 𝑗 = 1,2,⋯ , 𝑛 
𝑝𝑟𝑗 − 𝑢𝑟 ≥ 0 , 𝑟 = 1,2,⋯ , 𝑠; 𝑗 = 1,2,⋯ , 𝑛 
𝑞𝑖𝑗 − 𝑣𝑖 ≥ 0 , 𝑖 = 1,2,⋯ ,𝑚; 𝑗 = 1,2,⋯ , 𝑛 
𝑢𝑟 𝑎𝑛𝑑 𝑣𝑖 ≥ 𝜀   ∀r, i 
In the above model, if the lower and upper bounds of an interval number are equal, i.e. 
a crisp value, the model will transform again to a normal CCR model. So, if we set the 
level of outputs and inputs in favour of the under-evaluation unit of 𝑗0, which means 
we consider all the outputs in their highest level and inputs in their lowest level then 
through model 3 we can obtain the upper bounds of our efficiency scores.  
max    𝐷𝑗0
𝑈 =  ∑𝑢𝑟𝑦𝑟𝑗
𝑢
𝑠
𝑟=1
 
𝑠. 𝑡.  ∑𝑣𝑖𝑥𝑖𝑗0
𝐿
𝑚
𝑖=1
= 1 
∑𝑢𝑟𝑦𝑟𝑗0
𝑈 −∑𝑣𝑖𝑥𝑖𝑗0
𝐿
𝑚
𝑖=1
𝑠
𝑟=1
≤ 0  ,                                                                                𝑀𝑜𝑑𝑒𝑙 (3) 
∑𝑢𝑟𝑦𝑟𝑗
𝐿 −∑𝑣𝑖𝑥𝑖𝑗
𝑈
𝑚
𝑖=1
𝑠
𝑟=1
≤ 0  ,           𝑗 = 1,2,⋯ , 𝑛  𝑎𝑛𝑑 𝑗 ≠ 𝑗0 
𝑢𝑟 𝑎𝑛𝑑 𝑣𝑖 ≥ 𝜀   ∀r, i 
Similarly, if we set the level of outputs and inputs extremely against the under-
evaluation unit of 𝑗0, which means we consider all the outputs in their lowest level and 
all the inputs in their highest, then through model 4 we can obtain the lower bound of 
our efficiency scores.  
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max    𝐷𝑗0
𝐿 =  ∑𝑢𝑟𝑦𝑟𝑗
𝑙
𝑠
𝑟=1
 
𝑠. 𝑡.  ∑𝑣𝑖𝑥𝑖𝑗0
𝑈
𝑚
𝑖=1
= 1 
∑𝑢𝑟𝑦𝑟𝑗0
𝐿 −∑𝑣𝑖𝑥𝑖𝑗0
𝑈
𝑚
𝑖=1
𝑠
𝑟=1
≤ 0  ,                                                                                 𝑀𝑜𝑑𝑒𝑙 (4) 
∑𝑢𝑟𝑦𝑟𝑗
𝑈 −∑𝑣𝑖𝑥𝑖𝑗
𝐿
𝑚
𝑖=1
𝑠
𝑟=1
≤ 0  ,           𝑗 = 1,2,⋯ , 𝑛 𝑎𝑛𝑑 𝑗 ≠ 𝑗0 
𝑢𝑟 𝑎𝑛𝑑 𝑣𝑖 ≥ 𝜀   ∀r, i 
By calculating the above boundaries of efficiency, we can confirm that efficiency 
scores higher than 𝐷𝑗0
𝑈  or lower than 𝐷𝑗0
𝐿  for unit 𝑗0 cannot be obtained regardless of 
the variable values assigned. 
5.3 Numerical Example 
One detailed application of the proposed FA-PCA-DEA methodology that has been 
described in previous sections is presented in this section to demonstrate the approach 
and deal with nuances in different steps of this approach. Firstly, a new case enters and 
in order to suggest a dose plan prescription to oncologists, all the other existing cases 
in our case pool compete with each other. The most efficient case evaluated by the FA-
DEA approach is the winner to be prescribed as the solution to the new case. Our data 
set consists of 49 real case scenarios and information about prostate cancer patients, 
treated by Gamma-ray radiotherapy at Nottingham University Hospital. In order to 
choose a new case, we select one of these cases as a new case and the other 48 cases 
remain the case pool. This way we can compare the final result obtained from FA-DEA 
with the actual prescription of the case and measure the precision and success rate of 
109 
 
the system. Every one of the cases in the case pool has been considered as a DMU in 
this research. Based on the nature of the attributes in the data set they were divided into 
input and output criteria. Table 5.1 shows the features and criteria used in the suggested 
solution for selecting the best radiotherapy dose plan. 
Table 5.1 Input and output criteria used for efficiency evaluation 
Criteria Explanation Input/Output 
Gleason Score 
A parameter which defines the grade of cancer, lower the amount, 
the lower risk of cancer is  
Input  
PSA-B 
Prostate Specific Antigen before the treatment, this protein is 
elevated in men’s blood if the prostate is cancerous 
Input 
D1 
The distance of radiation dose received by 66% of the rectum to 
standard limitation based on DVH values 
Input 
D2 
The distance of radiation dose received by 50% of the rectum to 
standard limitation based on DVH values 
Input 
D3 
The distance of radiation dose received by 25% of the rectum to 
standard limitation based on DVH values 
Input 
D4 
The distance of radiation dose received by 10% of the rectum to 
standard limitation based on DVH values 
Input 
Similarity 
Measure 
The similarity of the new case with previous cases in the data set, 
calculated through Cased-Based Reasoning  
Input 
Dose I Dose plan applied to a case in the first phase of the treatment Output 
Dose II Dose plan applied to a case in the first phase of the treatment Output  
Success rate 
How successful the treatment is, based on PSA measurement 2 
years after the treatment 
Output  
 
In above table Gleason Score (GS) and PSA values before the treatment are parameters 
regarding the stage of cancer and D1, D2, D3 and D4 are parameters regarding risk 
assessment of the treatment. As previously mentioned rays also damage surrounding 
organs, among all rectum, is the most vulnerable one and thus, is a priority to control 
for side effect damage. DVH values determined how much of the radiation is being 
absorbed by the 66, 50, 25 and 10% of the rectum. As an example, if the DVH value 
in phase I of the treatment states that 66% of the rectum will receive 55% and 45% of 
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the radiation in phase I and II of the treatment respectively and dose plan is 46Gy in 
first and 24Gy in second phase of the treatment then based on follow D1 is calculated: 
𝐷1 = 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑙𝑖𝑚𝑖𝑡𝑎𝑡𝑖𝑜𝑛 𝑓𝑜𝑟 66% − [(55% × 46) + (45% × 24)] 
As previously explained (section 1) oncologists are not so precise about the amounts 
of various criteria when they make a decision about a dose plan. For example, 
similarities above 90% between two cases is acceptably high or in case of distance to 
standard recommendations, there is not a meaningful difference between 0.2 and 0.5 
Gy. Therefore, in this research, the crisp criteria are transformed into grey numbers to 
reflect the uncertainty of oncologists’ judgments. 
The transformation of data into interval grey numbers is based on table 5.2 where the 
original amount, linguistic terms and interval grey numbers allocated to them are 
elucidated based on consultation with experts.  
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Table 5.2 Linguistic terms and values respect to original amounts of data 
Criteria Original value                      Linguistic term Grey number 
Similarity ≥ 90%                                           Very High (VH) 
[80 to 90) %                                  High (H) 
[75 to 80) %                                  Medium High (MH) 
[70 to 75) %                                  Medium (M) 
[60 to 70) %                                  Low Medium (LM)               
< 60%                                           Low (L) 
 
[8  9] 
[7  8] 
[6  7] 
[5  6] 
[3  5] 
[1  3] 
PSA-B > 30                                              Very High (VH) 
[22 to 30)                                      High (H) 
[15 to 22)                                      Medium High (MH) 
[9 to 15)                                        Medium (M) 
[0 to 9)                                          Low (L)       
 
[8  9] 
[7  8] 
[5  7] 
[3  5] 
[1  3] 
Distances to 
recommended 
standard 
limitations 
[0 to 1]                                          Excellent (EX) 
[1 to 3.5)                                       Very Good (VG) 
[3.5 to 5.5)                                    Good (G) 
[5.5 to 9.5)                                     Fair (F) 
> 9.5                                              Poor (L)       
 
[8  9] 
[7  8] 
[5  7] 
[3  5] 
[1  3] 
Success rate 
(PSA value 
after 2 years) 
[0 to 0.4]                                       Excellent (EX) 
[0.4 to 0.8)                                    Very Good (VG) 
[0.8 to 1.6)                                    Good (G) 
[1.6 to 2.4)                                    Fair (F) 
> 2.4                                              Poor (L)       
 
[8  9] 
[7  8] 
[5  7] 
[3  5] 
[1  3] 
 
5.3.2 Procedure for FA-DEA 
In this research, the importance level of criteria is not the same. Through oncologist 
opinions about the inputs and outputs, the importance weight of each criterion in 
linguistic terms, the grey number assigned to it and normalized amount of it is shown 
in table 5.3. The importance of these criteria is relative to each other. In order to 
normalize them, they will be divided by the maximum amount existing in each criteria 
type.  
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Table 5.3 importance weights of criteria 
Type of criteria Criteria Linguistic term Grey value 
Normalized 
weight 
Input     
 Similarity High Importance [8, 9] [0.88, 1] 
 Distances Medium High Importance [6, 7] [0.66, 0.77] 
 G.S Low Importance [1, 3] [0.11, 0.33] 
 PSA Low Importance [1, 3] [0.11, 0.33] 
Output     
 Dose in Phase I Medium Importance [3, 5] [033, 0.55] 
 Dose In phase II Low Importance [1, 3] [0.11, 0.33] 
 Success Rate High Importance [8, 9] [0.88, 1] 
 
After that, the normalized weights are being multiplied by decision matrix to obtain 
the weighted decision matrix. With weighted inputs and outputs, the following 4 steps 
are required: 
(1) Standardizing and normalizing the decision matrix; preparing it for PCA. 
(2) Applying PCA on the decision matrix of inputs and outputs separately. 
Computing the PCs and eigenvalues corresponding to them.  
(3) Selecting the sufficient PCs, account for the inclusion of data more than 75 
percent, and calculating factor loadings and factor values of each case by use 
of PCs. 
(4) Normalizing the factors, and calculating upper bound and lower bound of each 
case (unit) efficiency by interval DEA.  
5.3.3 Principal Components 
Noting that the decision matrix we have for both input and output criteria are in 
different scales and belonging to different types of benefit (the higher the better) and 
cost (the lower the better) criteria, first we need to standardize and normalize the data 
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set before starting the PCA procedure. First, by using the equation 41 cost criteria (i.e. 
PSA-B and G.S) are inverted into benefit criteria. 
𝐺𝑖𝑗
𝑠 = [𝑀𝑎𝑥𝐺𝑗 − 𝐺𝑖𝑗 , 𝑀𝑎𝑥𝐺𝑗 − 𝐺𝑖𝑗] ;  for 𝑖 = 1,2,⋯ , 𝑛 and 𝑗 =
1,2,⋯ , 𝑝                         (41) 
Where 𝐺𝑖𝑗
𝑛  is the standardized element in the standard decision matrix and 𝑀𝑎𝑥𝐺𝑗 is 
the maximum upper bound of the criterion 𝑗.  
After that, there is need to normalize the decision matrix so that each criterion has mean 
and variance equal to zero and 1 respectively. The decision matrix is being normalized 
through equation 42. 
𝐺𝑛 = [𝐺𝑖𝑗
𝑛] =
𝐺𝑖𝑗
𝑠 − 𝐸(𝐺𝑗)
√𝑉𝑎𝑟(𝐺𝑗
𝑠)
= [
𝐺𝑖𝑗
𝑠 − 𝐸(𝐺𝑗
𝑠)
𝑉𝑎𝑟(𝐺𝑗
𝑠)
−
𝐺𝑖𝑗
𝑠
− 𝐸(𝐺𝑗
𝑠)
𝑉𝑎𝑟(𝐺𝑗
𝑠)
] : for 𝑖 = 1,2,⋯ , 𝑛 & 𝑗
= 1,2,⋯ , 𝑝                                                                                                        (42)    
Where 𝐺𝑖𝑗
𝑛  is the normalized element in our final normalized decision matrix which the 
PCA procedure will be applied on. Through equation 19 we compute the covariance 
matrix from 𝐺𝑛, which here due to normalization is also the correlation matrix between 
our grey variables. By eigendecomposition of the correlation matrix, we finally have 
the PCs and the corresponding eigenvalues for input and output variables separately, 
determining how much of information representing by original variables is being 
summarized by each of them, which are shown in tables 5.4 and 5.5. 
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Table 5.4 Input PC variances and inclusion percentages 
PCs, Input PC variences Cumulative Inclusion% 
PC1 1.9784 28.26 
PC2 1.3077 46.95 
PC3 1.1413 63.24 
PC4 0.9515 76.85 
PC5 0.8125 88.46 
PC6 0.5828 96.78 
PC7 0.2256 99.99 
 
 
Table 5.5 Output PC variances and inclusion percentages 
PCs, Output PC variences Cumulative Inclusion% 
PC1 1.3281 44.27 
PC2 0.9854 77.12 
PC3 0.6865 100 
 
 
The first four PCs of the input variables can be accounted for more than 76 percent of 
the input information and respectively the first two PCs of the output variables include 
more than 77 percent of the output information. So hereby, they are chosen to form the 
factors.  
5.3.4 Factor Analysis  
Selecting the first four and two PCs for inputs and outputs respectively to compute the 
factors and by having PC coefficients and variances (eigenvectors and eigenvalues 
obtained from the eigen decomposition of the correlation matrix), the model 1 to 4 was 
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applied to calculate the un-rotated factors. The Factor Analysis model for input 
variables is based on:  
𝐺1
𝐼𝑛 = −0.1976𝐹1
𝑖𝑛 − 0.5193𝐹2
𝐼𝑛 − 0.1543𝐹3
𝐼𝑛 + 0.3875𝐹4
𝐼𝑛 
𝐺2
𝐼𝑛 = −0.1203𝐹1
𝑖𝑛 + 0.4597𝐹2
𝐼𝑛 − 0.1544𝐹3
𝐼𝑛 + 0.6696𝐹4
𝐼𝑛 
𝐺3
𝐼𝑛 = 0.2541𝐹1
𝑖𝑛 − 0.4801𝐹2
𝐼𝑛 + 0.0183𝐹3
𝐼𝑛 + 0.2773𝐹4
𝐼𝑛 
𝐺4
𝐼𝑛 = −0.4297𝐹1
𝑖𝑛 + 0.0550𝐹2
𝐼𝑛 − 0.0666𝐹3
𝐼𝑛 − 0.0723𝐹4
𝐼𝑛 
𝐺5
𝐼𝑛 = −0.4379𝐹1
𝑖𝑛 − 0.2223𝐹2
𝐼𝑛 − 0.0173𝐹3
𝐼𝑛 − 0.2079𝐹4
𝐼𝑛 
𝐺6
𝐼𝑛 = −0.0915𝐹1
𝑖𝑛  − 0.0219𝐹2
𝐼𝑛 + 0.5978𝐹3
𝐼𝑛 + 0.5207𝐹4
𝐼𝑛 
  𝐺7
𝐼𝑛 = −0.0515𝐹1
𝑖𝑛 + 0.0184𝐹2
𝐼𝑛 + 0.6828𝐹3
𝐼𝑛 − 0.2366𝐹4
𝐼𝑛 
In the above equations, 𝐺𝑝
𝐼𝑛 is the Grey input variable described by four input Factors 
of. 𝐹1,2,3,4
𝐼𝑛  The Factor Analysis model for output variables is also based on follow: 
𝐺1
𝑂𝑢𝑡 = −0.1794𝐹1
𝑂𝑢𝑡 + 0.9854𝐹2
𝑂𝑢𝑡  
𝐺2
𝑂𝑢𝑡 = −0.6014𝐹1
𝑂𝑢𝑡 − 0.1340𝐹2
𝑂𝑢𝑡  
𝐺3
𝑂𝑢𝑡 = 0.5992𝐹1
𝑂𝑢𝑡 + 0.1606𝐹2
𝑂𝑢𝑡 
In the above equations, 𝐺𝑒
𝑂𝑢𝑡 is the Grey output variable described by two output 
Factors of 𝐹1
𝑂𝑢𝑡.  
To obtain simpler and more interpretable Factors, by using Varimax rotation with 
Kaiser normalization criterion (section 2.7), the rotated factors were calculated for 
input variables as following:  
 
𝐺1
𝐼𝑛 = −0.1812𝐹1
𝑖𝑛 − 0.6622𝐹2
𝐼𝑛 − 0.035𝐹3
𝐼𝑛 + 0.0978𝐹4
𝐼𝑛 
𝐺2
𝐼𝑛 = 0.0501𝐹1
𝑖𝑛 + 0.0056𝐹2
𝐼𝑛 − 0.0123𝐹3
𝐼𝑛 + 0.8339𝐹4
𝐼𝑛 
𝐺3
𝐼𝑛 = 0.2551𝐹1
𝑖𝑛 − 0.5444𝐹2
𝐼𝑛 + 0.0437𝐹3
𝐼𝑛 − 0.0943𝐹4
𝐼𝑛 
𝐺4
𝐼𝑛 = −0.432𝐹1
𝑖𝑛 + 0.0716𝐹2
𝐼𝑛 − 0.0196𝐹3
𝐼𝑛 + 0.0723𝐹4
𝐼𝑛 
𝐺5
𝐼𝑛 = −0.4906𝐹1
𝑖𝑛 − 0.0816𝐹2
𝐼𝑛 + 0.0004𝐹3
𝐼𝑛 − 0.1931𝐹4
𝐼𝑛 
𝐺6
𝐼𝑛 = 0.0716𝐹1
𝑖𝑛  − 0.2229𝐹2
𝐼𝑛 + 0.7037𝐹3
𝐼𝑛 + 0.2953𝐹4
𝐼𝑛 
  𝐺7
𝐼𝑛 = −0.0299𝐹1
𝑖𝑛 + 0.2266𝐹2
𝐼𝑛 + 0.6150𝐹3
𝐼𝑛 − 0.3077𝐹4
𝐼𝑛 
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As can be seen, before rotation most of the variables were depended on more than two 
factors by having factor coefficients higher than 0.1, while after rotation other factors 
can be described by one or two factors. In the final step of Factor analysis by applying 
formula 33, the Final factors are computed based on variables to apply them within 
interval DEA and calculate the efficiency score for each of the cases. The Factors 
which are  shown below and in table 5.6 show the results after multiplication of variable 
coefficients by the normalized interval grey variable values.  
Input Factors: 
 
𝐹1
𝐼𝑛∗ = −0.3906𝐺1
𝐼𝑛 − 0.0583𝐺2
𝐼𝑛 + 0.4787𝐺3
𝐼𝑛 − 0.8380𝐺4
𝐼𝑛 − 0.9110𝐺5
𝐼𝑛 − 0.0127𝐺6
𝐼𝑛 −
0.0665𝐺7
𝐼𝑛   
𝐹2
𝐼𝑛∗ = −0.7909𝐺1
𝐼𝑛 + 0.1372𝐺2
𝐼𝑛 − 0.6576𝐺3
𝐼𝑛 + 0.0781𝐺4
𝐼𝑛 − 0.1491𝐺5
𝐼𝑛 − 0.2055𝐺6
𝐼𝑛
+ 0.2367𝐺7
𝐼𝑛 
𝐹3
𝐼𝑛∗ = −0.0324𝐺1
𝐼𝑛 + 0.0004𝐺2
𝐼𝑛 + 0.0087𝐺3
𝐼𝑛 + 0.0314𝐺4
𝐼𝑛 + 0.0609𝐺5
𝐼𝑛 + 0.7924𝐺6
𝐼𝑛
+ 0.7178𝐺7
𝐼𝑛 
𝐹4
𝐼𝑛∗ = 0.0400𝐺1
𝐼𝑛 + 0.9126𝐺2
𝐼𝑛 − 0.2351𝐺3
𝐼𝑛 + 0.1705𝐺4
𝐼𝑛 − 0.1356𝐺5
𝐼𝑛 + 0.2723𝐺6
𝐼𝑛
− 0.3053𝐺7
𝐼𝑛 
Output Factors: 
𝐹1
𝑂𝑢𝑡 = −0.2383𝐺1
𝑂𝑢𝑡 − 0.7988𝐺2
𝑂𝑢𝑡 + 0.7958𝐺3
𝑂𝑢𝑡  
𝐹2
𝑂𝑢𝑡 = 0.9711𝐺1
𝑂𝑢𝑡 − 0.1321𝐺2
𝑂𝑢𝑡 + 0.1583𝐺3
𝑂𝑢𝑡  
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Table 5.6 Final factors values respect to each case 
 𝐹1
𝐼𝑛∗ 𝐹2
𝐼𝑛∗ 𝐹3
𝐼𝑛∗ 𝐹4
𝐼𝑛∗ 𝐹1
𝑜𝑢𝑡 𝐹2
𝑜𝑢𝑡 
C1 [0.080,2.534] [-2.207,-0.12] [-2.335,2.482] [-0.064,0.159] [0.21,0.25  ] [0.411,1.33] 
C2 [0.570,2.905] [-0.381, 1.332  ] [-3.765,-1.084] [-0.126,-0.119] [0.21,0.25  ] [0.411,1.33] 
C3 [-2.932,-0.329 ] [-1.923, 0.007  ] [-2.059,3.017  ] [-0.110,0.057] [0.826,0.85  ] [-2.099,-1.114] 
C4 [ -0.432,1.903] [-0.474, 1.574  ] [-2.272,2.545  ] [-2.131,-1.76] [-3.143,-1.058] [-1.688,-0.998] 
C5 [-3.072, -1.07] [-0.306, 1.763  ] [-1.992,3.08  ] [0.220,0.220] [0.21,0.25  ] [0.411,1.33] 
C6 [0.566, 2.967] [-2.683, -0.649] [-2.335,2.468  ] [-0.398,-0.383] [-1.613,-0.664] [0.256,0.991] 
C7 [-0.511, 1.835] [0.971, 2.814] [-2.319,2.491  ] [2.099,2.373] [0.21,0.25  ] [0.411,1.33] 
C6 [-2.331, 0.199] [-0.705, 1.079  ] [-2.015,3.066  ] [-0.164,-0.004] [0.6508,0.6509] [-1.381,-0.299] 
C9 [0.222, 2.477] [1.887, 3.618  ] [-2.275,2.54  ] [0.238,0.268] [-3.543,-1.498] [0.104,0.631] 
C10 [0.688, 3.065] [-0.884, 0.986  ] [-2.428,2.123  ] [-0.165,-0.042] [0.298,0.35  ] [0.052,0.922] 
C11 [-2.182, 0.070] [-1.68, 0.53  ] [-2.363,2.181  ] [-0.054,0.011] [0.6508,0.6509] [-1.381,-0.299] 
C12 [-2.146, 0.094] [-1.807, 0.445  ] [-2.62,1.795  ] [0.055,0.17] [0.298,0.35  ] [0.052,0.922] 
C13 [-3.072, -1.07] [-0.306, 1.763  ] [-1.992,3.08  ] [0.220,0.220] [0.826,0.85  ] [-2.099,-1.114] 
C14 [-3.459, -1.218] [-2.204, -0.204] [-2.542,1.859  ] [-0.181,-0.139] [0.6508,0.6509] [-2.099,-1.114] 
C15 [1.869, 4.1] [-1.307, 0.612  ] [-2.19,2.886  ] [-0.45,-0.389] [0.21,0.25  ] [0.411,1.33] 
C16 [-4.285, -2.143] [-0.63, 1.524  ] [-2.172,2.636  ] [2.324,2.773] [0.6508,0.6509] [-1.381,-0.299] 
C17 [1.905, 4.112] [-1.434, 0.57  ] [-2.319,2.5  ] [-0.395,-0.225] [0.21,0.25  ] [0.411,1.33] 
C18 [-2.085, 0.172] [-1.864, 0.306  ] [-2.235,2.566  ] [-2.226,-1.886] [-0.833,-0.277] [0.323,1.13] 
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5.3.5 Interval DEA 
To evaluate the efficiency of each treatment plan we have applied CCR-DEA model 
(section 2.8). Due to the inability of CCR-DEA models to handle negative values which 
we have in the factors, a normalization has been done based on the following formula: 
𝐹𝑖𝑗
𝑛 = 𝐹𝑖𝑗
𝑖𝑛∗𝑜𝑟 𝑜𝑢𝑡 −𝑀𝑖𝑛𝐹𝑗
𝑖𝑛∗/𝑜𝑢𝑡
+ 0.5  
In above normalization, each element in one factor is subtracted by the minimum value 
existing in the factor j and then to avoid zero amounts in each factor a constant value 
of 0.5 is added to each of them. Such a normalization has been applied in several 
research projects dealing with negative values in DEA (255). By applying models 7and 
8, (section 2.8), for upper and lower bound of the DMUs efficiency scores the 
efficiency results were calculated (table 5.7). As can be seen when the outputs and 
inputs are set in favour of each treatment plan all treatment plans are completely 
efficient. When the situation is critical and all the uncertain decisions made by 
oncologists are against the treatment plans, only case 18 with dose plan of 50Gy in the 
first and 20Gy in the second phase is efficient and thus the case 18 will be suggested 
to oncologist as the best treatment plan.  
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Table 5.7 Lower and upper bounds of efficiency scores 
DMUs ( treatment plans) Lower bound of efficiency Upper bound of efficiency 
C1 0.4142 1 
C2 0.5876 1 
C3 0.5584 1 
C4 0.1256 1 
C5 0.5334 1 
C6 0.3609 1 
C7 0.3025 1 
C6 0.5066 1 
C9 0.2425 1 
C10 0.3469 1 
C11 0.5147 1 
C12 0.4661 1 
C13 0.6036 1 
C14 0.6732 1 
C15 0.3637 1 
C16 0.4976 1 
C17 0.3627 1 
C18 1 1 
 
5.4 Discussion 
In this section, we try to analyse the factors and determine their characteristics. At first, 
we investigate the communalities described by each variable and overall FA model for 
input and output variables. Commonality can be interpreted as the proportion of 
variance accounted for by each variable. In order to compute the commonality of a 
variable, we need to sum the squared factor loadings of the variable. In the un-rotated 
model (9) for input variables the commonalities are 0.482, 0.695, 0.372, 0.197, 0.285, 
0.6373 and 0.525 respectively for the 7 input variables. Also, large and moderate factor 
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loadings can indicate how a factor is related to a variable and factors which are related 
at least to one and maximum two variables are our desirable factors and loading factors 
more than 0.5 can be interpreted as moderate or large. So higher loading factors related 
to a variable is favourable. As can be seen in model 9 and 11, after Varimax rotation 
the balance of loadings has become in favour of some factors in most of the variables 
and provided for a better solution to interpret each factor. Also, the amount of 
communalities remained the same as it should be. The diagrams depicted in figure 5.4 
show the differences between loadings before and after Kaiser Varimax rotation.  
 
Figure 5.4 Factor loadings before (a) and after (b) the rotation 
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Figure 4(a) is showing the factor loadings before and figure 4(b) after the rotation 
where the number of loadings with amounts of more than 0.5 are reduced as a result of 
rotation and the amounts of remaining loadings more than 0.5 are increased which can 
help us by relating the factors to variables.  
To determine the characteristics of factors applied in DEA, we use model 10 and 11 
for output and input variables respectively. Starting with output factors, the first factor 
has big loadings on the second and third variable, dose plan in second phase and 
success rate. Due to the approximately equal positive value of success rate and negative 
value of second phase dose plan loadings, it can be said that this factor is associated 
with success rate and is in contrast with amount of dose plan in the second phase. The 
second factor is only highly associated with the dose plan in the first phase of the 
treatment. As the dose plan in the first phase of the treatment increases, oncologists 
apply lower amounts of radiation in the second plan and the success rate in these 
scenarios is usually higher due to more effective treatment; the factor analysis supports 
this observation.  
Regarding our input factors, the first factor has only relatively low moderate loading 
in fourth and fifth variables, distances to standard recommendations for 50% and 66% 
of the rectum. Because of their negative values, this factor can be labelled as slightly 
opposite of the Distances to standard recommendations for 50% and 66% of the 
rectum. Similarly, the second factor can be labelled as the moderate opposite of 
similarity measure and distance to 25% of the rectum with slightly more importance of 
similarity measure. The third factor has a strong association with G.S and PSA before 
the treatment. The fourth factor only has high loading in the second variable, distance 
to standard recommendations for 10% of the rectum. Also by summation of individual 
commonalities, the total commonality can be estimated and it indicates how much of 
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the variation in original data is explained by the factor model. For output variables, this 
summation is 1.7577 out of 3 (the overall variance of output data). So factor model 
describes 58.59% of the variances in output data. 
5.5 Overall results and success rate of the approach 
In order to assess the approach of interval FA-DEA, the same leave-one-out strategy 
which was used in previous chapters was applied. A case was pulled out of the dataset 
and was treated like a new case. The result obtained was compared with the original 
result that was prescribed by oncologists. However, the success rates of the treatment 
(PSA values 5 years after the radiotherapy) were available for only 49 cases of our case 
pool; thus, the result comparison of different approaches was performed considering 
these 49 cases (table 5.8).  
Table 5.8 Comparison of the proposed methodology of interval FA-DEA with other approaches 
 Simple CBR CBR+TOPSIS 
CBR+TOPSIS 
+ 
GP 
Interval FA+DEA 
Number of 
successful obtained 
cases 
34 out of 49 38 out of 49 43 out of 49 43 cases out of 49 
Number of cases 
with better dose plan 
9 12 21 16 
Success rate (%) 69.38 77.55 87.75 87.75 
 
The application of interval FA-DEA results in 43 successful dose plan prescriptions 
which is higher than CBR and CBR-TOPSIS methods and equal to CBR-TOPSIS-GP 
approach. However, the number of cases with better dose plans is less than CBR-
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TOPSIS-GP which is due to not performing the optimization process in this approach 
and using only evaluation of cases. The obtained results are demonstrating the 
effectiveness of the proposed approach. 
5.6 Conclusion 
This chapter has presented a hybrid approach of FA with the help of PCA and DEA to 
help oncologists with dose planning in radiotherapy for prostate cancer. In previous 
chapters, in the process of MCDM approach in order to assess different cases, all 
criteria were treated in the same way. This chapter demonstrates that classifying them 
in two categories of input and output delivers improved results. Thus, DEA was chosen 
to evaluate the cases as it is a non-parametric method based on multiple inputs and 
outputs to obtain the efficiency of available options. Moreover, in order to capture the 
uncertainty that oncologists have in their judgments in real life scenarios while dealing 
with values of different factors (human imprecise evaluation), we used grey numbers 
and adjusted our system as close as possible to real life oncologists’ way of thinking.  
Applying more criteria, inputs and outputs, in DEA makes the methodology to consider 
more dimensions of the problem and thus result in more comprehensive answers, 
however, due to characteristics of DEA, while the accumulative number of inputs and 
outputs increase in comparison to DMUs, it can be problematic because of weak 
discrimination among DMUs. We initially used 7 inputs including the similarity 
measure obtained from CBR and 3 outputs including a new criterion of the success rate 
of the treatment. To solve the problem, we applied FA based on Principal Components 
to reduce the dimensions of the problem. Because of using grey numbers, we developed 
the FA for grey numbers and we presented the novel hybrid approach of interval FA-
DEA. The approach was tested on a real dataset collected from Nottingham University 
Hospital consisting of 49 cases and the results were compared with previous 
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approaches applied in chapters three and four. The results show the effectiveness of 
the proposed approach and demonstrate its applicability for prostate cancer dose 
planning. The detailed numerical example presented can be a guide for other 
researchers to apply the interval FA-DEA in other domains.  
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Chapter 6 
New similarity measures and mechanism for feature weight assigning  
6.1 Introduction 
In previous chapters, CBR in collaboration with MCDM techniques has been applied 
to present a solution to radiotherapy dose planning problem. However, the weights 
applied for each feature of the case-base reasoning, to calculate the similarity measure, 
have been considered equally. In real-life problems, the decision makers can take into 
account different weights for each feature of the problem. Moreover, in various 
situations based on the circumstances, some features play a more significant role than 
others. Prostate cancer dose planning in a similar way to the other real-life problems 
can benefit from different weight features. 
On the other hand, the similarity between a new case and an existing case in the case 
pool has been calculated through CBR with Euclidean distances. When researchers are 
confronted with the problem of low predictive rate of CBR, the common approaches 
to increase the accuracy of the case retrieval are assigning weights to features or 
changing the features selection strategy (256). However, in addition to feature weight 
optimization, application of different types of distances for similarity calculation other 
than Euclidean distance has also been suggested through literature (257-261). The 
Euclidean distance is independent of the data distribution (262), in presence multiple 
dimensions may cause a poor performance for CBR and as it uses square root to 
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measure a geometrical distance, its performance is only reliable in a linear domain 
where the attributes of the problem have linear or near linear relation to each other. 
Moreover, in CBR many researchers have found the fact that due to characteristics of 
the data set some methods may perform with better precision or can provide a better 
explanation for a part of the search space (263). Thus, using other similarity methods 
or a combination of them may improve the accuracy of the predictions in complex 
systems (264).   
To this end, to cover the two mentioned problems in this chapter, we present two new 
similarity calculation approaches i.e. similarity measure based on Grey Relational 
Analysis (GRA) and Gaussian CBR. Also, to find the most appropriate set of weights 
for each feature and increase the precision of the system a Genetic Algorithm (GA) 
based feature weight selection is being performed for each new distance. GRA is a 
mathematical approach that is distinguished with excellent performance while the 
number of variables is high in comparison to the data and can efficiently describe the 
relationship between two series of information as well as avoiding the subjective 
setting of parameters within the model (257).  
Also, when the problem space shows non-linear characteristics, non-linear Gaussian 
transformation can transform the space into linearly separable space and therefore 
enhance the effectiveness of finding similar neighbours (265). The radiotherapy dose 
planning problem suffers from both of the aforementioned issues i.e. a high number of 
variables and non-linearity among different features. In our problem and similarity 
measuring operation we have 14 different features and usually, the number of cases in 
the dataset is not sufficient for this quantity of features. The relation among the features 
is also not linear, e.g. there is no specific global linear relation between the increase in 
PSA value and Gleason Score in various cases.  
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Application of a heuristic model in order to determine the optimal weights for features 
of the CBR has been successfully applied throughout the literature in medical and other 
domains. Ahn and Kim (266) used GA for weight assigning of the features in a CBR 
problem of bankruptcy prediction n and obtained successful results and improvement 
in the precision of the predictions. Wu et al. (258) developed a hybrid model of CBR 
system for estimation of software effort failure by applying a different type of distances 
for CBR and obtaining the optimal weights of the features by Particle Swarm 
Optimization (PSO) technique. Inbarani et al. (267) applied PSO on a feature retrieval 
model regarding a diagnosis data set to improve the efficiency of the retrieval process. 
A complete literature of the recent body of research regarding the hybrid application 
of heuristic algorithms and CBR in radiotherapy treatment has been provided in chapter 
2, sections 2.2 and 2.3.  
GA has received remarkable attention among researchers due to its unique 
characteristics and advantages. GA is an adaptable technique and does not require a 
heavy mathematical computational load for the optimization of a model. GA will 
search for the optimal matter with no regards of the specific problem function and can 
be applied to a wide range of linear or non-linear, discrete or continuous and defined 
or mixed search spaces (268). Evolutionary nature of GA makes it effective to run a 
better global search than many other heuristics as well as reducing the computational 
effort. Also, GA has the ability to deal with complex systems and large objective 
functions and provide a great flexibility to solve hybridized and domain-specific 
problems (269). 
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6.2 Methodology 
In this section, the applied methodologies, i.e. Grey Relational Analysis, Gaussian 
distance CBR and Genetic Algorithm are explained in detailed for use in radiotherapy 
dose planning problem.      
6.2.1 Grey Relational Analysis  
Grey system theory has been introduced by Deng (240) in 1982 and has the capability 
to deal with both known and unknown information. GRA is part of the grey system 
theory which is distinguished by the ability to deliver excellent performance in 
presence of problems with a high number of variables. The main goal in GRA is to 
undertake a comparison between two sequences to measure the similarity or difference 
between them (270).  
Assuming two objective and reference sequences as: 
Objective sequence: 𝑋0(𝑘) = {𝑋0(1), 𝑋0(2),⋯ , 𝑋0(𝑘)}        𝑘 = 1,2,⋯ , 𝑛;                    
Reference sequence: 𝑋𝑖(𝑘) = {𝑋𝑖(1), 𝑋𝑖(2),⋯ , 𝑋𝑖(𝑘)}   𝑘 = 1,2,⋯ , 𝑛;       𝑎𝑛𝑑 𝑖 =
1,2,⋯ ,𝑚; 
To obtain the grey similarity between two series, the following steps should be 
followed.  
Step 1: Normalization of the objective and reference sequences based on the features 
nature, if the feature belongs to cost or benefit criteria (the lower or higher values are 
more desirable respectively) or values closer to the Desired Amount (DA) are more 
favourable: 
𝑅𝑖(𝑘) =
𝑋𝑖(𝑘) − min (𝑋𝑖(𝑘), 𝑖 = 1,2,⋯ ,𝑚)
max(𝑋𝑖(𝑘), 𝑖 = 1,2,⋯ ,𝑚) − min (𝑋𝑖(𝑘), 𝑖 = 1,2,⋯ ,𝑚)
                           (1) 
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𝑅𝑖(𝑘) =
𝑚𝑎 𝑥(𝑋𝑖(𝑘), 𝑖 = 1,2,⋯ ,𝑚) − 𝑋𝑖(𝑘)
max(𝑋𝑖(𝑘), 𝑖 = 1,2,⋯ ,𝑚) − min(𝑋𝑖(𝑘), 𝑖 = 1,2,⋯ ,𝑚)
                           (2) 
𝑅𝑖(𝑘) = 1 −
|𝑋𝑖(𝑘) − 𝐷𝐴|
max {max(𝑋𝑖(𝑘), 𝑖 = 1,2,⋯ ,𝑚) − 𝐷𝐴,𝐷𝐴 −min(𝑋𝑖(𝑘), 𝑖 = 1,2,⋯ ,𝑚)}
 (3) 
 
Step 2: Calculating the grey coefficient between the objective sequence and the 
reference sequence applying equation 4.  
𝛾 =
min
𝑖
min
𝑘
∆0𝑖 + 𝜁max
𝑖
max
𝑘
∆0𝑖
∆0𝑖 + 𝜁max
𝑖
max
𝑘
∆0𝑖
                                                                                     (4) 
Where ∆0𝑖 = |𝑅0(𝑘) − 𝑅𝑖(𝑘)|, and 𝜁 is the distinguished coefficient (𝜁 ∈  [0,1]). 
Adopting different values for distinguishing coefficient results in compressing or 
expanding the range of grey relational coefficient and usually 𝜁 = 0.5 is being used by 
researchers.  
Step 3: Calculating the grey relational degree between a reference sequence and the 
objective sequence based on equation 5: 
Γ𝑖 =∑𝑤𝑘𝛾(𝑅0(𝑘), 𝑅𝑖(𝑘))
𝑛
𝑘=1
    𝑓𝑜𝑟 𝑖 = 1,2,⋯ ,𝑚.                                                           (5) 
The full comparison between the objective sequence and all the reference sequences 
provides us with a set of similarity measures. The highest grey relational degree 
indicates the most similar sequence to the objective sequence.  
 
6.2.2 Gaussian similarity measure 
 In Gaussian distance Cased-Based Reasoning, the Gaussian distance which is a non-
linear transformation of Euclidean distance is applied to compute the similarity 
between a new case and cases in the case pool. This Gaussian transformation indicates 
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the similarity of the two cases based on each feature. Assuming two cases of 𝐶𝑎 and 
𝐶𝑏 consisting of 𝑘 features, Equation 6 shows the non-linear Gaussian transformation 
between them on each feature: 
𝑔𝑘(𝐶𝑎, 𝐶𝑏) = exp [−(
𝑑𝑘(𝐶𝑎, 𝐶𝑏)
√2 × 𝜎𝑘
)
2
]                                                                                 (6) 
 
Where  𝑔𝑘(𝐶𝑎, 𝐶𝑏) is the Gaussian indicator between two cases on the kth feature, 
𝑑𝑘(𝐶𝑎, 𝐶𝑏) is the distance between the kth feature of cases a and b and is calculated by 
equation 7 and  𝜎𝑘 is the flexure point and is obtained through equation 8.  
𝑑𝑘(𝐶𝑎, 𝐶𝑏) = |𝑐𝑎𝑘 − 𝑐𝑏𝑘|                                                                                                      (7) 
𝜎𝑘 = 𝜎 × (max 𝑐𝑘 −min 𝑐𝑘)                                                                                               (8) 
𝑐𝑎𝑘 and 𝑐𝑏𝑘 are the values of cases a and b over the kth feature and 𝜎 ∈ [0, 1] is the 
parameter of flexure point.  
Finally, the Gaussian similarity measure between cases a and b is obtained by 
integration of the Gaussian indicators based on equation 9. 
𝐺𝑆𝐼𝑀(𝐶𝑎, 𝐶𝑏) = ∑𝑤𝑘
𝑛
𝑘=1
𝑔𝑘(𝐶𝑎, 𝐶𝑏)                                                                                    (9) 
Where 𝑤𝑘 indicates the importance weight for each Gaussian indicator or case feature.  
6.2.3 Genetic algorithm 
Genetic algorithms (GA) are stochastic random search techniques providing us with 
near to optimum solutions for the objective functions of an optimization problem. They 
are part of the heuristic methods which follow the natural pattern of evolution theory 
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and were introduced by Barricelli (271). GA functions as an iterative search method, 
where a new answer is created out of the combination of previously developed answers. 
There are certain terms in GA which refer to different operations and components of 
the methodology. Chromosomes are candidates for solutions and a feasible set of them 
creates a population. In each iteration of GA, each chromosome is evaluated based on 
the objective function value and is accordingly assigned with a survival probability. 
The better the solution provided with the chromosome the higher the survival 
probability assigned to the chromosome. Each of these iterations is called a generation 
and through two operations of cross over and mutation, the next population is 
generated. Selection process through survival probability filters the poor chromosomes 
and increase the probability of participation of fittest members of each generation in 
the next generation.; simultaneously the cross over and mutation guarantee the 
development of new chromosomes avoiding the possibility of GA to be trapped in local 
optima loop (figure 6.1). A typical GA can be executed through the following steps: 
Step 0: Generating the initial population based on the population size fitting the 
problem.  
Step 1: Evaluation of each chromosome by obtaining its objective function value. 
Updating the best solution, maximum or minimum value for objective function 
according to the problem.  
Step 2: Check for the stopping criteria, whether the number of iterations reached a pre-
defined maximum or the threshold for fitness function improvement has not been 
satisfied. If the stopping criteria have been met then stop and return the best value for 
fitness function as the solution.  
Step 3: Define the cross over and mutation process and probability.  
Step 4: Create a new generation of parents based on the survival probability mutation, 
and cross over operations. Go to step 1. 
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Figure 6.1 Genetic Algorithm procedures 
 
GA operations, namely cross over and mutation provide the situation for the birth of 
new chromosomes in each generation. Cross over is being done on two chromosomes 
at the same time and two other chromosomes are being born by the confusion of two 
parent chromosomes. Cross over probability is a defining factor in this operation which 
defines the proportion of newly born children with respect to original population. 
Larger cross over probability allows a wider part of solution space to be searched for a 
solution; however, it may result in a more time-consuming search. A common type of 
cross over being performed by many researchers is traditional random point cross over. 
Assuming there are two parents based on binary coding with 9 genes in each 
chromosome (figure 6.2). A point of cross over is randomly chosen and the two parents 
are separated into two parts from there and these two parts are exchanged among the 
parents two give birth to the new chromosomes. 
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1 0 0 1 1 0 1 1 0 
 
1 1 0 0 0 1 0 0 1 
 
1 0 0 1 1 0 0 0 1 
 
1 1 0 0 0 1 1 1 0 
 
Figure 6.2 Cross Over operation in GA 
Mutation operation causes random flips in the value of some genes and inserts the new 
chromosomes which did not previously exist in the population. The mutation 
probability determines the proportion of mutated chromosomes in respect of the 
original population size. Mutation operation is an effective tool to prevent the problem 
to be trapped in a local optima. The uniform mutation introduced by Michalewicz (272) 
is a common mutation approach applied by many researchers. Assuming a 
chromosome with 9 genes has been chosen for the mutation process. A random number 
Rand in the [1, L] range, in which L is the length of the chromosome, is extracted and 
then the gene associated with that number is exchanged (figure 6.3).  
1 0 0 1 1 0 1 1 0 
 
1 0 0 0 1 0 1 1 0 
 
Figure 6.3 Mutation operation in GA 
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6.3 Problem formulation 
In this chapter, in order to improve the efficiency of the CBR system in extracting a 
better dose plan prescription, firstly a case from the case pool is selected and the 
similarity measures based on GRA and Gaussian distance CBR with the cases in the 
case pool are calculated. Thereafter, through a GA optimization problem, the weights 
for the features involved in calculating the similarity is selected to guide the system 
towards better answers with higher precision. The similarity measures are computed 
with the new feature weights and finally, the final prescription is suggested. The overall 
implementation of the GA in combination with GRA and Gaussian distance CBR 
(figure 6.4).  
 
 
 
 
Figure 6.4 Hybrid GA-GRA, GA-Gaussian CBR approach 
 
The feature weight selection mechanism developed for this research is based on the 
total dose differences of the system. Initially, as the first iteration of the GA, a random 
weight value is assigned to each feature. Then through GRA or Gaussian distance CBR, 
the most similar case to each of the cases in the case pool is extracted and the difference 
between the original dose plan prescribed for the case and the dose plan obtained by 
the system is calculated. The goal of the GA is to minimize the dose difference between 
extracted dose plan and the original dose plan for each case in each iteration. The 
objective function of the GA is defined as equation 10.  
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min𝑓(𝑤1, 𝑤2, ⋯ ,𝑤𝑛) =∑(𝐷𝑜𝑠𝑒𝑖
𝑜,1 + 𝐷𝑜𝑠𝑒𝑖
𝑜,2) − (𝐷𝑜𝑠𝑒𝑖
1 + 𝐷𝑜𝑠𝑒𝑖
2)
𝑚
𝑖=1
                (10) 
Where 𝐷𝑜𝑠𝑒𝑖
𝑜,1
 and 𝐷𝑜𝑠𝑒𝑖
𝑜,2
 are the original dose plan of the case i for phase I and II 
of the treatment respectively. 𝐷𝑜𝑠𝑒𝑖
1 and 𝐷𝑜𝑠𝑒𝑖
2 are the obtained dose plans through 
GRA or Gaussian distance CBR in phase I and II of the treatment respectively and their 
values is a function of (𝑤1, 𝑤2, ⋯ , 𝑤𝑛) i.e. the weights for each feature of the CBR. 
The total number of cases in the case pool is m.  
6.4 Results 
In order to demonstrate the efficiency of the proposed methodology, it has been applied 
on a real dataset from the Nottingham University Hospital. To find the similarity 
measures among a new case and cases in the case pool 14 features have been applied 
i.e. fuzzy memberships of low, medium and high regarding the Prostate Specific 
Antigen (PSA) and Gleason Score, which consists in total 6 of features, the DVH levels 
in the first and second phase of the treatment for 66%, 50%, 25% and 10% of the 
rectum which create the rest of the 8 features of the CBR problem. A detailed 
explanation of each of the features can be found in chapter 3 section 4. The GA 
procedure has been performed by MATLAB Global Optimization Toolbox GA 
function on a core i7 3.2 GHz CPU. The efficacy has been measured by leave-one-out 
strategy in which after calculation of the features weight, a case is being chosen as a 
new case out of the case base. Then after, the chosen case for the new case based on 
the similarity measure is being evaluated regarding its dose plan to investigate the 
succession of the case extraction. The flowchart of the leave-one-out strategy further 
illustrates the success rate calculation (figure 6.5).  
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Figure 6.5 Success rate calculation flowchart 
 
There are 69 cases in the database and the experiment has been carried out for all the 
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a. The dose plan does not violate the recommended standard dose limit received 
by each volume of the rectum 
b. The total dose plan in phase I and II of the treatment is higher or equal to the 
dose plan originally prescribed by the oncologists. 
c. In situations where the obtained total dose plan is equal to the original dose 
plan, obtained dose plan in Phase I of the treatment has to be equal or higher 
than the original dose plan in phase I of the treatment.  
Firstly, we have obtained the success rate for each of the FRA and Gaussian distance 
CBR with equal weights for each feature (table 6.1).  
Table 6.1 Success rate of the approaches with equal weights for features 
CBR approach Simple CBR GRA Gaussian CBR 
Success Rate (%) 73.43 78.26 79.71 
 
As can be seen the application of GRA and Gaussian distance CBR even without any 
weight selection of the features have improved the results in comparison to Simple 
CBR by use of Euclidean distance. Through applying GRA, dose plan prescription for 
54 out of 69 cases have been done successfully. By applying Gaussian distance CBR, 
the number of successfully predicted dose plans has been increased to 55 out 69 cases.  
The GA with 14 variables, 𝑤1, 𝑤2, ⋯ , 𝑤14 has been implemented by MATLAB 17a 
version. The initial number of chromosomes in each generation has been chosen as 20 
and the stopping criterion has been chosen as if there was no significant improvement 
in dose difference of the current generation and the previous generation, i.e. 10 for this 
threshold or the running time exceeds 6 hours. The initial starting point for the GA has 
been selected as equal weights for all the features i.e. 1/14 (~0.071). The following 
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weights have been selected as the weight features for each of the GRA and Gaussian 
distance CBR approaches (table 6.2).  
Table 6.2 Features weights obtained by GA 
Feature 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14 
GRA 0.055 0.035 0.052 0.056 0.059 0.057 0.087 0.05 0.035 0.092 0.02 0.071 0.277 0.056 
Gaussian 0.022 0.034 0.035 0.028 0.102 0.043 0.03 0.032 0.032 0.052 0.021 0.03 0.039 0.03 
 
𝐹𝑘 shows each feature of the problem. PSA membership functions of low, medium and 
high are indexed with k = 1,2,3; Gleason Score membership functions of low, medium 
and high are indexed with k = 4,5,6; The DVH values in the first and second phase of 
the treatment for 66%, 50%, 25% and 10% of the rectum are indexed with k = 7,8,9,10 
and k =11,12,13,14 respectively.  
Using the features’ weights calculated by the GA to compute the success rate of the 
GRA and Gaussian distance CBR has resulted in new success rates (table 6.3).  
Table 6.3 Success rate of the approaches with optimal feature weights 
CBR approach GRA Gaussian CBR 
Average similarity of GRA 
and Gaussian CBR 
Success Rate (%) 81.15 82.6 82.6 
   
Applying the feature weight selection mechanism has improved the results of both the 
CBR approaches and their combination.  The average similarity measure for a case 
obtained from two approaches has been calculated and based on the most similar case 
the dose plan was assigned to the test case. However, as can be seen the number of 
successful cases has been similar to Gaussian distance CBR approach.  
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6.5 Conclusion 
In this chapter, an approach based on GRA and Gaussian distance CBR has been 
developed to help a better case extraction by applying methods which can result in 
higher precision similarity measures in presence of high number of features for CBR 
and the non-linear relationships among the parameters of the problem. Additionally, to 
make the problem more similar to a real-life scenario, different features of the CBR 
problem have been assigned an importance weight for each of the similarity measuring 
techniques of GRA and Gaussian CBR. In order to avoid the objective weight 
assignment by the decision makers, medical planning team, and enabling the system to 
update the feature weights based on the existing cases in the case pool a GA weight 
selection mechanism has been proposed. The leave-one-out strategy has been applied 
on a real data set of the successful prostate cancer cases treated by radiotherapy to 
measure the success rate of the proposed approaches. Firstly, the results for GRA and 
Gaussian distance CBR has been carried out with equal weights of the features. The 
results showed a significant improvement in comparison with Euclidian distance based 
CBR. Furthermore, the GA features weight assigning mechanism has been adapted to 
the problem and the success rates have been calculated based on the weighted features. 
Both of the new CBR approaches showed a better performance in integration with GA 
and newly obtained weights in the prescription of the successful dose plans. However, 
the performance of the Gaussian distance CBR was slightly superior to GRA. Finally, 
the average similarity measures of both approaches have been tested and the efficiency 
of this approach has shown more promising performance compared to GRA. The 
results clarify the advantages of a hybrid approach of GA with GRA and Gaussian 
CBR in providing a better platform for measuring the similarity between the cases and 
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performing CBR in order to achieve better solutions for radiotherapy dose planning 
problem.   
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Chapter 7  
7.1 Conclusion  
The problem of radiotherapy dose planning involves intricacies and significant 
complexities, which make it hard to define. A common approach for most oncologists 
is to rely on radiotherapy planning software to generate an initial dose plan for 
treatment. These software applications require a considerable amount of information 
from different teams of radiotherapy departments to generate a useful output. However, 
while the plans created by software may seem clinically acceptable, in practice they 
often fail. Moreover, different software may generate different plans which are far too 
distant from each other (273); thus, software credibility is questionable. In some cases, 
even the proposed solutions are not acceptable by oncologists due to errors in satisfying 
their expectations, i.e. prescribing a low dose to respect OARs, while violating dose 
limit in that case seems necessary to oncologists due to exceptional situation of the 
patient, or otherwise, prescribing a high dose resulting in a hazardous situation for the 
patient. Large solution space of the problem, different clinical and environmental 
conditions of the patients and necessity of trade-offs between risks and benefits of the 
high radiation in exceptional circumstances are among the factors contributing to the 
failure of software generated plans.  
144 
 
In real life scenarios, the oncologists make trade-offs between the risks of a high 
radiative dose plan and the benefits it may cause to effectively eradicate the cancerous 
cells. Therefore, sometimes the oncologists prescribe a high dose plan, which can even 
be harmful to other surrounding sensitive organs, such as the rectum in case of the 
prostate cancer, in order to fight cancer which can be fatal to the patient. This 
compromising balance among the unavoidable risks is based on oncologists’ 
experiences and cannot be formulated by any mathematical model or operational 
research technique. There is no common rule about the violation of dose limits in 
different volumes of the rectum or other surrounding organs. Thus, there is a good 
chance that subjective decisions of different oncologists also lead to distinctive plans 
of treatment even about the same patient. Furthermore, various oncologists may 
consider different weights to different attributes related to clinical and operational 
factors and this can make the reliable formulation of the radiotherapy dose planning 
problem even more complicated. Moreover, while oncologists take into account 
different factors related to operational and clinical criteria of the problem, their 
judgments about the values of the criteria are not crisp, fixed or certain. There is a 
certain ambiguity within all human judgment and to follow their true judgment, their 
perception of a value may be better categorized into a range definable with qualitative 
words. Grasping the experiences of oncologists dealing with judgment uncertainty is 
one more problem that needs to be addressed. 
Taking into consideration the aforementioned complexities and obstacles, a number of 
research objectives have been defined in this thesis and throughout the chapters of this 
research, an effort has been made to accomplish the research objectives. Achieving the 
defined research objectives can assist oncologists to develop the quality of decisions 
they are making regarding dose planning and deal with complexities and obstacles.  
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Investigating the radiotherapy treatment planning problem as well as reviewing the 
state-of-the-art literature of radiotherapy dose planning with a particular focus on 
operational researches approaches have been considered as the first objective of this 
thesis. To achieve this objective, we proceeded to review the radiotherapy planning 
problem and related research works with operational research background. This 
provided us with a valuable understanding of the problem, the critical features and 
parameters involved and the gaps in the previously done researches.  
Firstly, an overview of the importance of cancer and its fatality rate both globally and 
in the UK through recent statistical data has been provided to emphasize the 
significance of this research. After that, the treatment options have been explained and 
out of treatment options, the different types of radiotherapy have been introduced. The 
process of the radiotherapy treatment and different steps necessary for radiotherapy 
have been described further. Moreover, a comprehensive literature review of the 
studies based on the type of the problem they focused on and problem description has 
been presented. Finally, a review of the operational research methodologies which has 
been applied throughout the literature based on the main problem of their focus has 
been provided. The operational research methodologies have been divided into two 
categories optimization techniques and knowledge-based approaches to better 
distinguish the application of different methodologies.  
Exploring the decision-making principles based on which oncologists decide in real-
life scenarios and multi-criteria nature of the problem and incorporate them in a 
Decision Support System (DSS) to assists oncologists with their decisions has been 
introduced as the second objective of this thesis. Cased-Based Reasoning, a 
knowledge-based approach which can apply the previous experiences of the 
oncologists to solve the complex problem of the radiotherapy dose planning has been 
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selected to prescribe the dose plans. In chapter 3, the problem parameters are used to 
find the most similar case to a new case and then the dose plan of the exploited case is 
suggested as the final solution. However, in real-life scenarios, the similarity between 
two cases cannot be the only determining factor in matching two cases. In order to 
include other contributing factors, which are taken into account by oncologists in real 
life, an evaluation process based on TOPSIS has been designed to assess the most 
similar cases with respect to the multiple criteria and obtained the dose plan of the most 
appropriate case for the new case.  
In chapter 5, to improve the evaluation process of the treatment alternatives (cases in 
the case pool), the contributing criteria have been divided into two categories of inputs 
and outputs and DEA has been applied to obtain the efficiency of each of the 
alternatives. Furthermore, in DEA, in addition to criteria that were used in TOPSIS, 
the success rate of the treatment has been considered among the outputs to improve the 
assessment. Chapter 6, provides a better base for calculating the similarity measures 
and case extraction by testing different similarity measures. Two similarity measures 
of GRA and Gaussian distance have been introduced in this chapter to incorporate the 
non-linear relation between different parameters of the problem and enhancing the 
calculation of similarity in presence of a large number of criteria.  
Designing a mathematical programming model which is capable of directing the final 
doses towards optimal dose plans considered by oncologists and increase the efficiency 
of the dose plans while simultaneously looking after the risks of the treatment was 
considered as the fourth objective of this research. Thus, to optimize the final solutions 
generated by TOPSIS-CBR, a Goal Programming mathematical model has been 
proposed in chapter 4 of this thesis. The aim of the GP model is to optimize the final 
dose plan towards the ideal goal of the oncologists by considering the DVH level 
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associated with each volume of the rectum. The objective function of this GP model is 
to reduce the difference between each prescribed dose and the oncologists’ ideal goals 
and the constraint are in charge of considering the dose received by different volumes 
of the rectum based on DVH levels. At the same time, a rule-based process in assigning 
the right-hand side of the constraint was accommodated to consider the necessity of 
violating the standard limitations when it is vital to eradicate cancer effectively. This 
rule-based approach is also making the problem more similar to the real-life decision-
making process of oncologists and is a contributor to second objective research.  
In order to achieve the fourth research objective, incorporating the existing 
uncertainties in oncologists’ judgments about the values of different criteria and factors 
in dose planning, in chapter 5 we presented grey DEA. In this chapter and evaluation 
process, the values for inputs and outputs have been considered as grey numbers to 
better cover the uncertainty of the oncologists’ judgments regarding the crisp values to 
make the problem closer to real-life decision-making process. FA based on principal 
components have been applied to reduce the number of attributes for inputs and outputs 
and assist with the better performance of grey interval DEA. 
The fifth research objective of the thesis is to develop a mechanism to assign optimal 
non-objective importance weight to each feature of the radiotherapy dose planning 
problem. The importance of different features of the CBR can be assigned based on 
oncologists’ opinions, however, this would be objective as it depends on the singular 
preference of oncologists. Also, the opinions of the oncologists change throughout the 
time with gaining new experiences. To add the automatic capability of features weight 
assignment to our dose planning prescriptions, an optimal weight calculation model 
has been developed in chapter 6. The optimal weight for each feature is being 
calculated through GA and minimization of a dose difference function as the fitness 
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function for the GA. Thus, every time a case is added to the case pool, the optimal 
weights of each feature is calculated so that the total dose difference between the 
prescribed doses for each case and the original doses in the case pool is minimized.  
The success rate of the approaches throughout the whole process has been examined 
with a strategy called leave-one-out. In this strategy every time one case is selected 
from the case pool and is treated as a new case. After calculation of the dose plan for 
the case, a comparison has been made between the obtained and original dose plan and 
after performing this strategy for all the cases in the pool, the total success rate of the 
approach has determined. The results for approaches that were applied based on 
different necessities have shown better coherence with the oncologists’ original dose 
plans compared to simple CBR, confirming in this way the effectiveness and 
robustness of the proposed methods.  
7.2 Contributions 
The contributions of this research can be divided into two categories of theoretical 
implications or methodological contributions and practical implication or contributions 
to practice.  
Decision making is a necessary procedure which plays a significant practical role in 
many areas of human activities. There are basic principles and methodologies 
developed in this thesis, the application of which can solve real-world problems and 
assist with making decisions in other domains rather than radiotherapy dose planning 
problem as demonstrated in this thesis. These can be considered as theoretical 
implications.  
1- PCA and FA are two useful means of variable or dimension reduction with 
minimum loss of information and thus are very popular where the problem at 
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hand consists of multiple dimensions or the complexity of the system under 
investigation is extremely high. The application of PCA and FA is not limited 
to MCDM techniques and is extended to other operational research and 
statistical approaches. Also, the grey numbers are widely used in dealing with 
uncertainty and interval-valued parameters. Thus, the presented PCA and FA 
for grey numbers can be helpful to reduce complexity and dimensions essential 
to providing acceptable inputs to continue with other methods.  
2- DEA is a well-known method to measure the efficiency of multiple units with 
consideration of several inputs and outputs at the same time without 
considering the distribution of the data. The integrated FA-DEA approach 
proposed in this thesis is generic in nature and is able to increase the accuracy 
and discrimination ability of DEA regarding the efficiency measuring problems 
in presence of interval data type and high numbers of inputs and outputs in 
comparison to the number of decision-making units. Following the detailed 
procedural steps provided and the normalization nuances, the approach is 
generalizable to other domains.  
3- Successful application of CBR with TOPSIS shows the promising benefits of 
this approach, which can be further, applied in other research with knowledge-
based methods. Although the criteria and decision makers’ opinions about each 
criterion’s importance should be modified and utilized depending on the target 
domain.    
Throughout this thesis, a number of contributions to improve the efficiency of the dose 
plan prescriptions for radiotherapy dose planning have been made. Following the 
practical implications of this thesis is listed.  
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1-  An extensive literature review on radiotherapy and dose planning stage of the 
radiotherapy has been represented. An overview of the radiotherapy treatment 
approaches, problem features, crucial barriers in the treatment planning and 
essential constraints for radiotherapy have been discussed. Moreover, the 
operational research techniques and mathematical applied model have been 
investigated and the application of them as well as a knowledge-based model, 
in particular, CBR, within different phases and problems of radiotherapy 
planning have been provided.  
2- Through a combination of a number of MCDM techniques such as TOPSIS and 
DEA, the multi-criteria nature of the problem has been considered in this thesis.  
In previous researches where CBR was used to prescribe the dose plans in 
radiotherapy, it was only based on a similarity measure between different cases. 
While in real life scenarios, the oncologists’ decisions depend on many other 
factors. Relying only on similarity measure can result in loss of information 
that can be provided by other cases with lower similarity measure but more 
appropriate for the problem at hand. By application of TOPSIS in combination 
with CBR, the risks of each treatment and the amount of dose plans in addition 
to the similarity between two cases have been considered. To improve the 
evaluations by TOPSIS, DEA was applied to assess the efficiency of prescribed 
cases based on an input-output approach and be able to better utilize the success 
rate of the previously done treatments.   
3- Investigation and testing multiple types of similarity measures which have not 
been applied in radiotherapy planning is among the practical contributions of 
this research. The Euclidean similarity measure that has been applied in 
previous research has some main problems. Being independent of the data 
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distribution, weak performance in presence of multiple dimensions and 
inability to adapt the non-linear relation among different features of the 
problem can lead to non-satisfactory results. To improve the similarity measure 
calculation, GRA and Gaussian distance CBR have been applied in this thesis 
and the singular and combinatorial performances of them have achieved a 
higher success rate than simple Euclidean CBR. 
4- In real life scenarios, the importance weight for each feature of the problem, 
i.e. clinical features regarding finding similarity measures, is assigned based on 
experience and preference of the decision makers, i.e. oncologists. Different 
oncologists might have varying opinions about the significance of various 
features and consider their preference may result in subjective weight assigning 
of the features that can affect the success rate and coherence of the dose 
planning. In this thesis, an automatic weight assigning strategy based on GA 
and minimization of a total dose difference function has been proposed. The 
robustness and effectiveness of the proposed algorithm have been demonstrated 
through a success rate calculation test.  
5- The dose plans obtained based on the original prescription of the oncologists 
may not be the optimal dose plan. There are situations when the dose plan can 
be increased without compromising the safe limits for different percentages of 
the rectum. Also in some exceptional situations, the oncologists overlook the 
dose limit, do a trade-off between risks of the treatment and the benefits of 
deviating the sensitive limits by applying higher than standard doses to kill the 
cancerous cells effectively. To generalize the two aforementioned points into 
the dose plan suggestion and optimize the dose plans towards the preferable 
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dose goals suggested by oncologists. The developed GP model optimises the 
CBR-TOPSIS dose plans.  
 
7.3 Limitations 
While the performance of the developed approaches has been evaluated successfully 
and the practical, as well as methodological contributions, have been explained, like 
any other researches this PhD has certain limitations.  
In the calculation of the similarity between two cases a set of clinical parameters 
including the PSA values, Gleason score and DVH values of different volumes of the 
rectum. However, the general condition of the patient e.g. age, fitness level and other 
physical characteristics could influence the decision-making process of the medical 
planning team. Given the availability of the aforementioned parameters in the dataset 
and by developing approaches to consider and properly incorporating them into the 
problem, the precision of results can be improved. Due to current lack of availability 
of these parameters in the accessible dataset, this has not happened for this thesis.  
The success of the approaches has been evaluated based on the final obtained doses 
and whether those were coherent or provided a better dose plan compared to the 
original dose plan prescribed by the oncologists. The research at current stage suffers 
from the fact that there is no ascertained method of determining the quality of a dose 
plan in the literature.  
The variety of the dose plans in the dataset is not very high and in some occasions, the 
most similar cases to the new case did not have adequate similarity measure; thus, some 
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cases had to be omitted completely. A larger dataset with more cases and variety of 
dose plans may lead to better results in terms of reliability and practical success rate.  
7.4 Future research work 
The novel hybrid approaches to support oncologists’ decisions on dose planning for 
radiotherapy presented in this thesis have shown robustness and effectiveness through 
computational experiments. Moreover, the research done in this thesis provides an 
appropriate context for further extension. In this section will follow suggestions for 
future quality improvements and directions to better fill the gaps.  
Incorporation of more clinically related features, such as age, fitness level and physical 
attributes of the patient as well as information on additional radiation effects on other 
sensitive surrounding organs rather than just the rectum can lead to a better similarity 
measure calculation and better experience on retrieval process. The availability of data 
on mentioned features and attributes makes the problem more similar to a real-life 
scenario where oncologists take into account more aspects of the problem.  
The performance of the approaches with regards to larger datasets should be examined. 
Larger datasets with more cases can provide a better variety of the cases. In addition, 
integration of the datasets collected from different treatment centres can increase the 
flow of experiences by different oncologists into the system and lead to a more global 
decision support system. However, the increase in the number of the cases can result 
in an increase in required time for computational operations. In particular, for the 
feature weights operation done by GA, this problem can be more serious due to high 
time-consuming nature of the operation. In order to solve the problems associated with 
larger data sets, feature selection and feature categorization as well as case 
classification approaches to divide and restrict the solution space can be introduced to 
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the problem. Also, a research on more effective and faster-converging heuristics to 
reduce the computational time and effort can be an important direction for further 
research. 
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Appendix 1: Medical terminology 
 
Biopsy: Is a medical procedure in which a small sample of 
body tissue is taken out for further tests. 
 
CT scan: Also called as CAT scan, Computed Axial 
Tomography, is a technology that utilized two-
dimensional images to build three-dimensional 
images that shows inside a body part in medical 
imaging.  
 
Fluence: The fluence of a beam is the number of photons that 
enter to an imaginary sphere with a cross-sectional 
area of A in m2. 
 
Gastrointestinal: Any issues related to stomach and digesting organs. 
 
Gray (Gy): The unit for radiation dose which is expressed in 
terms of absorbed energy per unit of tissue mass in 
international system (SI). i.e. 1 Gy is 1 joule per 
kilogram. 
 
Gynecologic malignancies: Cancers related to female reproductive systems such 
as ovarian cancer, uterine cancer, vaginal cancer, 
cervical cancer, and vulvar cancer. 
 
Isodose: Isodose curves are the lines joining the points of equal 
Percentage Depth Dose (PDD). The curves are 
usually drawn at regular intervals of absorbed dose 
and expressed as a percentage of the dose at a 
reference point (274). 
 
Multi-leaf collimators: Is an important part of equipment for a radiotherapy 
dose delivery system that is consisted of individual 
leaves made of a material with high atomic numbers 
e.g. tungsten. These leaves can move independently 
and block the radiation.  
 
MRI: Magnetic Resonance Imaging, an imaging 
technology in radiology which uses radio waves and 
magnetic fields to form pictures of healthy and 
diseased body parts.  
 
Pediatric malignancies: Cancers related to infants and children.  
 
Sarcomas: 
 
Is cancer that arises from transformed cells of 
mesenchymal origin i.e. bone, fat, muscle and 
vascular cells.  
 
156 
 
Therapeutic ratio: 
 
Is the ratio of therapeutic agents that causes the 
beneficial effects in a treatment to the amount that 
causes toxicity.   
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